Molecular regulation of fibrinogen and albumin synthesis during the acute phase response: a study on possible mediators of the acute phase response by Moshage, A.J.
Han Moshage 
MOLECULAR REGULATION OF 
FIBRINOGEN AND ALBUMIN 
SYNTHESIS DURING THE 
ACUTE PHASE RESPONSE 
A study on possible mediators 
of the acute phase response 

MOLECULAR REGULATION OF FIBRINOGEN AND ALBUMIN 
SYNTHESIS DURING THE ACUTE PHASE RESPONSE. 
A study on possible mediators of the acute phase response 

MOLECULAR REGULATION OF FIBRINOGEN AND ALBUMIN 
SYNTHESIS DURING THE ACUTE PHASE RESPONSE. 
A study on possible mediators of the acute phase response 
PROEFSCHRIFT 
ter verkrijging van de graad van doctor 
in de wiskunde en natuurwetenschappen 
aan de Katholieke Universiteit te Nijmegen 
op gezag van de Rector Magnificus 
Prof.Dr.B.M.F. van lersel 
volgens besluit van het College van Decanen 
in het openbaar te verdedigen 
op donderdag 26 november 1987 
des namiddags te 4 uur precies. 
door 
ALBERT JOHANNES MOSHAGE 
geboren te Goor 
Promotor: Prof.Dr.H. Bloemendal 
Co-referent: Dr.S.H. Yap 
Dankwoord 
Dit proefschrift kent slechts één auteur, hoewel de totstandkoming er-
van het werk van velen is geweest. Allen die een bijdrage hebben ge-
leverd wil ik hartelijk danken: 
Jos Kleuskens, Hennie Roelofs en Hans de Haard, die met nimmer afla-
tend enthousiasme en nauwgezetheid een grool deel van de experimenten 
hebben uitgevoerd; 
Joop Janssen, Jan-Huib Franssen, Jos van Pelt en Bernhard Kleter, die 
in het kader van hun wetenschappelijke stages belangrijke bijdragen 
hebben geleverd; 
Jos Rijntjes, José Holtslag, Hans Pnncen en alle andere (ex-)colle-
ga's van het laboratorium voor maag-, darm- en leverziekten voor de 
uitstekende samenwerking, suggesties en adviezen; 
Paul van Gemert van de afdeling Toxicologie voor het inwijden in de 
techniek van de hepatocyten isolaties; 
Aart Plas van het laboratorium voor Bloedziekten voor de assistentie 
bij de isolaties van Kupffer cellen; 
Wiljan Hendriks en Jack Schalken van de afdeling Biochemie (W 4 N) 
voor de hulp bij het opzetten van de in vitro transcriptietechniek; 
Robert Polenewen van het laboratorium voor Bloedziekten voor de plasma 
f ibnnogeenbepal ingen; 
de heer Hafkenscheid en Bea Köhler van het Klinisch Chemisch Laborato-
rium voor de bereidwilligheid bij de bepalingen van leverenzymen; 
Piet Spaan en Hendrik-Jan Janssen van het Centraal Dierenlaboratorium 
voor de assistentie bij het uitvoeren van de dierexperimenten; 
de heer Nicolasen en de heer van Uden van de afdeling Medische Illu-
stratie voor het vervaardigen van de figuren voor dit proefschrift; 
Tine Reintjes voor het snelle en accurate typewerk. 
Een speciaal woord van dank en waardering voor het 'lever-team': Paul 
van Gemert, Hennie Roelofs, Jos Rijntjes, Jos van Pelt, William 
Leenders en Ivo van Munster voor de vele gezellige, vruchtbare en vaak 
nachtelijke uurtjes. 
Alle vrienden en familie voor de morele ondersteuning en in het bij-
zonder mijn huisgenoten Onno en Renate voor hun steun en geduld. 
The investigations described in this thesis were carried out under the 
auspices of the Netherlands Foundation for Medical Research (MFDIGON) 
with financial support from The Netherlands Organization for the 
Advancement of Pure Research (ZWO) and performed under the direction 
of Dr. S.H. Yap at the Division of Gastrointestinal and Liver Diseases 
(head: Dr. J.H.M. van Tongeren), Department of Medicine, St. Radboud 
University Hospital, Nijmegen, The Netherlands. 
CONTENTS 
CHAPTER 
CHAPTER 
I 
1.1 
1.2 
1.3 
HA 
Introduction 
The acute phase response 
Interleukin-1 
Aim of the study 
The influence of glucocorticoid on the fibri­
nogen messenger RNA content of rat liver in 
vivo and in hepatocyte suspension culture 
1 
2 
θ 
17 
2Θ 
CHAPTER IIB The influence of glucocort icoid on albumin 
synthesis and i t s messenger RNA in rat in 
vivo and in hepatocyte suspension culture 
36 
CHAPTER III Fibrinogen fragments X,Y.D and E increase 
levels of plasma fibrinogen and liver mRNAs 
coding for fibrinogen Polypeptides in rats 
CHAPTER IVA Influence of monocytic (macrophagic) products 
and interleukin-1 on fibrinogen synthesis and 
its messenger RNAs in rat and in primary cul­
tures of hepatocytes 
44 
49 
CHAPTER IVB Study of the molecular mechanism of decreased 
liver aynthesis of albumin in inflammation 
71 
CHAPTER IVC Primary culture of adult human hepatocytes on 
homologous extracellular matrix: influence of 
monocytic products on albumin synthesis 
79 
CHAPTER IVD Prostaglandins E2 and F2a are not involved 
i n the monocytic product ( inter leukin-1) i n ­
duced hepatic fibrinogen synthesis in rats 
103 
CHAPTER V Transcriptional regulation of fibrinogen and al­
bumin synthesis during the acute phase response 
121 
SUMMARY 
SAMENVATTING 
CURRICULUM VITAE 
133 
137 
141 
LIST OF PUBLICATIONS 142 

CHAPTER I 
INTRODUCTION 
Introduction. 
1.1. The acute phase response. 
Under normal circumstances, maintenance of physiologic homeostasis in 
man (or mammals) is guaranteed by a number of mechanisms. However, 
deviations of this stable situation may occur which impose a serious 
threat to the health of the organism. The organism responds to these 
challenges, such as tissue injury and infection, by a coordinated se­
quence of systemic and metabolic changes, collectively known as the 
acute phase response (APR) and local changes as inflammatory reac­
tions, to restore homeostasis and to remove the cause of the deviation 
(1). As stated by Sir John Burden-Sanderson in 1ЙВ : "The process of 
inflammation is the succession of changes which occurs in a living 
tissue when it is injured, provided that the injury is not of such a 
degree as at once to destroy its structure and vitality" (2). 
The characteristic clinical symptoms of the local response (inflamma­
tion) of tissue injury, first documented by the Roman historian Celsus 
in the first century, include redness (rubor), swelling (tumor), heat 
(calor) and pain (dolor), later expanded by Virchow to include loss of 
function (functio laesa). The systemic changes or acute phate respon­
se, comprise a number of metabolic changes occurring within hours to 
days after the challenge. As an exhaustive inventory of all these 
systemic and metabolic changes involved in the APR is beyond the scope 
of this introduction, only the most important phenomena will be pre­
sented below. 
1. Fever. One of the first discernable phenomena of the APR is fever. 
It has been shown that fever is caused by the action of prostaglan­
dins, notably those belonging to the E-senes, in the nuclei preoptica 
of the anterior hypothalamus, where they act by increasing the thermo­
static setpoint of the thermoregulatory center (3,4). Prostaglandin 
release in the hypothalamus is mediated by the action of endogenous 
pyrogen, resulting in the liberation of arachidomc acid from membrane 
phospholipids and the subseguent conversion of arachidomc acid into 
prostaglandins via the cyclo-oxygenase pathway (4,5,6). 
2. Neutrophilia. An increased number of circulating peripheral neutro­
phils is usually one of the hallmarks of the APR as a conseguence of 
the accelerated release of neutrophils from the bone-marrow reserves 
(7,8''. It has been shown that endogenous pyrogen is responsible for 
the neutrophilia observed during the APR and identical to the earlier 
reported leukocytosis-inducing factor (LIF), a soluble factor present 
in plasma of animals or humans during (experimental) inflammation 
'9,10). It should be noted that the neutrophilia associated with in­
flammation is distinct, both in magnitude and duration, from the neu­
trophilia induced by stress or adrenal hormones. 
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3. Endocrine changes. Plasma levels of the hormones glucagon, insulin, 
ACTH, growth hormone, (nor)adrenaline, TSH (thyroid stimulating hor­
mone), Тз (tri-iodotyrosine), Тц (thyroxine), aldosterone and vaso­
pressin are all found to be increased during the APR (11,12), although 
it has yet to be elucidated to what extent these endocrine changes 
actually contribute to other phenomena of the APR. 
u. Increased protein catabolism in skeletal muscle, accompanied by a 
negative nitrogen balance is another common finding during the acute 
phase response (11,13,14). Plasma levels of phenylalanine and trypto­
phan are increased as a conseguence of their inability to be used as 
energy source in skeletal muscle. In contrast, the release of bran-
ched-chain amino acids from skeletal muscle is relatively low, due to 
the utilization of these amino acids in skeletal muscle (15.) 
5. Lipid metabolism. Changes in plasma concentrations of triglyceri­
des, free fatty acids, ketone bodies and VLOL have been found to vary 
and apoeared to be dependent on factors such as the infectious agent 
and the degree and duration of the illness (16,17). In some instances, 
a reduced lipoprotein lipase activity has been observed (18). 
6. Serum cation concentrations. During the APR the serum concentration 
of copper is increased as the result of an increased concentration of 
the copper-binding plasma protein ceruloplasmin (19), whereas serum 
concentrations of zinc and iron are decreased. The hypozincaemia is 
most likely due to an increased synthesis of the zinc-binding protein 
metallothionein (20). Hypoferraemia is the result of a transfer of 
iron from plasma, where it is bound to transferrin, to tissue where it 
is bound to ferritin, a process in which lactofernn might be involved 
(21,22,23). In this regard, it is interesting to note that synthesis 
of the intracellular iron-storing protein ferritin is increased after 
tissue injury (24). 
7. Immunosuppression has been described in patients after major trau­
mata (surgery, accidents, burns) as well as in various malignant sta­
tes.Cell mediated immunity has also been reported to be reduced (25). 
8. In the liver, metabolic changes and reorganization of intracellular 
structure can be observed during the APR: gluconeogenesia and synthe­
sis of RNA and protein are all markedly increased (26,27,28), whereas 
the intracellular rearrangements are prepared for enhanced synthesis, 
transport, processing (glycosylation) and secretion of protein (see 
1.2.). 
1.2. The acute phase response and the liver. 
During the APR, metabolic changes and ultrastructural rearrangements 
take place in the liver. In general, the ultrastructural reorganiza­
tion in liver cells can be described as an adaptation to an increased 
synthesis, processing and secretion of proteins: in the hepatocyte 
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nucleus, an increased ava i lab i l i t y of chromatin template (29) and i n -
creased synthesis of RNA, in part icular nbosomal RNA (30), have been 
reported. In the cytoplasm increased formation of microtubules, espe-
c i a l l y in the sinusoidal and Golgi-regions have been observed (31,32). 
Synthesis of smooth endoplasmic reticulum (33), p ro l i fe ra t ion of mem-
branes of the Golgi complex, in part icular in the cisternae (29,34) 
with an associated increase in Golgi glycosyltransferases (33) and he-
patocyte plasma membrane synthesis (35) are a l l increased during the 
APR. Degradati ve processes in hepatocytes appear to be depressed as 
indicated by a reduced peroxysomal content of hepatocytes and a de-
creased concentration of peroxysomal catalase (36). In accordance with 
the u l t ras t ruc tura l adaptation of l i ver ce l ls to an increased synthe-
s i s , processing and secretion of proteins the ac t i v i t i es of a number 
of enzymes involved in glycosylation of proteins are increased, i n c l u -
ding s i a l y l - , galactosyl - , N-acetylglucosaminyltransferase (33,37), 
L-glutamineiD-fructose-é-PO^-aminotransferase (38) and UDP-N-acetyl-
glucosamine-2'epimerase (39). In addit ion, ac t i v i t i es of several other 
enzymes in the l i ver are also increased: hydroxymethylglutaryl-CoA-
reductase, involved in steroid synthesis, NADH-cytochrome c-reductase, 
tyrosine aminotransferase and tryptophan oxygenase (11,37). The la t te r 
three enzymes may be involved in the supply of fuel for the increased 
metabolic ac t i v i t y of the l iver during the APR. Decreased enzyme a c t i -
v i t i e s in rat l i v e r , following endotoxin administration have been re-
ported for phosphoenolpyruvate carboxykinase (40) and glucose-6-
phosphatase (37), enzymes involved in gluconeogenesis and the endo-
plasmic reticulum associated enzymes 5'-nucleotidase, NADPH-cytochrome 
c-reductase and nonspecific esterase. Furthermore i t has been reported 
that endotoxin administration inh ib i t s the ac t i v i t y of the Na+-K+-
ATPase pump (41). 
In the organism, adaptation of l i ver cel ls to an enhanced synthesis 
and secretion of proteins during the acute phase response, manifests 
i t s e l f by character ist ic changes in plasma protein concentrations. 
These changes comprise the appearance or substantial increase in con-
centration of a large number of proteins, co l lect ive ly known as the 
acute phase proteins. The acute phase proteins are synthesized exclu-
sively in the l i ver and are mostly glycosylated (26). They can be 
c lass i f ied into three groups, depending on the magnitude of their r ise 
in plasma concentration during the APR (26). 
1. Plasma concentration increases about SOS 
ceruloplasmin 
C3 (complement factor 3) 
2^ . Plasma concentration increases severalfold (200Чо-400А) 
d^-acid glycoprotein (orosomucoid) 
щ-antitrypsin 
<4 -ant ichymotrypsin 
- 4 -
i^-roacrofetoprotein (in rat) 
fibrinogen 
haptoglobin 
З^. Plasma concentration increases several hundredfold, or normally not 
detectable in plasma 
C-reactive protein (CRP) 
Serum amyloid A protein (SAA) 
In addition to these well-stuoieo and characterized (26) acute phase 
proteins, several other proteins have been reported to behave as acute 
phase proteins, including the complement factors C2, Сц and Cg, factor 
В (42-45), plasma ferritin (46,47), angiotensinoqen (4B), fibronectin 
(49) and hemopexin (50,51). In contrast to these acute phase proteins, 
plasma concentrations of a relatively small number of proteins are 
found to be reduced during the APR: albumin, transferrin, liver cata-
lase, Cholinesterase, immunoqlobulin-G and prealbumin (50,51,52). It 
should be emphasized that none of the acute phase proteins mentioned 
above is specifically associated with a particular type of trauma, 
tissue injury or infection. Furthermore, although the acute phase pro­
teins can be classified into three groups according to the magnitude 
of their response, the rapidity of rise varies considerably for the 
various acute phase proteins (53). 
The exact biological significance of the acute phase proteins is not 
yet completely understood. However, some interesting speculation about 
their function has been made and will be discussed below. 
Ceruloplasmin is essential for the transport of copper and may play an 
important role in the supply of copper to cytochrome oxydase, an enzy­
me participating in the respiratory chain (26). Furthermore, it con­
tains oxidase activity and may be involved in the oxidation and inac-
tivation of specific bioactive amines (26). Finally, it has been re­
ported that ceruloplasmin is able to oxidize Fe + to Fe +, facili­
tating the binding of iron to apotransfernn (26). 
Complement factor 3 (C3) is involved in the lysis of antibody-coated 
bacteria. 
ai-Acid-glycoprotein (orosomucoid) is able to bind progesterone and 
vitamin-B12 (cyanocobalamin) and inhibits the conversion of prothrom­
bin into thrombin thus preventing excessive blood clotting (26). 
a\-Antitrypsin and ai-antichymotrypsin: both have protease inhibiting 
activity, particularly serine proteases. They bind to many plasma pro­
teases (trypsin, chymotrypsin, thrombin) and to granulocytic neutral 
protease, collagenase and elastase, suqaesting a role in preventing 
vascular injury and tissue damage during an inflammatory response 
(26). 
Hbrinoqen plays an important role in haemostasis, during which pro­
cess it is converted to fibrin, giving rise to a matrix for the spa­
tial organization of blood platelets, fibroblasts and leukocytes thus 
-5-
preventing extensive hemorrhages and promoting wound healing and tis-
sue repair. Finally, fibrinogen contributes to the viscosity of the 
blood (26). 
Haptoglobin binds hemoglobin, preventing glomerular filtration of 
hemoglobin and, as a consequence, preventing kidney siderosis and ir-
reversible iron loss fron the body (26). The haptoglobin-hemoglobin 
complex contains peroxidase activity and might be involved in the ac-
tivation of specific agents responsible for tissue injury. 
C-reactive protein (CRP) is able to bind pneumococcal C-polysacchande 
and could have bacteriocidal effects (54). Furthermore, it could en-
hance the phagocytosing capacity of neutrophils (26). 
Serum amyloid protein A (SAA) is a precursor protein of the secondary 
amyloid protein that forms fibrils in patients with secondary amyloi-
dosis. It is speculated that it has an immunoregulatory, i.e. immuno-
suppressive role (55,56). 
1.3. Fibrinogen and albumin in the acute phase response. 
During the acute phase response, plasma concentration of fibrinogen is 
increased, whereas the serum albumin level is decreased. A reduced 
concentration of serum albumin or an elevated plasma level of fibrino-
gen is a common finding in clinical practice. In contrast, a reduced 
plasma concentration of fibrinogen rarely occurs, except in conditions 
associated with massive liver cell necrosis, fibnnogenolysis or ge-
netic defects in fibrinogen synthesis. An increased level of serum al-
bumin is almost exclusively found in haemoconcentration (dehydration) 
and in excessive administration (intravenously) of albumin. 
1.3.1. Fibrinogen. 
Elevated plasma concentrations of fibrinogen can be observed in a wide 
rdnge of pathological conditions (26,57). These conditions include: 
1_. Infections (bacterial and parasitic) 
2. Inflammatory conditions (rheumatoid arthritis, inflammatory bowel 
disease) 
3. Traumatic events (surgery, burns) 
4. Thrombo-embolic events (myocardial infarction, embolism) 
¿. Intoxications (cobalt, mercury, zinc) 
6. Conditions such as diabetes mellitus, nephrotic syndrome and neo-
plastic diseases) 
Furthermore, increased plasma levels of fibrinogen are associated with 
pregnancy (59), mental stress (59), smoking (59,60) and grade of em-
ployment (60). There are several possible mechanisms by which elevated 
fibrinogen levels could contribute to the pathological conditions: in-
creased fibrin deposition and reduced fibrinolytic activity have been 
found to precede fibrosis in the pathogenesis of rheumatoid arthritis 
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(61). In addition, experimental studies revealed a possible role of 
fibrin in autoimmune joint disease (62). Increased fibrin deposition 
and depressed fibrinolytic activity have been incriminated in the 
development of atheromatous pldcques, suqqesting a role in the patho-
genesis of atherosclerosis (57,63-66). Finally, hyperfibrinogenaemia 
has been observed in various conditions associated with a state of 
hypercodgulability and consequently an impaired blood flow and tissue 
perfusion, such as congestive heart failure and thrombo-embolism, as 
well as in kidney transplant rejection, localized necrosis and tumor 
metastasis (57,66). Changes in the plasma concentration of fibrinogen 
could be the result of changes in synthesis (transcription, transla-
tion or posttranslational modification, i.e. glycosylation), intracel-
lular transport, secretion, consumption (conversion to fibrin), degra-
dation, distribution between intra- and extravascular spaces or chan-
ges in a combination of these processes. 
Numerous studies on fibrinogen synthesis and degradation have demon-
strated that, in a variety of inflammatory processes, fibrinogen syn-
thesis is increased, while the fractional transfer rate of fibrinogen 
from plasma to the interstitial fluid remains constant and proportio-
nal to the absolute amount of intravascular fibrinogen (26). Further-
more, the ratio of intravascular to interstitial fibrinogen is not 
changed during inflammatory processes (26). In addition, the fractio-
nal catabolic rate of fibrinogen remains constant, while the absolute 
amount of fibrinogen degradation products remains proportional to the 
total mass of circulating fibrinogen (26). These findings demonstrate 
that the increased plasma concentration of fibrinogen during inflamma-
tory processes are the result of increased synthesis of fibrinogen by 
the liver cells and not the result of a change in the rate of degrada-
tion or redistribution of fibrinogen. Experimental studies on the re-
gulation of fibrinogen synthesis on the "intracellular" level revealed 
significantly increased levels of mRNAs coding for fibrinogen polypep-
tides during acute inflammation and after partial hepatectomy or lapa-
rotomy (67,68). 
1.5.2. Albumin. 
Albumin is freguently designated as a "negative acute phase protein", 
as its serum concentration is often decreased during inflammatory pro-
cesses. Conditions in which serum albumin concentration is freguently 
decreased include liver cirrhosis, surgical trauma, burns, extensive 
hemorrhages, severe bacterial infections, neoplastic diseases, nephro-
tic syndrome and starvation (69). However, it should be emphasized 
that these pathological conditions are not always accompanied by a de-
creased serum albumin concentration. Studies designated to investigate 
albumin synthesis under various pathological conditions do not yield a 
clear picture. Following partial hepatectomy or laparotomy, albumin 
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synthesis was found to be increased (7Π,71,72) or unchanged (75,76), 
although in all these studies concpntrat ion of serum albumin was de­
creased. Furthermore, it was demonstrated that albumin mRNA concentra­
tion in rat liver was significantly reduced after partial hepatectomy 
or laparotomy '68). In contrast to these findings, increased synthesis 
of albumin was observed during acute inflammation following injection 
of Celite (70) or administration of endotoxin (77) to rabbits.However, 
serum albumin concentration was found to be decreased during the in­
flammatory response evoked by administration of turpentine (78), car-
rageenan (51) or endotoxin (51). Furthermore, albumin mRNA content in 
rat liver was als markedly decreased after turpentine administration 
(67). Likewise, severe burns and extensive hemorrhages leads to in­
creased albumin syntheqis, although a reduced serum albumin concentra­
tion was found (69,79,80). In patients suffering from nephrotic syn­
drome and hypoalbuminaemia, both increased (81,82) and normal (83,83) 
albumin synthesis have been observed. In neoplastic diseases, a de­
creased serum albumin concentration is a well known feature, although 
albumin synthesis is found to be both increased or unchanged (85,86). 
Finally, radiation exposure may lead to a reduced serum albumin con­
centration, while albumin synthesis remains unchanged (87). These fin­
dings indicate that a reduced serum albumin concentration or hypoalbu­
minaemia during inflammatory processes, does not always reflect the 
synthetic rate of albumin in the liver, as is the case for fibrinogen 
(see section 1.З.1.), but that changes in a variety of processes, in­
cluding albumin synthesis, transfer of albumin from intra- to extra-
vascular spaces, degradation and loss of body fluids (severe tissue 
injury and burns) all contribute to the changes in serum albumin con­
centration. The extent to which each of these processes contributes to 
the observed changes in serum albumin concentration will, most likely, 
depend on the nature of the condition that triggers the inflammatory 
response, its seventy and duration. 
2. Interleukin-1. 
2.1. Historical introduction. 
Since the first description of the clinical symptoms and biochemical 
changes of the APR, numerous investigations have been performed to 
identify possible mediators and to elucidate the molecular mechanisms 
of this physiologic response. In 1948, Beeson and Bennet demonstrated 
that a protein, containing pyrogenic activity, was present in perito­
neal exudate cells of rabbits with a sterile peritonitis and in ex­
tracts of Arthusreactions in skin (88,89). The term endogenous pyrogen 
(EP) or leukocytic pyrogen (LP) was introduced to designate this fac­
tor, responsible for the pathogenesis of fever. In addition to these 
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investigations, studies were perFormed to identiFy and isolate the 
Factor(s) mediating other phenomena oF the acute phase response and 
the term LFM (leucocytic endogenous mediator) was introduced to des­
cribe the Factor responsible For the characteristics oF the APR as the 
induction oF the synthesis of acute phase associated proteins, hypo-
Ferraemia, hypozincaemia, hypercupraemia, leukocytosis (spec, neutro­
philia), enhanced amino acid Flux from muscle to the liver, increased 
muscle protein catabolism, exocytosis of specific granules containing 
lactoFerrin and lysozyme and enhanced oxidative metabolism from neu­
trophils (10,19,21,27,90-96). It was subsequently shown that EP is 
able to elicit the full spectrum of changes associated with the APR, 
in addition to its ability to induce Fever (10,97-105). Furthermore, 
it proved to be impossible to separate EP and LEM activities and it 
was strongly suspected that EP and LEM were closely related, iF not 
identical, substances. In recent years it has also been demonstrated 
that the factor mediating the immunologic response during inflamma­
tion, called LAF (lymphocyte activating factor) and first described by 
Gery et al (106,107) is also closely related to ЕР/LEM and subsequent 
studies have shown that LAF-activity could, likewise, not be separated 
from ЕР/LEM activity (108-111). In 1979, the term Interleukin-1 was 
introduced to describe the factor containing EP/LEM/LAF activity and 
was designated as the common mediator of the acute phase associated 
phenomena (112-114). 
2.2. Cell sources, inducers, biological activities and assays. 
Since the recognition that EP, LEM and LAF represent an identical fac­
tor, now called interleukin-1 (IL-1), numerous studies have been per­
Formed to identify the cellular sources, inducers and biological acti­
vities of 11-1. In this section, the most important and well establi­
shed cellular sources, inducers of IL-1 production, biological activi­
ties of IL-1 and several assays for IL-1 activity are summarized. 
Table 1: cellular sources of IL-1. 
mononuclear phagocytes 
peripheral blood monocytes (106,115,116) 
lung and peritoneal macrophages (110,111,115-123) 
Kupffer cells and splenic macrophages (116,124,125) 
bone marrow macrophages (120,125) 
synovial macrophages (126,127,128) 
Lanqerhans' cells (129) 
gingival exudate cells (130) 
human umbilical blood monocytes/placenta (131,132) 
large granular lymphocytes (133) 
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in vitro propagated cell lines 
fmyelo)nonocytic leukemia cell lines 'including the human mono­
cytic leukemia cell line THP-1 (134-140) 
Hodgkin's lymphomas, E8V-transformed B-cell lines and the human 
histiocytic lymphoma cell line LI937 (141-147) 
other cell sources 
epidermal keratinocytes (148,149) 
corneal epithelial cells (150) 
astrocytes/glial cells (151) 
glomerular mesanqial cells (152,153) 
renal cell carcinomas (154,155) 
hepatoma cell lines (human hepatic adenocarcinoma cell line 
SK-hep-1 (156) 
In recent years, numerous inducers of IL-1 production have been iden­
tified (157). 
These inducers include: 
1_. Microorganisms (bacteria, viruses, Spirochetes) 
2^ Microbial products (endotoxins and exotoxins from Staphylococcal 
and Streptococcal pathogenic strains). 
3^. B- and T-cell mitogens and antigens (e.g. plant lectins as phyto-
haemagglutmm and concanavalin A). These agents indirectly induce 
IL-1 production by тасгорЬаоеч through the activation of lymphocy­
tes and the secretion of antibodies. 
4^ Activated T-lymphocytes and their products (lymphokines), such as 
γ-interferon, colony-stimulating factor and macrophage-activating 
factor. 
¿. Antigen-antibody complexes. The formation of these complexes is 
facilitated by the secretion of antibodies to specific antigens by 
B-lymphocytes. 
£. Membrane perturbating agents and phagocytic stimuli, including 
latex particles, silica, asbestos, urate crystals, calcium lonopho-
res, complement cleavage products (C5a), bile salts, etiocholano-
lone and antigen-antibody complexes. 
2.· Other (synthetic) compounds, such as muramyldipeptide, dimethylsul-
foxide, dextrane sulfates and polyltC. 
Some of these agents probably act indirectly through the formation of 
one or more of the other inducers. Thus antigens activate T-lymphoey-
tes to secrete lymphokines, which are the actual inducers of IL-1 pro-
duction; antigens and mitogens may induce proliferation and subse-
guent formation of antibodies by B-cells, giving rise to antigen-anti-
body complexes. These antigen-antibody complexes can, in turn, act as 
phagocytic stimuli. It should be noted however, that not all phagocy-
tic stimuli inevitably lead to IL-1 production. Finally, viruses and 
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polyliC, may promote IL-1 production by their ability to induce the 
release of interferons, which could subsequently enhance the IL-1 qene 
transcription, as has been shown for macrophages (123). 
Numerous biological activities have been attributed to IL-1 and the 
number is still increasing. It is therefore beyond the scope of this 
introduction to present a complete inventory of all these activities. 
In table 2, the most important and well established biological activi-
ties of IL-1 are summarized. 
Table 2: biological activities of IL-1. 
1_. Fever (4,5,6,158) 
2^ . Hypoferraemia, hypozincaemia, hypercupraemia (10,19,23,93,97, 
98,119,159,160,161) 
3. Neutrophilia (10,97,98,119) 
^. Increased synthesis of hepatic acute phase proteins (19,50,90, 
98,99,105,162-169) 
¿. Increased bone resorption (170) 
6. Increase degradation of cartilage (126,127,171,172,173) 
7^ Increase muscle proteolysis (13) 
j[. Increased slow-wave sleep (174) 
9^. Increased production of chondrocyte proteases and synovial 
collagenases (172,175-180) 
10. Induction of release of secondary granules from neutrophils 
(102) 
11. Stimulation of superoxide generation in neutrophils (103) 
12. Induction of interferon production (181) 
13. Enhanced endothelial procoagulant activity (182) 
14. Increased endothelial neutrophil adherence (183) 
15. Induction of endothelial plasminogen activator inhibitor (184) 
16. Increased proliferation of: 
fibroblasts (185-189) 
glial cells (190) 
mesangial cells (191) 
EBV-transformed B-cell lines (192,193) 
endothelial cells (194,195) 
17. Chemotaxis of monocytes, neutrophils and lymphocytes (196-199) 
18. Stimulation of PGE2 production in: 
hypothalamus (4,5,6,158) 
skeletal muscle (13) 
fibroblasts (dermal and synovial) (176,177,179,200-203) 
chondrocytes (128,175,203) 
endothelial cells (PGI2) (205) 
monocytes/macrophages (206) 
^9. Decreased hepatic albumin synthesis (164) 
20. Decreased appetite (207) 
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2 1 . Enhancement o f : 
T - c e l l responses (107) 
B-cell responses (208-214) 
NK-cell activity (215,216) 
IL-2 and lymphokine production (101,107,109,217,218,219) 
22. Decreased lipoprotein lipase activity (220) 
23. Increased synovial cell plasminogen activator production 
(221,222) 
Interleukin-I-assays 
A number of assays have been developed to measure and quantitate IL-1 
activities (157,223). These assays all rely on the response of speci-
fic target cells upon exposure to IL-1 containing preparations. One of 
the first methods used to assay for IL-1 (EP) activity was the pyro-
qemc activity assay (224). In this method trained rabbits with in-
dwelling rectal thermometers, were injected intravenously with test 
substances and rectal temperatures were monitored. IL-1 activity was 
determined hy the characteristic monophasic rise in temperature and 
the time elapsed before the onset of fever. The most serious disadvan-
tages of this assay are its low sensitivity and the possible distur-
bance by contaminating endotoxins, although this latter problem can be 
circumvented by the use of polymyxin-B, an inhibitor of the biological 
activity of endotoxin (224,225). The most widely used assay nowadays, 
is the thymocyte proliferation assay, developed by Gery et al (106). 
In this assay, the proliferation of thymocytes is measured by deter-
mining the incorporation of [ H-]thymidine into thymocytes after sti-
mulation with IL-1 in the presence of suboptimal concentrations mito-
gens, usually phytohaemoaqqlutinin or concanavalin A. This method is 
3 4 
10 -10 -fold more sensitive than the pyrogenic activity assay. How-
ever, the thymocyte proliferation assay is not exclusively specific 
for IL-1 and, in fact, this assay measures the IL-1 activity indirect-
ly by the IL-1 induced release of IL-2, which is the actual prolifera-
tion-inducing factor. In another more sensitive assay, originally 
developed by Gillie and Mizel (226), IL-1 induces the release of IL-2 
by a murine T-lymphocyte cell line (originally LBRM-33) in the presen-
ce of phytohaemagqlutinin. The IL-2 released in the incubation medium 
is subseguently quantitated in a proliferation assay, using an IL-2 
dependent T-cell line (CTLL-2). Recently, variations of these methods 
have been developed, which are more sensitive for IL-1 or insensitive 
to IL-2 (227-230). In vivo bioassays using rats or rabbits and emplo-
ying the changes in metal serum concentration or neutrophilia to de-
tect IL-1 (LEM) activity have now been largely supplanted by more sen-
sitive assays. These in vivo bioasbays are, in general, a 1000-fold 
less sensitive than the thymocyte proliferation assay and vulnerable 
to endotoxin contamination and biological variation (157). Other in 
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vitro bioassays have been described, using PGE2 and collaqenase pro­
duction by synovial cells (201), proliferation of fibroblasts (185), 
degradation of proteoglycan in cartilage expiants (173) and antibody 
synthesis by B-lymphocytes (209). However, these assays are less sen­
sitive than the thymocyte proliferation assay and require longer incu­
bation times. Finally, assay systems employing cultured hepatocytes 
have been described: Koj et al reported a method in which changes in 
the ratio of synthesized <i2-macroalobulin to albumin were used as a 
reliable and sensitive measure for IL-1 activity (231). Ritchie and 
Fuller used cultured hepatocytes as an in vitro bioassay by measuring 
fibrinogen synthesis (232). 
2.3. Molecular biology and physicochemical characteristics. 
Before the introduction of recombinant IL-1, no clear picture existed 
with regard to the exact biochemical properties of IL-1. Several in­
vestigators reported different data on the molecular weight and iso­
electric point (pi) of IL-1. It was assumed that considerable charge 
and molecular weight heterogeneity existed. More recently, it was de­
monstrated that many of these heterogeneities could be attributed to 
isolation artifacts, aggregation to di-, tri- or oligomers, binding to 
higher molecular weight (serum) proteins and interspecies differences. 
With the introduction of recombinant IL-1, these problems were soon 
resolved (233,234). Human IL-1 consists of two species, now designated 
IL-I0 (pi 5.0) and IL-ip (pi 7.0) encoded by two different genes (235, 
236). The secreted form of both species has a molecular weight of 17 
kD. From the nucleotide sequence of the cloned cONAs, it could be in­
ferred that the processed mRNAs code for a 31 kD precursor protein 
(269 amino acids), although on SDS-PAGE, this precursor has an appa­
rent molecular weight of 35 kD (234). The homology between the human 
IL-1a and IL-1 β is 26л in amino acid seguence and 45S in nucleotide 
sequence (235,236). The amino acid sequence of the human IL-1 precur­
sor is umgue in lacking a hydrophobic signal peptide seguence, a com­
mon feature of secreted proteins (233,234). Similar findings have been 
reported for murine and rabbit IL-1: the precursor proteins have mole­
cular weights of 31 kD (270 amino acid) and 30,2 kD (267 amino acids) 
respectively and both consist of two forms with pi 5.0 and pi 7.0 
(237,238). The amino acid sequence homology between human IL-1ß and 
murine IL-la is 20Й and the nucleotide seguence homology 458. The 
nucleotide sequence homology between human IL-1a and murine IL-Ια is 
62"« (233,235). 
In stimulated human monocytes, the relative abundance of IL-1ß mRNA 
compared to IL-la is about 10:1 and the same ratio has been observed 
for the secreted species (233). Following stimulation of human monocy-
tes with endotoxin, the mRNA levels of IL-Ια and IL-1ß increase by a 
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factor 2-3 and 4Π respectively. Furthermore, m unstimulated human 
monocytes, a low level of mRNA for IL-1P could be detected, whereas, 
in the samp study, IL-lot mRNA was not detectable. In contrast, other 
investigators demonstrated the presence of IL-I0 mRNA in unstimulated 
monocytes (233,236). These findings suggest that a differential regu­
lation of the expression of IL-1 qenes may exist. The lack of a hydro­
phobic signal peptide sequence raised the question whether IL-1 is a 
'truly' secretory protein. Other mechanisms may exist for the release 
of IL-1. Gery et al proposed that perforation of the plasma membrane 
might facilitate the release of IL-1 (239), although the more common 
opinion is, that the 31 kD precursor is processed by a sequence of in­
tracellular proteolytic cleavages, leading to the formation of the in­
tracellular and membrane-associated 23 kD intermediate, which 13 sub-
seguently processed to the extracellular 17 kD species (233). It has 
been demonstrated that the IL-ip precursor is biologically inactive, 
whereas the IL-1a precursor is active without processing (181). 
In recent years, numerous studies have been performed with recombi­
nant -derived IL-1, which showed identical biological activities as 
IL-1 obtained by 'classical techmgues' (164,234,240-242). 
In table 3, some biochemical properties of human IL-1, obtained from 
stimulated monocytes are summarized (157). 
Table 3: biochemical properties of himan IL-1. 
molecular weight 
130-electric pH(pI) 
sensitivity to: 
chymotrypsin 
trypsin 
neuraminidase 
RNAse 
thermal stability: 
30 min. bé'Z 
10 min. B(f С 
carbohydrate groups 
sialic acid groups 
functional groups: 
arginine 
sulfhydryl 
15000-17000D 
5.1 6.8 
pi 5.0 pi 7.0 
stable denatured 
denatured denatured 
2.4. Mode of action. 
The availability of pure, recombinant-derιved IL-I made it oossible to 
study the binding of IL-1 to target cells. It has been firmly establi-
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shed now, that IL-I binds to speci f ic r e c e p t o r s , located in the plasma 
membranes of a var ie ty of c e l l - t y p e s , p a r t i c u l a r l y lymphocytes, lym­
phocytic c e l l l i n e s and f i b r o b l a s t s . In t a b l e 4, some of these c e l l 
іуреч on which s p e c i f i c receptors for IL-1 have been i d e n t i f i e d , are 
l i s t e d . 
Table 4 number of IL-I r e c e p t o r s / c e l l 
human gingival fibroblasts 
human dermal fibroblasts 
murine 3T3 fibroblasts 
murine T-lymphoma cell line LBRM-33/A5 
murine T-lymphoma cell line EL-4 
murine T-lymphoma cell line EL-4 6.1C10 
human myeloma cell line ARH77 
human large granular lymphocyte cell line YT 
EBV-transformed B-cell line VDS-0 
bovine endothelial cell line CPAE 
rat hepatoma cell line Hep-2 
human peripheral blood mononuclear cells 
4900 
2400-2B00 
4BO0-5500 
500 
290-3430 
1 5 
1200 
20000 
330 
11000 
7000 
110-220 
750 
540 
27 
(243) 
(244) 
(244) 
(243) 
(244) 
(243) 
(245) 
(246) 
(243) 
(244) 
(247) 
(192) 
(243) 
(243) 
(243) 
The IL-1 receptor i s s p e c i f i c and binding of IL-1 i s not competetively 
inhib i ted by human tumor necros i s fac tor-α, i n t e r f e r o n - a , i n t e r f e r o n -
-γ, murine colony-st imulat ing factor 2a, EGF, PDGF, NGF, bovine p i t u i ­
tary f ibroblast growth f a c t o r , human growth hormone, human l u t e i m s i n g 
hormone, thyroid s t imulat ing hormone, bovine i n s u l i n , f o l l i c l e st imu­
la t ing hormone and IL-2 (192,243,245,248). IL-1a and IL-1p bind t o the 
same receptor with comparable a f f i n i t i e s and binding of one IL-1 spe­
c ies is competetively inhib i ted by the other (244,245,24В). I t has 
been demonstrated that the IL-la precursor i s able to bind to the IL-1 
receptor, in contras t t o the IL-Ιβ precursor , thus providing an expla­
nation for the lack of b iological a c t i v i t y of the IL-1ß precursor 
(249). Up-requlation of IL-1 receptor expression has been observed 
following mitoqemc s t imulat ion of T-lymphocytes (250), whereas down-
regulat ion of IL-1 receptor expression can be accomplished by exposing 
the human large granular lymphocyte ce l l l ine YT to IL-1 (247). A pre -
liminary i d e n t i f i c a t i o n and charac te r i za t ion of the IL-1 recep to r , 
using a f f i n i t y c ros s - l i nk ing experiments demonstrated that the 11-1 
receptor i s a pro te in with a molecular weight of 79- 0 kD (243,248, 
251). However, o thers reported an IL-1 receptor protein with a molecu-
lar weight of 60 kD on the EBV-transformed B-cell l ine VDS-0 (192); 41 
kD on the human leukemia ce l l l ine K562, where IL-1 binding induced 
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Ine phobphorylation of tyrosine residues and which contained in addi­
tion an ATP binding and cleavage site (252) and 116 kD on the LRRM-
33Ά5 cell-line, although this latter protein might possibly by а 8Π 
kD receptir in сіоье association with a 42 kD protein (243,250). 
Little is known about the intrat-pl lular events following binding of 
IL-1 to its receptor. Receptor-mediated uptake of IL-1 has been obser­
ved, after which IL-1 was found to be located in the cell nucleus 
(¿46,250). Much attention has been devoted to the hypothesis that IL-1 
2 
acts by changing the intracellular Ca + concentration. Many of the 
biological activities of IL-1 are shared by the calcium lonophore 
А231 7, which increases the intracellular Ca + concentration: 423187 
is able to increase the production of PGË2 in isolated muscle strips, 
leading to increased protein degradation (253), in renal medullary 
cells (254) and human platelets (255), where it acts by increasing the 
phospholipase A2 activity, leading to increased hydrolysis of membrane 
phospholipids and arachidon'c acid formation (254,255). Moreover, 
A23187 is mitogenic for lymphocytes (256) and can replace IL-1 in the 
mitogen-induced T-cell proliferation (257) and causes the release of 
secondary granules from neutrophils (102). These findings suggest that 
IL-1 exerts its effects by inducing a rapid rise in the intracellular 
Ca + concentration, leading to increased membrane phospholipase A2 
activity and arachidonic acid formation. Arachidomc acid is subse-
guently converted to prostaglandins via the cyclo-oxygenase pathway or 
to leukotnenes via the lipo-oxygenase pathway, dependent on the cell 
type involved. Recent observations indicate that the increased forma-
tion of prostaglandins is the predominant pathway in skeletal muscle 
cells, hypothalamic cells and fibroblasts (13,158,176,177,200-203, 
253), whereas increased formation of leukotnenes is the major route 
in the mitogenic response of lymphocytes (258) and superoxide genera-
tion and deqranulation of neutrophils (102,103,206). However, not all 
reports support a direct role of IL-1 in the increased intracellular 
2 
Ca + concentration: Matsushima and Oppenheim observed that А231 7 
acts synergistically with IL-1 in augmenting the lectin-induced thymo­
cyte proliferation, whereas A23187 alone was ineffective (259), sug­
gesting that IL-1 does not directly induce changes in the intracellu-
2 2 
lar Ca + concentration, but depends on Ca +-channel formation for 
its effects. Furthermore, Stanton et al observed that the IL-1 induced 
differentiation of the murine pre-B cell line 70Z/3, IL-1 leads to an 
increased intracellular Na + concentration and a transient fall in 
intracellular Ca + concentration (260). Finally, it has been demon­
strated that IL-1 increases cyclic-RMP concentration in stimulated 
lymphocytes in the Gi-phase (261). These results illustrate the com­
plexity of the mode of action of IL-1 and demonstrate the need for 
further investigation on this topic. 
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3. AIM OF THE STUDY. 
During inflammatory processes, elevated plasma concentrations of 
fibrinogen are observed, whereas serum albumin concentrations are de-
creased. It has been shown that these changes are regulated at the 
mRNA level (262). However, little is known about the mediatorfs) 
responsible for the observed changes in the synthesis of fibrinogen 
and albumin during inflammation. Several factors have been suggested 
to play an important role in the regulation of fibrinogen and albumin 
synthesis during inflammation. These factors include several hormones, 
notably adrenaline and corticosteroids, fibrinogen- and fibrin degra-
dation producta, free fatty acids, interleukin-1 and tumor necrosis 
factor. 
The aim of this thesis is to elucidate the role of these factors in 
the molecular regulation of the synthesis of fibrinogen and albumin 
during the acute phase response. For these investigations, experiments 
were performed both in vivo, using rats and in vitro, using primary 
cultures of hepatocytes. 
-17-
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CHAPTER IIA 
THE INFLUENCE OF GLUCOCORTICOID ON THE FIBRINOGEN 
MESSENGER RNA CONTENT OF RAT LIVER IN VIVO AND IN 
HEPATOCYTE SUSPENSION CULTURE 
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The influence of glucocorticoid on the fibrinogen messenger RNA content of 
rat liver in vivo and in hepatocyte suspension culture 
Hans M G PRINCEN.Í Hans J MOSHAGF,* Hans J W de HAARD,* 
Paul J L van OEIVíERTt and Sing Hiem YAP*§ 
•Du mon oj Gastrointestinal and Liter Disease Department oj Meditine, and tDepartment of Pharmacology 
St Radboud Hospita! ¡Jnn er sity of Nijmegen 6500 HB Nijmegen The Netherlands 
(Recened 24 October 1983/Accepted 28 February ¡984) 
The plasma concentration of fibrinogen, one of the major acute-phase proteins 
produced by the liver, increases during ihe acute-phase response as a result of en-
hanced synthesis in liver Since adrenal-cortical hormones have been thought to have 
a key role in the regulation of the fibrinogen $>nthesis, fibrinogen-polypeptide 
mRNA sequences were determined in the present study, by using a specific comple-
mentary-DNA probe, in RNA fractions obtained from rat hepatocytes exposed to 
glucocorticoids in atro (hepatocyte suspension cultures) and m ino Maximal 
induction of the fibrinogen-polypeptide mRNA (to 400% of the control value) WJS 
found ш i/fro at 0 1 μΜ-dexamethasone after 9 h of incubation The same magnitude of 
induction was obtained with 20/jM-corlisol or 60/ÌM corticosterone In contrast with 
the findings in atro, no induction of the fibrinogen-pol\ peptide mRNA was observed 
in the liver at various times after injection of different doses of glucocorticoids into 
rats These results suggest that more complex regulatory mechanisms are involved 
and that glucocorticoids are not the sole regulatory factors m mo in the enhanced 
synthesis of fibrinogen during the acute-phase response 
In response to physical trauma, infection or 
inflammation, a co ordinated sequence of altera-
tions in the сопсстгаиоп« of specific plasma pro­
tein« occurs This response is associated with meta­
bolic changes, which together are referred to as the 
acute-phase reaction Fibrinogen or coagulation 
factor I one of the major acute-phase proteins 
produced by the liver has been investigated 
intensively in the last few \edrs It is a gl>coprotein 
and consists of a dimenc molecule of three non-
idenlical polypeptides, namely 2Ai 2B/Î and 2) 
chains of W, 61 000(Aai. SSOOO(B/J) And 51000dì 
respectively in the rat (van Ru>vcn-Vermeer & 
Nieuwenhui?en, 1978, Nickerson A Fuller, 1981) 
Although it has been documented that the plasma 
Abbrewations used cDNA complementar} DNA 
Rüt the product of initial RNA concentration (mol of 
nucleotides litre) ¿nd time (s) (assuming that A2b, of 1 0 
corresponds to 4C^g oí RNA ml) R >f, the Λ(,ί value at 
50 o
o
 maximal hybridization Hepcs 4-(2-hvdroxvcthyl)-
l-piperarine-echanesulphonic acid SDS sodium 
dodecy) sulphate 
X Present address Gaubius Institute Health Research 
Organization INO, leiden. The Netherlands 
§ To whom reprmi requests should be addressed 
concentration of fibrinogen increases during the 
acute-phase response as a result of enhanced syn­
thesis in liver (Weimer & Humelbaugh, 1967, 
Kampschmidt &. Upchurch, 1974 Koj, 1974), 
little is known about the molecular regulatory 
mechanism of the fibrinogen biosynthesis in 
the liver PreviousI), using a cDNA probe specific 
for fibnnogen-polvpeptide mRNA. we have 
demonstrated that the regulation of fibrinogen-
polypeptide synthesis m ino after inflammation 
(Princen et al, 1981ft), after partial hepatectomy 
and surgical trauma (Princen et al. 1982). or in 
developing organs (Selten et al 1982), occurs via 
modulation of the contents of mRNA species 
coding for fibrinogen polypeptides Similar find­
ings were also reported after defibrination of rats 
with Malayan-pit-viper venom (Crabtree & Kant, 
1982) 
Although the precise molecular mechanisms 
that bring about the dramatic increase in the pro­
duction of fibrinogen and the increase in fibrin­
ogen-polypeptide mRNA are still not known, 
numerous studies showed thai a variety of hor­
mones (( rane & Miller, 1977. Gneninger et al, 
1978 Herl7berg et al. 1981, Liang & Gneninger, 
Vol 220 
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1981) fibrinogen degradation products (Bernhardt 
e¡al 1970 Franks etat 1981 Fuller et ai 1982) 
and certain leucotyiic products (Kampschmidt et 
ai 1982)mavpla\ an importanl role in the hepatic 
regulation of fibrinogen synthesis However, 
considerable controversy exists as to the result and 
to the mechanism by which such substances exert 
their influences on the fibrinogen synthesis 
Investigations on the effect of corticosteroids on 
the fibrinogen synthesis have been pursued in the 
intact animal (McKenzie & Fowler. 1968 Cain et 
al 1970 Jeejeebhoy et al, 1972) m isolated 
perfused liver (John & Miller, 1969), in sus-
pensions of hepalocytes (Crane & Miller 1977) 
and in monolayer hepatocyte cultures (Gneninger 
er al 1978) In the present study, we report the 
effects ol these hormones on the synthesis in liver 
of fibrinogen at the level of their specific mRNA 
species in hepatocyte suspension cultures and in 
intact animals The results indicate that there is a 
differential regulation of the fibrinogen synthesis 
in isolated hepa toe vies and in the liver of intact 
rats 
Materials and methods 
Materials 
L-[4 5-3H]Leucine (76Ci mmol) was obtained 
irom The Radiochemical Centre (Amersham, 
Bucks V К ) Collagenasc type I, soya-bean 
trvpsin inhibitor, bovine serum albumin, heparin 
from pig intestinal mucosa, dithiothreitol and 
Hepes were purchased from Sigma Jokhk-modi-
fied Minimum Fsscntial Medium (MEM) was 
Irom Gibco and foetal bovine serum was from 
Flow Laboratories All salts and solvents aere 
purchased Irom С Merck Oradexon (dcxa-
mcthasone d ι sodium phosphate) and dcxa-
methasone were obtained from Organon Oss The 
Netherlands Cortisol and corticosterone were 
from Steraloids Wilton, NH U S A ) All glass­
ware v,ds sterilized and solutions were freshly pre­
pared and autoclaved. before use Bovine serum 
albumin and soya-bean trypsin inhibitor were 
dialvsed against 0 l5M-NaCl and all solutions used 
in the hepatocyte isolation and culture were 
filtered through a 0 22μπι Millipore filter and 
stored frozen 
Animals 
Male Wistar rats weighing 160-220g were used 
throughout and maintained on standard Purina 
Chow and water ad libitum Animals were injected 
with corticosteroids and hepalocytes were always 
prepared at 09 00 h 
Hepatoc\ te preparation ana incubation 
Liver cells were prepared as described by Seglen 
(1976), with the following modifications All 
buffers were supplemented with 100 units oí 
penicillin and lOOjig of streptomycin ml and were 
oxygenated by direct bubbling with oxygen 
Collagcnase buffer (120ml, 0 5mg ml) was supplc-
memed with 6mg of soya-bean trypsin inhibitor 
(( rane & Miller 1977) After 25 mm perfusion the 
Glisson capsules were removed in 100ml of (Ca1* 
and Mg1" )-free Hanks' balanced salt solution con-
taining 2<,0(w v) bovine serum albumin Cells were 
filtered, preincubated and centnfuged (50^, 5mm) 
in the same buffer to remove damaged and non-
parenchymal cells Alter centnfugation the pellet 
was resuspended in fresh Jokhk-modified MfcM, 
containing 25 тч-Hepes (pH 7 5), 0 1 mg of hepar­
in/ml and 10D
o
 (v/v) foetal-calf serum Cells were 
counted, and viability was determined by Trypan 
Blue exclusion In a typical experiment 15 χ 106 
hepatocytes were incubated in 10 ml of suspension 
at 37X in 50ml polypropylene Erlenmeyer flasks 
with gentle rotational shaking (90 rev mm) under 
0
:
 CO, (19 1) Freshly prepared hormones and 
labelled precursors were added as concentrated 
stock solutions After incubation, cell suspensions 
were quickly chilled and centnfuged (50;. 5 mm) 
The cell pellets were frozen in liquid N
:
 for 
subsequent analysis 
Incorporation of labelled precursor into protein 
PHlLeucine (5/iCi/ml) was added to the cell 
suspension At the indicated times, duplicate 50μ1 
samples were withdrawn and spotted on 2 3cm 
Whatman 3MM filter-paper discs, which were im­
mersed in cold 10ο
ο
 trichloroacetic acid containing 
5mM leucine Filters were washed to remove free 
labelled precursor as described (Mans & Novelli 
1960) Protein precipítales were solubihzcd from 
the fillers bv treatment with 2x lml of 30oo 
НЮ, 350
o
 NH, solution (17 3, ν,ν) for lOh at 
55 С and counted for radioactivity in 10ml of 
Aqualuma Plus (Lumac), giving a counting el fi­
elen c> of 41% Cell protein was determined by the 
method of Lowry et al (1951) 
Immunoprecipitation of3 Η-labelled fibrinogen 
3H-labelled fibrinogen secreted in the incuba­
tion medium was determined as described pre­
viously, with minor modifications (Pnncen et al, 
1981 α), 1 Отм-leucine, 0 I тм-phcnylmethane-
sulphonyl fluoride and 1 тч-EDTA were added to 
the immunoprecipitation mixture 14C-labelled 
fibrinogen was prepared chemically from the 
punned proteins with [l4C}lormaldehyde by re­
ductive metbylation as described by Crane & 
Miller (1975) 
Preparation of ¡пег and cell RNA 
Total post-nuclear liver RNA was prepared as 
described by Taylor & Schimke (1973) Cell pellets 
- 3 0 - 1984 
Glucocorlicoid dnd liver fibrinogen mRNA content 
were quickly thawed and homogenized m a buffer 
contdining 50m4-Tris/HCl, pH7 4, 25тч NaCl, 
5тм MgCU, 0 25M-sucrose and 0 3 mg of hcpar-
m'ml After addition of Π I vol of IO0,, Triton X-
100 and removal of the paniculate material by 
centrifugalion lor lOmin at I6000jf. RNA was 
extracted by addition of 0 5vol of n Зм 
NaCl 1 5% SDS,15mM-EDTA'30m4-Tris'HCl, 
pH9 0, and an equal volume of phenol'chloro-
forTii'3-methylbulan-l-ol (25 24 1, by vol) When 
no detectable interface remained, 2 5vol of cold 
ethanol was added RNA was precipitated over 
night at - 20°C and isolated by centrifugalion at 
16000$ for 20 mm at -5°C 
Preparation of purified mRNA and 3H-lahelIed 
cDNA 
Purification of mRNA species specific for 
fibrinogen polypeptides and the synthesis of the 
specific cDNA probes from these purified mRNA 
species have been reported previously (Strair el al, 
1977 Pnncen el al, 198l¿, 1982') Analytical 
RNA-cDNA hybridization was performed as 
described (Pnncen el al, 1982 Seltenffo/, 1982) 
Results 
Characteristics o/ the hepaioc\ te suspension culture 
To study the effects of glucocorticoids on the 
synthesis of fibrinogen and on the amount of its 
mRNA in hepatocyle culture, it is necessary to 
characterize the capabilities of the hepatocytes in 
this system to synthesize RNA and protein A high 
yield of isolated liver parenchymal cells (50 χ lO6-
80 χ 10* cellsfg of liver) was obtained by the 
isolation technique in our present study The cells 
were morphologically intact showing a viability, 
as determined by Trypan Blue exclusion, higher 
than 90°,, After 22h of incubation, 75-80% of the 
hepatocvtes was still viable Isolated liver cells 
inLorporated labelled precursor into hepatic RNA 
linearly with time (results not shown) Incor­
poration of ('HJleucmc into total hepatic protein 
continued at an approximately linear rate for over 
22h (Fig 1) Newly synthesized proteins were 
actively secreted into the medium throughout this 
period 
Glucocorticoid induction of fibrinogen synthesis and 
the fibnnogen-pol\peptide mR\'A content in isolated 
hepaioc ι ίί'ΐ 
When the synthetic glucocorticoid dexametha-
sonc disodium phosphate (0 48μΜ) was added to 
the culture medium, the synthesis of total protein, 
as a reflection of the synthesis of secretory 
proteins was stimulated (Fig 1) There was also a 
marked stimulation of fibrinogen synthesis by 
glucocorticoid (Fig 2) After a lag period of 6 h, 
613 
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Fig 1 Incorporation of[ìH]leucine into total and secreted 
protein of hepatocytes in suspension cultures 
Hepatocytes (I 5x10^ cells/ml) were incubated for 
22h in the presence of $μΟ of ['Hpeucine/ml At 
Ih intervals, total (#) and secreted (A) protein was 
measured The effeel of 0 48 μΜ-dexamethasone di­
sodium phosphate on protein synthesis by these cells 
was also determined total (O) and secreted (Δ) 
protein Each pomi on the curves is the average 
value obtained from cell preparations of three 
different rats Protein content was 1 ZOmg/lO4 
hepatocytes 
fibrinogen synthesis increased very rapidly, to 
Ì00\ of the control value at 22 h of incubation 
Fibrinogen comprised 4 2% of the secreted pro-
teins during the first 15 h of incubation, but 
decreased to 3 4% after 22 h Addition of 0 48 тм-
dcxamethasonc at the beginning of incubation 
increased fibrinogen synthesis to 8 1% of the 
secreted proteins at 22 h of culture 
In an attempt to gain some insight into the 
biochemical processes by which glucocorticoids 
enhance the fibrinogen synthesis, the content of 
fibrinogen-polypeptide mRNA in these hepato-
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I ig 1 Si irrtwn iti fihrnittgen h\ isolated ral hepatocytes 
Γ lie iiHijhtiiion LuntJitions were ,is described in Fig 
I \\ ihc indutitod limes samples were withdrawn 
and piiriiuns ol the medium were frozen until 
jvsjvui I ibrmogcn w.ii quJnt]tiiii\el> determined 
by daplictie immunoprctipitations from proteins 
xctrcted in the tulture medium Fibrinogen secre-
iion m the ргечепіе (A) and in the absence (A) of 
U 4H/j\f-dt.4.imeitusonc disodium phosphate was 
examined 
L>tC4 uas qiuniified b\ molccuhr hvbndi/dtion 
with t D N A piohcs spcciht. for fibrmogen-polv-
peptidf mRNA Ì ig 1 shows some representative 
π Milts of the hvbruIiAihon kincli(.s ol various 
RNA lr.i(.iions prep ired I rom hepaiocyte suspen-
ΝΚ·Π (.ulturcs When the purified hbnnogen-poly-
pcptidc mRNA species were hybridized in RNA 
eui.s4 io their own c D N A probes, a RQÍ value of 
4 47 χ 10 mol I ' s was found (Pnncen et al. 
ІЧНІЛ, 1982) B\ comparing the Яц/, values of 
various RNA IraUions with that of the purified 
fibrinogcn-pol\peptide mRN \ species, it was cal­
culated that fihrinogen-polvpeptide mRNA in 
ton ι rol rats Lomprised U О^б*,, ol the lotal RNA or 
I 6 e 0ofihepol\(A)-con[ainingRNA Thesevalues 
were also found with the RNA fraction from 
ІгеФІ> prepared hepaU4>ies (A,,/, 7 94mo1 I 1 s) 
Alter a single dose of 0 48/(4-dexamethasone di-
stKlium phosphate at zero time to a hepatocy te sus­
pension culture, a continuous decrease in the Н0(\ 
value was obtained, with the maximal effect after 
9h ol incubation {R, t 2 00) The lime course for 
the elevation ol the hbrtnogen-polypeptide 
mRNA umient bv dexamcthasone disodium phos­
phate was studied as shown in Fig 4 Afteralagof 
\ogRoi 
Fig 3 H\hntii:ation kmtnet of RNA fractions isolateti 
from rat hepatfK} ie* in suspension cultures in the presence 
and absence of dexamethawne disodium phosphate 
PHRDNA specific for fibrinogen-polypeptide 
mRNA were hybridized to punned fibrinogen-
polypeptides mRNA (•). lo RNA isolated from 
hcpaUHvtes immediately after preparation (O) to 
RNA isolated from hepatotyies after 6 (•) or 9h 
(•) of incubation in the presence of 0 48¿iM-dexa-
methasone disodium phosphate Each hybridiza-
tion curve was the average result of at least three 
experiments 
appro* 3h, an increase in mRNA was observed, to 
à maximum (400 e oof the initial value) after 9-[Oh 
of exposure to dexamcthasone A second addition 
of 0 48/iM-dexamethasone led to persistence of the 
maximal value for a longer period When gluco-
corticoid was omitted, the fibrinogen-polypeptide 
mRNA content was constant for9-12h However, 
there was a gradual decrease in the mRNA content 
to 50o o of the control value at 22 h Despite these 
findings, the hepatoevtes cultured for9h were still 
able to synthesize fibnnogen-polvpeptide mRNA 
at a maximal rate in response to a delayed dexa-
meihasone exposure We can therefore conclude 
that these hepatocytes were still very viable and 
metabohcally active in the observed experimental 
period 
The relationship between steroid concentration 
and degree of stimulation of ihe fibrinogen-poly-
peptide mRNA content is demonstrated in Fig 5 
I h e effect of dexamcthasone disodium phosphate 
was compared with that of the naturally occurring 
glucocorticoids, Cortisol and corticosterone A sig-
nificant increase in the fibrinogen-polypeptide 
mRNA content was detectable at 20пм and 
reached a maximum (400oû of the initial control 
value) at 0 1 μΜ-dexamethasone disodium phos­
phate Similar findings were obtained with pure 
dexamcthasone (instead of Oradexon, dexa­
mcthasone disodium phosphate) In these expen-
mems, however, no induction of fibrinogen-poly­
peptide mRNA was found with 17-oxo-dexa-
- 3 2 - 1984 
Glucocorticoid and liver fibrinogen mRNA content 635 
3 6 9 12 15 16 21 
Incubation time (h) 
Fig 4 Tme course of the fibnmgen-polvpepude mRNA 
¡nduLtion m the pretence of dexamethasone disodmm 
phosphate 
The relative changes in fibrinogen pol>peptide 
mRNA contents were determined from the repre-
sentative hybridization cUu as partly shown in Fig 
3 by companion of the Rntl value of RNA isolated 
from hepatocytes immediately after preparation 
with the Ao', values obtained from RNA of 
cells after various time intervals of incubatiún 
The mR N A contení was investigated m the absence 
(A — • ) or in the presence ( · · ) of 0 48 μΜ-
dexamethasone disodium phosphate at the begin­
ning of (he intubation or after 9h of incubation 
(O ΟΪ. addition of a second dose of 0 4βμΜ-
dcxamethasone disodium phosphate after the 
initial addition at zero time ( # # ) was also 
examined 
-log11( iHticosieroidl (м)| 
Fig 5 Dme response of fibt mogen poh peptide mRNA 
mduLtioti hi (oniLosieroid·; 
Vdlues weie obtained ds described in Fig 4, 
1 5x10° cells,ml were intubated for 9h in the 
presence of vanouä coiuentraiions of dexa-
methasone disodium plio^phate or dexdmethdsone 
( · ) Cortisol (A) or согііоыегопе (•) 
methdM>ne, an oxidation produci of dexa­
methasone 
The maximal stimulation of the ñbnnogen-pol)-
peptide mRNA content in the experiments using 
the naturally occurring glucocorticoids was 
achieved wiih a concentration of 20pM-cortisol or 
60^M-corticosierone, the native corticosteroid of 
the rat 
Effect of glucocorttcotd given in uto on the hepatic 
contení of fibrinogen-polypeptide mRNA 
To examine the possible role of glucocorticoid in 
the regulation of fibrinogen synthesis, it is neces-
sary to investigate the effect of this hormone in 
intact animals Knowing that dexamethasone is 
able to induce the fibrinogen-polypeptide m R N A 
content in hepatocytes in vitro and that there are 
controversies about the influence of glucocorti-
coids on the plasma content and the synthesis of 
fibrinogen іл ULO (McKenzie & Fowler, 1968, Cain 
et ai, 1970, Jeejeebhoy et al, 1972, Seligsohn et al, 
1973, Miller, 1975, Majumdar & Jorgensen, 1977, 
Gordon & Limaos. 1979, Crabtree & Kant, 1982), 
< 
2 
О 25 
III 
/.' ƒ 
ι ι ι ι ι 
logfly 
Fig 6 Hybridization kmetits uj RM fraitions isolated 
from rat ¡ner after injection иігА corttcosterouJs 
[3H]cDNA species specific for fibrinogen-pol>pep­
tide mRNA were hybridized to RNA isolated from 
livers of control rats (O - O). orto RNA isolated 
after various time internals from livers of rats 
injected with different amounts of corticosteroids 
(^g-10mg) ( φ φ) For comparison, the hy­
bridization kinetics of fibrinogen polypeptide 141)-
cDNA with the total cellular RNA from hepato-
cyies isolated 9h after incubation in (he presence ol 
0 48 /iM dexamethasone disodium phosphate 
( · · ) and «uh the total liver RNA isolated 
from rats 24h alter lurpenune injection (• -A) 
(Prmcen el al 19816) are shown 
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we decided to examine the hepatic contents of 
fibrinoEcn-polypeplidc mRNA in intact rats after 
dexametltasone administration. After injection of 
this synthetic hormone either intraperitoneally or 
intravenously into (he animals with a dose ranging 
from 5/ig to 10mg per rat. there was no detectable 
change in fibrinogen-polypeptide mRNA content 
up to 24h. as compared with findings in control 
animals (Fig. 6). In addition, no induction of 
fibrinogen mRNA was observed after repealed 
injections with 10mg of dexamethasone at 6, 9-16 
and 21 h after the initial injection (lOmg). These 
findings show that glucocorticoids given in vivo, in 
sharp contrast with the findings m vitro, are not 
able to increase the content of fibrinogen-poly­
peptide mRNA in the liver. 
Discussion 
An elevated plasma concentration and an en­
hanced hepatic synthesis of fibrinogen have been 
observed after exposure to a variety of noxious 
stimuli or tissue injuries (Weimer & Humelbaugh, 
1967: Kampschmidt & Upchurch, 1974: Koj, 
1974). Since the plasma concentrations of the 
adrenal-cortical hormones are increased in all 
these "stress' conditions, these hormones have been 
thought to have a key role in the regulation of the 
fibrinogen synthesis. To investigate the possible 
stimulalory effect of glucocorticoids in the genesis 
of the acute-phase fibrinogen response, two experi­
mental approaches have been used by different 
groups of investigators. In the first, glucocorticoids 
have been administered in vivo and in vitro with the 
aim of stimulating fibrinogen synthesis. In the 
other approach, it was determined whether adren-
aleciomy prevents an increase in fibrinogen syn­
thesis caused by infiammatory stimuli known to be 
effective in control experiments. By using these 
approaches in the isolated perfused rat liver (John 
& Miller. 1969), in suspensions of hepatocytes 
(Crane &. Miller, 1977) or in monolayer cultures 
(Grienmger et al., 1978). the stimulatory effect of 
glucocorticoids on the fibrinogen synthesis has 
been reported. In the present study, we have 
demonstrated that the enhanced synthesis of 
fibrinogen in a hepaiocyte suspension culture after 
exposure to glucocorticoids is regulated at the 
mRNA level as found in intact animals during the 
acute-phase response (Princen et al.. 1981. 1982). 
Whether this increase in mRNA is caused by 
increased transcription or mRNA slabilizalion 
remains to he determined. 
There is a substantial degree of controversy in 
the literature about the effect of glucocorticoids on 
fibrinogen synthesis in intact animals, with or 
without adrenalectomy. Several investigators pre­
sented evidence thai glucocorticoids are able to 
stimulate (Cain et ai.. 1970: Jeejeebhoy. 1972) or 
have only a limited 'permissive' role in the 
stimulation of the fibrinogen synthesis (Miller, 
1975: Crabtrce & Kant. 1982). 
In ihe present experiments, glucocorticoids may 
influence the synthesis of fibrinogen by more than 
one mechanism. As in tirro, these hormones may 
exert their effects directly on the liver cells by 
affecting one or more of the many subcellular 
processes involved in protein synthesis. Alternati­
vely, ihe changes in fibrinogen synthesis could be 
induced indirectly, occurring secondarily to the 
effects of these hormones on the metabolic path­
way of other organs or tissues. In our present study 
we demonstrated that there was no detectable 
increase in the fibrinogen-polypeptide mRNA 
content after dexamethasone exposure in vivo. 
These contradictory findings from studies in vivo 
and in vitro suggest that there is a differemial effect 
of glucocorticoids on fibrinogen synthesis in 
he pat осу te suspension cultures and in intact 
animals, although the details of the molecular 
mechanism remain unclear. Since glucocorticoids 
are not able to stimulate the fibrinogen mRNA 
content in the liver and to increase the plasma 
fibrinogen concentration, wc believe that gluco­
corticoids are not the sole regulatory factor in the 
acute-phase fibrinogen response in vivo. Further 
study on the molecular mechanisms for the 
dramatic increase in the production of fibrinogen 
and the enhanced content of fibrinogen-poly­
peptide mRNA during the acute-phase reaction is 
required. 
This research was supported in pari by a grant from 
the Foundation for Fundamental Medical Research 
(FUNGO). Wc thank Dr. H. Bloemendal and Dr. P. Th. 
Henderson for iheircritical comments on the manuscript. 
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CHAPTER IIB 
THE INFLUENCE OF GLUCOCORTICOID ON ALBUMIN 
SYNTHESIS AND ITS MESSENGER RNA IN RAT IN 
VIVO AND IN HEPATOCYTE SUSPENSION CULTURE 
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The influence of glucocorticoid on albumin synthesis and its messenger RNA in 
rat in vivo and in hepatocytc suspension culture 
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Keywords Albumin Glucocorticoid RNA, Proletn synthesis. (Ral hepalocvte) 
Corticosteroids are known to stimulate the synthesis of a number of liver-specific proteins. The reports 
regarding the effect of glucocorticoid on albumin synthesis in vivo and in vitro are controversial. In an 
attempt to determine the mechanism by which glucocorticoid exerts its influence on hepatic albumin 
sxnthesis and to find an explanation for the conflicting data, we have studied the effect of dcxamethasone 
disodium phosphate on albumin synthesis and albumin messenger RNA as determined by the molecular 
hybridization technique in hepatocytes in rat in vivo and in suspension culture. In hepatocyle suspension 
culture, addition of 0.48 μ M dexamcthasone in medium at zero time led to a significant increase (20%) in 
incorporation of labeled precursor into albumin as compared to control experiments; this was accompanied by 
a mainlainance of the initial level of full-length albumin mRNA for a 9 h period. In hepatocytes cultured 
without dcxamethasone in the medium there was a progressive loss of albumin mRNA content. Despite this 
finding, dexamelhasone was not able to increase the albumin mRNA content in hepatocyle to a level higher 
than the initial \alue Moreover, administration of this hormone either intraperitoneally or intravenously into 
rats did not lead to enhanced cell-free albumin s>nthesi4 or to an increased level of albumin mRNA. These 
findings suggest that glucocorticoid does not play an essential role in the regulation of albumin s}nthesis in 
vivo. In vitro, however, glucocorticoid leads to a preservation of the initial level of albumin mRNA and thus 
plays a role in the control of spontaneous dedifferentiation of liver cells in culture. 
Introduction 
Corticosteroids are known to stimulate the 
synthesis, of liver RNA and proteins |1] ll has 
been shown that liver protein synthesis or enzyme 
* Present address Gaubius Institute Health Research 
Orgaimanon ΓΝΟ, 1 eiden. The Neiherlandi 
**To «hom correspondence should be addressed 
Abbreviations Λ,,ί the product of initial RNA concentration 
in mol nudeoudes/liler and time m sccunds (assuming that 
Л2Ыу of I 0 corresponds to 40 μg RNA/ml). А 0 / 1 / г > 'he Ä0f 
value at 50% maximal hybridization Hcpes 4-(2 
hydrox>ethylH-piperazinceihanesu1fonii aud 
0167 4781/β5/$01 W ^ 1985 Flsevier Sciente Publishers В V 
activities of tyrosine aminotransferase [2], tryp­
tophan oxygenase [3] and serine dehydratase [4] 
are regulated by glucocorticoids The synthesis of 
other liver-specific proteins such as a2tl-globulin 
and a-macrofetoprotein can also be induced by 
corlitosteroids [5.6] In our previous study, we 
demonstrated that glucocorticoids stimulate the 
synthesis of fibrinogen and its messenger RNA 
content in hepatocyle suspension culture but not 
in intact animals [7) Concerning the effect of 
glucocorticoid and the specificity of this effect on 
albumin synthesis, a substantial degree of con­
troversy exists in the literature The important role 
- 3 7 -
28 
of (.orticosteroid in maintaining serum albumin 
levels was first recognized by I evm and Leather 
[8] Subsequently и has been shown that gluco­
corticoids can stimulate albumin synthesis in vivo 
(9] in the isolated perfused liver [10] and in a 
hepatoma cell Ime (11 12] However unchanged or 
depressed albumin synthesis upon administration 
of glucocorticoid has also been demonstrated by 
other investigators [13 14] 
Our prestnt study was designed to investigate 
the effect of glucocorticoids on albumin synthesis 
and us albumin messenger RNA in vivo and in 
hepatocyte suspension culture m an attempt to 
determine the mechanism by which glucocorticoid 
exerts its influences on the hepatic albumin 
svnthesis 
Materials and Methods 
Matenah \ [A 5 4H]Leucme (76 Ci/mmol) [6 
,4C]orotic acid (61 mCi/mmol) [l4C]formalde 
hyde (176 rnCi/moI) and [5-'H]dCTP (184 
С i/mmol) were obtained from the Radiochemical 
Centre Amersham Collagenase type I so\bean 
tr>psin inhibitor bovine serum albumin heparin 
from porcine intestinal mucosa dithiolhreitol and 
Mepes were purchased from Sigma Joklik mod 
ι ficd Minimum Essential Medium was from Gibe о 
and all sera were from Flow Laboratories or pre 
pared b\ ourself Triton X 100 and SDS were 
obtained from BDH Chemicals Ltd Ribonucleasc 
free sucrose EDTA phenol sodium deoxvcholaie 
sails and solvents were purchased from E Merck 
Deoxvnhonuclcoside triphosphates were from 
Schwarz/Mann and Oligo (dT)1() was from Col 
laborative Research Avian myeloblastosis virus 
RNA dependent DNA pol\merase was kindly 
supplied b> Dr J W Beard National Cancer In 
stttute U S A Nuclease St {AspergiJiu\ on^ae) 
was purchased from Miles and stored at 2 5 IO* 
units/ml in 50% glycerol 100 mM NaCI 20 mM 
K H , P 0 4 5 mM Na^HPQ, (pH 70) at - 20oC 
Oradexon" (dexamethasone disodium phosphate) 
was obtained from Organon I he Netherlands All 
glassware was sterilized and solutions were freshly 
prepared and auloclavcd prior to use Bovine serum 
albumin and soybean trypsin inhibitor were di 
alvzed igainst 0 15 M NaCI and as all solutions 
used in the hepaiocMe isolation and culluring 
filtered through a 0 22 μνη Millipore filter and 
stored frozen 
Animals Male Wistar rats weighing 160 220 g 
were used throughout and maintained on standard 
Purine Chow and water ad libitum Animals were 
injected with corticosteroid and hepatocytes were 
always prepared at 9 00 a m 
Hepatocvte preparation and ¡mubatton I iver 
cells were prepared according to Seglen [15] with 
the following modifications All buffers were sup 
plemented with 100 units/ml of penicillin and 100 
/ig/ml of streptomycin and were ox>genaled b> 
direct bubbling with oxygen Collagenase buffer 
(120 ml 0 S mg/ml) was supplemented with 6 mg 
soybean trypsin inhibitor |16] After 20 mm perfu 
sion the Glisson capsules were removed in 100 ml 
Ca1*- and Mg1* free Hanks balanced salt solu 
lion containing 2% bovine serum albumin Cells 
were filtered premcubated and centri f uged in the 
same buffer to remove damaged and non 
parenchymal cells After centnfugation the pellet 
was resuspended in fresh Joklik modified mini 
mum essential medium containing 25 mM Hepes 
(pH 7 5) 01 mg/ml heparin and 10% fetal calf 
serum Cells were counted and viability was de 
termi ned b> trypan blue exclusion In a typical 
experiment 15 10* hepatocytes were incubated m 
10 ml suspension at 370C in 50 ml pol\prop>lene 
Crienmever flasks with gentle rotational shaking 
(90 rpm) under a 95% О /5% C0 2 atmosphere 
Freshly prepared hormones and labeled precursors 
were added as concentrated stock solutions After 
incubation cell suspensions were quickly chilled 
and centri f uged The cell pellets were frozen in 
liquid nitrogen for subsequent analysis 
Incorporation of labeiled precursor into protein 
['HJIcucine (5 fiCi/ml) was added to the cell 
suspension At the indicated times duplicate 50 μΐ 
samples were withdrawn and spotted on 2 3 cm 
Whatman 3 MM filter paper discs which were 
immersed in cold 10% trichloroacetic acid contain 
mg 5 mM leucine Filters were washed to remove 
free labelled precursor as described [17) Protein 
precipitates were solubilijed from the filters b> 
treatment with 2 X 1 ml of 10% Η О /35% NH, 
solution (17 3 \/v) for 10 h at 550C and counted 
for radioactivitv in 10 ml of Aqualuma Plus 
(LLMAC) giving a counting efficiency of 41% 
Cell protein was determined bv the method of 
I owry et al [18] 
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Immunoprecipilalion of 7/ labeled albumin De­
termination of 'H-labeled albumin in the incuba­
tion medium was e&senlially performed ds de­
scribed before (19] 50-μΙ samples were diluted in 
500 μΐ buffer containing 10 mM sodium phos­
phate (pH 7 2), 150 mM NaCl, 1% Triton X 100 
0 5% sodium deoxycholatc, 0 1% SDS, 10 i^M 
leucine, 0 1 mM phcnylmethylsulfon>l fluoride and 
1 mM EDTA and incubated with 1000 dpm 
[14C]albumin as tracer for recovery 15 pg albumin 
as carrier and goat-anti-rat-albumin γ-globulin 
After 16 h incubation at 4 0C, the mixture was 
layered over a 200 μΙ 10% (w/w) sucrose cushion 
and centnfuged for 5 mm in an Eppendorf centn-
fuge The pellet was washed three times, dissolved 
in 0 1 NaOH and precipitated with 10% trichloro­
acetic acid for counting using a double labeling 
program [l4C]-AIbumin was prepared chemically 
from the purified protein with [,4C]fornia]dehyde 
by reductive methylation as described by Crane 
and Miller [20] 
Préparation of liver and cell RNA Total post-
nuclear liver RNA was prepared as described by 
Taylor and Schimke [21) Cell pellets were quickly 
thawed and homogenized in a buffer containing 50 
mM Tns-HCl (pH 7 4), 25 mM NaCl. 5 mM 
MgCl2, 0 25 M sucrose and 0 3 mg/ml heparin 
After addition of 1/10 vol 10% Triton X-100, and 
cenlnfugation of the particulate material for 10 
mm at 16000 x g, RNA was extracted by addition 
of 1/2 vol 0 3 M NaCl. 1 5% SDS, 15 mM EDTA 
and 30 mM Tns-HCl (pH 9 0) and an equal 
volume of phenol/chloroform/isoamylalcohol 
(50 48 2, v/v) When no detectable interface re-
mained 2 5 vol cold ethanol were added RNA 
was preci pi a l ed overnight at — 20oC and isolated 
by cenlnfugation at 16000 Χ χ for 20 mm at - 5 0C 
Preparation of purified albumm mRNA and Ή 
labeled complementary DNA Purification of 
mRNA specific for albumin and the synthesis of 
the specific cDNA probe from this purified mRNA 
have been reported previously [22,23] Analytical 
RNA-cDNA hybridization was performed as de­
scribed [23,24] 
Isolation of polyribosomes from liver of intact 
animals Polyribosomes were isolated according to 
the method of Ramsey and Steele [25J as reported 
previously [26] 
Cell free protein and albumin synthesis Cell-free 
protein and albumin synthesis was performed as 
described previously [19] 
Cloning of the rat albumin с DNA in Escherichia 
toh The purified albumin mRNA was transcribed 
into albumin cDNA and the second strand was 
synthesized using reverse transcriptase as de­
scribed previously [22] Cloning of rat albumin 
cDNA was performed by annealing dC 'tailed' 
double-stranded purified albumin cDNA to 
bacterial plasmid pBR322 linearized by restriction 
enzyme Psil and 'tailed' with dG The recon­
structed plasmids were introduced into F coli HB 
101 according to method of Villa-Komaroff et al 
[27] as described previously [28] Clones contain­
ing albumin DNA sequences were grown in large 
scale and plasmids were reisolated by CsCI band­
ing. phenol extraction and ethanol precipitation 
The recombinant plasmids were then characterized 
using several techniques as described previously 
[28] 
Hybridization analysis of total liber RNA trans­
ferred to nitrocellulose paper Samples of 20 /ig of 
total RNA extracted from hepatocytes were dena­
tured for 20 mm at 550C in buffer containing 0 02 
M morpholinopropanesulfonic acid (pH 7 0), 5 
mM sodium acetate. 0 5 mM EDTA (pH 8 0), 2 15 
m formaldehyde and formamide, then placed in 
separate lanes of a 0 8% agarose slab gel, and 
electrophoresed according to the method as dé-
se π bed by Mamans et al [29] for 19 h at 70 V 
After electrophoresis, the RNA fragments were 
transferred to nitrocellulose paper [29] and hy­
bridized with a 600 basepair fragment of the al­
bumin gene coding sequence which was reisolated 
from plasmid pBR by Pst\ digestion, purified and 
'nick translated' Nick translation was accom­
plished according to a modified procedure of Rigby 
et al [38], using E coli DNA polymerase I Both 
[ 1 2 P]dCrP and [12P]dATP (spec act 3000 Ci 
mmol" l ) were employed to obtain labeling of 10H 
cpm per μ% of DNA After hybridization, the 
nitrocellulose paper was exposed for autoradiogra­
phy at - 7 0 o C on Kodak XAR-2 film 
Results 
A Ibumin secretion in hepatocyte suspension culture 
The capabilities of the isolated rat hepatocytes 
used m the present study have been characterized 
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рмоі ьес «і*а л bum 
ре IO6 hepaiocyies 
Fig 1 Set-ntion of j lbumm hv i iol j ted г л hepatocvuif l 5 10'' 
(.ells/ml) were iriLubated ïot 22 h in the prtstnue of * pC ι 
[ H]kuLint ml \ t the indica led times samples were 
withdrawn and portions of the medium were f гол. η until 
assayed Albumin wjs quantiUtivLlv deiermirn.d hv duplicale 
inimunoprtxipitddons from prot i i fb SLI-TLILÜ in (he Lulture 
medium Albumin stxruion in the presente ( О — — О ) and 
m ι lu. absente ( · · ) of 0 49 μ Μ Jexamethasom. dis 
»HJIUITI phosphate was examined The results are the means 
-' S Π »if five cxpenmems 
as described previouslv [7] The cells were morpho 
logiLjlK intact showing a \iabil itv as determined 
hv lr\pan blue exclusion higher than 904 After 
22 h of incubation 75 8 0 ^ of the hepatocMes 
were siili viable Incorporation of labeled pre­
cursor into hepatic R N A occurred hnearlv with 
time For over 22 h there w-as an incorporation of 
[ l H]leucine into total liver protein at an approxi 
matelv linear rate Newlv svnthesized proteins were 
activeh secreted into the medium throughout this 
period When the synthetic glucocorticoid dc-
xamethasonc disodium phosphate (0 48 μ Μ ) wjs 
added to the culture medium the synthesis of total 
protein as a reflection of the synthesis of secretory 
proteins w(is stimulated [7] 
Incorporation of pHJleucine into albumin 
secreted m the culture medium was found at an 
linear rate for the first 12 h Following this period 
ihe net release of labeled albumin was reduced as 
shown in Fig 1 This finding could be due lo a 
reduced svnthesis and secretion or an increased 
degradation bv proteolysis in the medium Addi-
'/· [3H| cUNA prctws hyti d r r d -
log Rot 
Fig 2 Hybrtduaiion kinetics of RNA Ггаспопь isolated from 
hepatoevtes using [ Ч і І а І Ь и т ш complement ar ν DNA probe 
and the relative coment of albumin mRNA in these hepato-
tvtes I 'HIcDNA specific for albumin mRNA was h>bridi/ed 
to RNA isolated from hepaiocvtes immediaielv after prepara 
lion ( О О ) io RNA isolated from hepalotvtes after 9 h 
(Π Ц) 15 h С? ν) and 22 h (О О ) о Г 
incubation without dexamethasone lo RNA isolaIed from 
hepjiotyies 9 h (Ш •) and 22 h ( φ φ ) of intuba 
lion in the presence of 0 48 μ Μ dexameihasone disodium 
phosphate and ю ihe purified albumin mRNA (* x) 
Kach hybridization curve is the average result of at least three 
experiments The relative content of albumin mRNA in these 
hep шж. s tes was calculated by comparing ihe A,,*, values and 
is shown m Table I 
l ion of 0 48 μ Μ dexamethasone at zero time led to 
a significant increase in incorporation of labeled 
precursor into albumin as compared to control 
experiments ( P < 0 0 5 at 12 and 15 h of incuba 
tion Student /-lest) However after a further 12 h 
incubation the ratio of labeling of albumin found 
in the culture medium was similar to (hat in the 
control experiments and relatively reduced as com­
pared to that of the initial phase (Fig 1) 
Albumin messenger RVA m atro experiments 
To study the effects of glucocorticoids on the 
ssnthests of albumin it is important to determine 
the influence of these hormones on the albumin 
messenger R N A content in hepatocytes As shown 
in f-tg 2 the albumin mRNA content as de 
termtned bv the molecular hybridization technique 
in hepatocyle suspension culture was progressively 
reduced with time After a 9 h incubation the 
albumin m R N A concentration was decreased to 
approx 50% of the initial value In the presence of 
0 48 μ M dexamethasone disodium phosphate at 
- 4 0 -
R Í L A T I V h LhVLL O F A t B L M l N mRNA AS PLR 
C E N T A O E OF CONTROL 
Values arc expressed os пмаш ± S D . p e r t c n i a g o of eonirol 
v.ilue ai Zero itme Signifitani-c is mcasurv-d b> (lie sludtrnl / 
les! 
InLubjlmn 
ΙΙΓΊ!. 
(h) 
0 
9 
15 
22 
W , i h 0 48 μΜ 
dcxiimolhdsontf 
100 
1Ü0±16 
K±4 
20 + 5 
Wiihom 
dexnniethasoiM 
100 
5 0 ± 8 ( / · < 0 . 0 5 ) 
3 5 ± 6 ( Я < 0 0 5 ) 
20+5 
sion culiure had an albumin mRNA level of ap-
prox. 20% of the imlial coneenlration in both 
conlrol and dexamelhasone expenmcnis (Table 1) 
To examine the possible effect of glucocorti-
costeroids on messenger RNA stabilization, the 
albumin mRNA in these experiments was electro-
phoretitally sized. The albumin mRNAs of freshlv 
prepared hepalocytes (at zero time) were slightly 
degraded, as shown in Fig 3 After a short period 
of incubation with or without dexamethasone in 
culture medium, all RNAi containing albumin 
mRNA sequences in these hepatocytes were found 
at the level of 16.5 S on a gel electrophoresis. 
indicating a full-length albumin mRNA. 
zero lime, the albumin mRNA content was main­
tained at the initial level for a 9 h period. There­
after. a progressive loss of mRNA content was 
observed to 55% of the initial value at 15 h of 
incubation. At 22 h. these hepatocytes in suspen-
Cell-free albumin sptíhtsh and albumin messenger 
RNA of in two experiments 
The effect of glucocorticoids on the liver 
synthesis of albumin in vivo was determined by 
measuring the serum albumin levels, the liver con-
tent of albumin mRNA and the cell-free albumin 
synthesis using polyribosomes isolated from the 
livers of intact rats after dexamethasone adminis-
tration. After injection of this synthetic hormone 
either intraperitoneally or intravenously into the 
1 2 3 4 5 6 7 8 8 10 
*»"fft 
% [Vt] cDMA probes nyt>fKS.zed 
./ 
Fig 3 Hybndi/diiijn лпаКми of UK albumin m R N A e m t e n l 
of isolated rat hopaUKVlcs cultured m medium »ilh ( І а т л 
6 10) and withoul (lanes 1-5) 0 4 8 μ Μ de χ ame lha чипе dis-
odium phoNphaic Total R N ^ s were extracted from liepato-
cytCS, denatured, eleelrophoresed. transferred to nitrocellulose 
paper, hybridized 4 i lh a '• Ρ labeled atbum;n probe and auto-
radiographed ач described m MalenaK and Methods. Lanes 1 
and 6. RNA*, fr,im freshly prepared hepaltxyles lanes 2 and 7. 
RNAs from hepatocytes after 9 h iniubaiion lanes ? and S 
RN As from hepatocytes after 12 h meubaiion. lanes 4 and 9. 
R N A s from h e p a i o o i e s after 13 h incubation; lanes 5 and 10, 
RNAs from htp.il teytes after 22 h incubation 
Юд Roi 
I ig 4 IKbndi/at ion kinetics of RN \s isolated from liver of 
rais .ifter mjeclion (cither intrapenlonealK or intravenously) of 
It) nig dcAamclli.isonedisodium phosph He [ И | і І ) \ Л specific 
tor albumin mRNA wm Inbndi/ed to RN V ol Ml uvera 9 h 
( : ( ) І^ h ( · · ) . 22 h . · - - · ) ..fier de 
xamethastme administration and lo purified albumin mRNA 
(>. xl I h e hvhridi/jtioii kinetics «·Ι RN \s lu.li icd liom 
livers of rats al /ero lime and frtWl COtttrvH rat livers were 
ideutical to those of RNAs isolated after dexamelliasotK ad-
ininfslratii-n I or technual reasons these li>brid /ali>n kinetics 
Ute not shewn HI lilis ІІіаіГі. 
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jnmuK Kith a Jose ranging from ^ /ig lo 10 mg 
per rat there was no deteuable «.hange in albumin 
inKNA lontini up to 24 h as compared «uh the 
limlings in conirol rat» (I ig 4) In addition no 
change in albumin mRNA (.ontent was observed 
liter repeated injections with 10 mg of dexametha-
sone at 6 9-16 and 21 h after the initial injection 
(10 mg) Also no changes in LCII free albumin 
synthesis or in serum albumin levels were observed 
in these experiments (data not shown) 
Discussion 
From numerous studies it has been demon-
strated that the synthesis of plasma protein in the 
liver in vivo is regulated by multiple control mech-
anisms To maintain a homeostatic condition, the 
rate of svmhesis of a speciTiL protein for example 
albumin depends not only on the availability of 
amino acids as building blocks (31.32) but also on 
other specific factors In the case of albumin. 
serum albumin concentration (oncotic pressure) 
[33) energy supplies (34) and specific ammo acid 
[15) plus important roles in the regulation of the 
svnthesis In iniacl animals glucocorticoids may 
influence the specific protein synthesis m the livei 
bv more than one mechanism These hormones 
mav exert their effects directly on the liver cells by 
affecting one or more of the many subcellular 
processes involved in protein synthesis but the 
changes m protein synthesis could also be induced 
indirectly occurring secondary to the effects of 
these hormones on the metabolic pathway of other 
organs or tissues Because of the complexities m-
voKed in nnalysing the influences of these 
hormones on the liver synthesis of a specific pro-
tein in vivo it seems suitable to use hepatocyte 
suspension culture to assess the specific protein 
s\nthesis under direct influence of these hormones 
on the hepatoevtes 
The effect of glucocorticoid on albumin s>nlhe-
sis in hepatocyte suspension culture can be de-
termined by comparing the albumin secretion by 
the hepatocytes exposed to glucocorticoid with 
that of control experiments By this approach 
glucocorticoid may be considered to have a stimu-
latory effect on albumin svnthesis as demon-
strated in Fig 1 However in these experiments 
we have also shown that glucocorticoid (de 
xamethasone) is not able to induce a rise in the 
albumin mRNA content to a level higher than the 
initial value as found in freshly prepared hepato-
cytes and in vivo although the level of albumin 
mRNA in hepatocyte suspension culture exposed 
to dexamethasone is significantly higher than that 
of control experiments for a 9 h period (Fig 2) 
This finding may be due to an enhanced synthesis 
of albumin mRNA or a result of mRNA stabiliza-
tion of glucocorticoid or a combination of these 
two effects Since the hepatocytes cultured for 9 h 
were still able to synthesize fibrinogen mRNA at a 
maximal rate in response to a delayed dexametha-
sone exposure as reported previously [7] the de-
creased albumin mRNA content in control experi-
ments cannot be the result of decreased viability of 
these hepatocytes The effect of glucocorticoids on 
cultured hepatocytes has been extensively studied 
It has been demonstrated that glucocorticoids pre-
serve to a certain extent the specific function of 
hepatocytes in vitro and prolong their retention of 
a polygonal morphology (36.37) Addition of this 
hormone in primary cultures of adult rat hepato-
cytes led to a preservation of the adult liver pat-
terns of pyruvate kinase and aldolase isoenzymes 
and to a maintamance of the initial level of gluco-
kmase (38) In the present study, we identified 
partially degraded albumin mRNAs in freshly iso-
lated hepatocytes. despite the albumin mRNA as 
determined by molecular hybidization assay being 
at the in vivo level After a short period of incuba-
tion the low molecular weight RNAs containing 
albumin mRNA sequences disappeared and there 
was a progressive loss of albumin mRNA se 
quences in hepatocytes cultured in the absence of 
dexamethasone After addition of a single dose of 
dexamethasone the albumin mRNA sequence 
content in these hepatocytes was maintained at the 
initial value and as full length mRNA for 9 h 
Nevertheless dexamethasone is not able to in-
crease the albumin mRNA content in hepatocytes 
in vitro and in vivo and to stimulate albumin 
synthesis We therefore believe that gluco-
corticoids do not play a key role in the regulation 
of albumin synthesis The above findings how-
ever support the conclusion that glucocorticoids 
preserve the initial level of albumin mRNA in 
hepatocytes in vitro and thus play a role in the 
control of spontaneous dedifferentiation of liver 
cells in culture [39] 
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CHAPTER III 
FIBRINOGEN FRAGMENTS X,Y,D AND E INCREASE LEVELS 
OF PLASMA FIBRINOGEN AND LIVER mRNAs CODING FOR 
FIBRINOGEN POLYPEPTIDES IN RATS 
Thromboses and HoeinosUsts - С h К Schatuuir Verhp GmbH Í19KM 
Fibrinogen Fragments X, Y, D and E Increase Levels of 
Plasma Fibrinogen and Liver mRNAs Coding for 
Fibrinogen Polypeptides in Rats 
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Summary 
Previously we demonstrated that in vivo regulation of liver 
fibrinogen svmhesis occurs via the fibrinogen mRNA level 
However the molecular rcguldlory mechanism of fibnnogen 
synthesis is still not well understood Fibrinogen or fibnn degra 
dation products might play an important role in regulating 
fibrinogen svnthciii In our present study we have injeclcd rats 
mirapentoncalh with purified homologous fragments and meas 
υ red the liter COHILOI »Γ mRNA % pea TIL coding for fibnnoaen 
Increased levels of fibrinogen mRNA and clesattd plasma 
fihrinocLii concLntrations were observed in rats after administra 
tion oí fibrinogen digradatKin pnnliitts Χ Y О ц г* D u l e or t 
I ragment L or E has η less siimulalorv effect than Χ Y or 
D
 ue whereas cross linked fibrin degradation produu D dimer 
dtx·. noi LiiLredM filmnogen synthesis This amele reports for the 
first time ¡) stimulator) efftet of ihc high molecular weight 
fibrinogen degradation products un fibrinogen synthesis 
Introduction 
Plasma ttbnnogen level is increased during the acute phase 
reaelion as ι result of enhanced biosynthesis in the liver ( I) 
PreMOiislv we demonstr.iLcd that regulation of the fibrinogen 
s\nihesis m the liver oeiurs νι ι modulation of the level of 
messenger RNAs coding *or fibrinogen polvpeptidcs l2-3) 
Several factors sueh as hormones (4-6) fattv acids P) certain 
leucoevtie priKluns (8-9) and phsmin degradation products of 
fibrinogen ind fibrin (1(1-18) have been reported to play an 
important role in the stimulation of fibrinogen synthesis dunng 
the acute phase response The exact molecular mechanism of the 
regulation of fibrinogen ьупіЬсмч is however still poorly under 
stood 
Stimulatory effects of fibrinogen dcgradidon products (FDP) 
or plasimn treated fibnnogen on plasma fibrinogen level have 
been shown bv numerous invesugaiors (10 12) bui other invev 
tigators (12-Ы) could not confirm these findings Most of thebc 
investigations were criticized since the methods for evuluating 
A prt hmm iry repon of ihiv WOTV has been published m abstrncl form 
in Hipiinlogy ІУЙІ i K14 
( orrcsponJenct to S H Yap M D Division of Gastrom lesti nal 
jnd Liver Disease Deparlnieni of Mt du. me Si RjJhoud Hospital 
UnivLTMiv of Mijmegcn AVK) HB Nijmegen Tbc Netherlands 
'Piesent nkJress Ojuhru·; Insutule Leiden Thi. Ncihcrlands 
fibrinogen synthesis m these studies were indirect Moreover 
mixtures of early fragments (X and Y) and/or late fragments (D 
and fc) of fibrinogen or degradation products of noncross linked 
fibnn or of cross linked fibrin (E and D dimcr) were used 
In this study, we demonstrate increased levels of liver 
messenger RNAs coding for fibnnogen polypeptides and elevated 
plasma fibrinogen concentrations m rats after intraperitoneal 
administration of purified homologous fibrinogen degradation 
products X Y Dtr.TA О
С И І
 or E Fragment E or E has a less 
slimulalory effeel than Χ Y or D u , c (on a molar basis) whereas 
crossi m к ed fibrin degradation product D dime г does not increase 
fibrinogen synthesis This article reports for the first time a 
stimulaiorv effect of the high molecular weight fibrinogen degra 
dation products X and Y on fibrinogen synthesis 
Materials and Methods 
Animals 
Mile Wistjr rais weighing 1Ш) 24(1 prams were used ihroughoul and 
were maini a med on slundartl Purina Cho* and »aicr ad libiium Animali 
were iii)icled mirapcrttoneally with plasmm derived fragments of fibnno 
fún dnd fihrm or an «.ЦІІНІ volume (I ml) ol 1)9"» N iCl solution column 
eluaie or intact fibrinogen as control ai midnight Rdts wen. sacritieed 
4 hr after injection (V a m ) for preparation of liver RNA or a hlood 
sample «as withdrawn bv orbital puncture 1Й hr after mieciion [b 00 
ρ m ) In some expenmenîs RNA *as also isolated 18 to 24 hr after 
ddmint·;! ration of |-[>P or f dp 
Prfparanon ami Punftcanon of FDP and fdp 
Rril fibrinogen uj« prepared under conditions lu prevent pro(ci>l>iic 
dcpratbtion (14) farly plasmm de m cd fibrinogen dearadjtion produis 
X Jtld Y »ere prepared as described (2I)-21) Latt fibrinogen fragments 
D *, Оц ι , and E and fibnn fragments D dimer and fc were purified 
according lo Van Ru>ven Vermeer et al (22) D(4,t is the terminal 
lihnnogen degradation product formed at 2(1 m M С л ' concenti mon 
(MW 41 (КЮ) D1 ( ^ is the main fragment D of fibrinogen with MW 
ftliniNi which is obi nned after prolonged incuba ι ion with plasmm in a 
medium com lining ** mM LOTA (22) Ь and E differ from cath other In 
the Π brino pept ides A and fi which arc present in l· (FDP) and liKt in b 
(fdp) by ihc aelton of ihrombin Column eluates were prepared hv 
running the column used for purification of the fragments with buffer and 
pooling the right fractions 
All preparations «ere endotoxin free as determined »uh the Limulin 
assav (23) and Stored frozen al -21ГС in (Ι Π M NdCI 
frcparalHHi of Purified РіЬппчцеп Polypeptide Vesttnger RH As and ¡Ή} 
Lubeteti Сomplrmcnran D\A\ (rD\Ai) 
Purification and eharaciciiution of fibrinogen polypeptide mRNAs 
and symhesis of tht specilie eomplemcntarv DNA probe from ihise 
mRNAs h ive bcin rtported previous!) (2 Τ 24) 
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Ргерапіішп of Ι iver RNA anil RNA-iDNA Hybridltatton 
Total post nuclear li^cr RNA *as isolated as described by Taylor and 
Schimke (25) An.il)tical RNA cDNA hybndizaiion was performed 
rfLCordmg to Housmjn el <il (36) as described previously (27) 
Other Methods and Assays 
RNA concentrations m the hybridization assay were determined by ihe 
method of Fleck and Munro (28) Polyacrylamide gel electrophoresis was 
performed .iccordmt; to Weber and Osborn without sample reduction with 
2-mcrLdptoethanol (29) Plasma concentrations of fibrinogen were deter 
mined as described bv Vermylcn ci al {Mi). 
Results 
To i iuth the effect of fibrinogen or fibrin degradation products 
on the biosynthesis of fibrinogen it is particularly important to 
utilizo purified homologous fragments As shown in Fig 1. the 
fragments used for the current experiments have been purified to 
homogeneity All fragments were endotoxin free as determined 
by a Limulus assay 
The plasma fibrinogen concentrations m rats 18 hr after an 
intrapcriloneal administration of fibrinogen fragments are shown 
in Table 1 As compared to control experiments (saline column 
cluate or fibrinogen), the plasma fibrinogen concentration was 
significantly increased in rats after injection of fragments X. Y. D. 
E or non cross-linked fibrin degradation product E Injection of 
either DCüt( (M W 93000) or D r ( , r A (M W 8000(1) resulted in л 
similar response However, administration of crosshnked fibrin 
degradation product D dimer did not lead to an increased plasma 
fibrinogen concentration Although the fibrinogen synthesis was 
not measured in these experiments, the increased levels of plasma 
fibrinogen represent an important indicator for enhanced fibrino­
gen synthesis in the liver 
During the acule phase response it has been documented that 
the liver content of fibrinogen mRNA is also markedly increased 
and the peak value of mRNA content is found several hours prior 
to the peak value of plasma fibrinogen after tissue injury (31) In 
order to gam some insight m Ihe biochemical processes for the 
enhancement of fibrinogen synthesis by Ihe fibrinogen fragments, 
wc thought that it was important to determine the sequence 
content ot fibrinogen mRNAs in rat^ in these ex)>erimcnts For 
this study liver RNA was prepared 9 hr after administration of 
libnnogen fragments As shown in Fig 2 an increase of fibrino­
gen mRNA level was obsened. when purified fragments X, Y D. 
E or E was administered Fibrinogen degradation product E or 
non cross-linked fibrin degradation produci E had a lesi stimula-
tory etfecl as compared with FDP X and Y (on a molar basis) An 
incredied level of fibrinogen mRNAs was not found in rats after 
intraperitoneal inieclion of cross linked fibrin degradation and 
these fragments did not influence the plasma fibrinogen concen 
Iration Thus increased levels of fibrinogen mRNAs m the liver 
correlate with elevated plasma fibrinogen coneentrations as 
shown m Table 1 
Discussion 
During the acute phase response, fibrinogen synthesis is 
markedly increased Although expérimental data have accumu-
lated m ihe last ten years, the precise molecular mechanism for 
the stimulation of the fibrinogen synthesis is still noi yet eluci-
dated However, a number of factors may play an importanl role 
in this regulation The first report concerning the role of 
fibrinogen degradation products or fibrin degradation products m 
the regulation of fibrinogen synthesis appeared around 1970 (10) 
The degradation of fibrinogen or fibrin takes place under 
influence of plasmin The fibnnogenolysis or fibrinolysis results 
Fig I SDS-Polyacrylamide gel electrophoresis cf fibrinogen and fibrin 
degradation products without reduction according to Weber and Osborn 
(39) Slot 1 Fibrinogen (MW 34Ü000), Slol 2 FDP X (MW 260000) 
Slot 3 FDP Y (MW ШООО). :>Ìot4 FDP D ^ (MW 93000), Sloi5 
FDP DK.T4 (MW 80000) Slot 6 fdp D dimei (MW 180000) Slot 7 
FDPE(MW 50000) fdp E behaves identically (data ηι·ΐ shown). Slot S 
Molecular weight markers Phosphorylase b (MW 94000) Albumin (MW 
68000). Ovalbumin (MW 45000), Carbonic anhydrase (MW WDOO), 
Trypsin inhibitor (MW 20100) and α Lact.ilbumm (MW 14400) The gel 
contained 9% acrylamide and was stained with Coomassie brilliant blue 
scquentialh to the following fragments X. (MW 260000), Y 
(MW 150000). D c i i e (MW 93000). D E 0 T A (MW 80000). E (MW 
50000) from fibrinogen, and D dimer (MW 180000) and E' (MW 
50000) from fibrin (28-30) 
In an m vivo model in dogs (10) and in rabbits (15). 
homologous FDP or plasmin-treated fibrinogen have been shown 
to increase Ihe plasma fibrinogen levels Similar results were 
obtained m rabbits {11, 12) and in mice (32) after an intravenous 
administration of thrombin 
Since FDP of fdp could not be detected after thrombin infusion 
and the stimulating effect of FDP or fdp could nol be confirmed 
by other investigators using the same techniques !o measure the 
fibrinogen synthesis in vivo (12-14), some authors suggested that 
the enhanced fibrinogen synthesis is due to в mechanism indepen­
dent of significant fibnnogenolysis or intravascular coagulation 
(12. 32) 
Recently using the ['''С] carbonate method to measure the 
fibrinogen synthesis m vivo and m perfused liver Franks et al 
Table I Concentrations of plasma libnnogen ш rats І8 hr after injection 
of FDP or fdp and in control animals 
Control 
after injection of 
IS mg (44 nM) fjlinnogcn 
3 mg (7 5 nM) FDP Χ 
2 mg (Π nMÌ FDP Y 
2 me (21 5 „M) FDP Dt.,t 
3 mg (35 nM) FÜPDbrT1. 
ί mg {20 nM) FDP E 
3 mg(40nM) FDP E 
2 mg ( I l nM) fdpD-D 
Fibrinogen (mg/ml) 
2 8 ± 0 ì 
2 7 ± Ü 2 n s 
4.9 ± 0 3 
4.1 ± 0.2 
4 2 * 0 4 
41 ± 0 3 
3.4 ± 0 2* 
4.0 ± 0.4 
2 8 ± 4 4 η s 
Data are expressed as the average of al least three experiments with 
3-5 rats per experiment ± Ь D As compared и ihe control value ihe 
increased plasma fibrinogen concentration is sla;isiie..ll> significant 
(p <0 001). except 'has a p-value <0 05 (Students t-tesi) 
213 
Relative іпсг*ме oí fi&m-iogen polypepi'de mRNiA «e. percer->i»ge 
500 η 
Coniroi Fiömogen Χ ν Oc »ie E D O 
IS mg 2 rr>9 2 mo 2 mg 1 mg 3 mg 
Fix 2 Hyhndiution kinctm of RNA traci ions isolami from livcre of 
r j t i 9 hr after intr.ipcntoncal injection of ЮР or fdp 
pH) C D N A specific for Tibniiogco polypeptide mRNAi was hybndued In 
RNA from control rats injected with 1 ml -aline ( · - # ) RNA isolated 
from animals injected with 2 mg (7 5 nM) FDP Χ (•-•). 2 mg (13 ηΜ) 
FDP Y (Α-A) IS mg (44 nM) ral fibrinofen (•-•) 2 mg (21 S nM) 
FDPD t »(u-A) I mg (20 nM) FDP E (D-Q) and 2 mg ( I I nM)fdpD 
dimcr (0-0) For companion hvbndizaiion of fibrinogen polypeptide 
cDNA 10 RNA from 24 hr turpentine treated rah η shown (я-х) E»ch 
hyh'idizanon curve was the average result of at least 3 cxpeninems with 
1 -S rats per experiment Log Rot the logjnthmK value of the product of 
inilml RNA сопсепігЛіоп (Ro) in mol nucleotides per liter and time (1) m 
stconds assuming that A260 of I 0 corresponds lo ·№ μg RNA per ml 
(16) reported a signtficanl increase in fibrinogen synthesis after 
administration of purified fragment D In these and other studies. 
к has been shown that fragment E is abo able to stimulate 
fibrinogen synthesis but less effective than fragment D (15-17) 
Fragment X was demonstrated not to have such an enhancing 
effect (11 14 18) 
In our cxpenmenis, we have injected n i s mtrapentoncally 
with purified homologous fragments and measured the plasma 
fibrinogen concentrations and the liver coment of the mRNAs 
coding for the fibrinogen polypeptides Alt early or late FDP or 
noncross linked (dp are able to increase the levels of fibrinogen 
mRNAs and of plasma fibrinogen Fragment E and E' hdve a lebs 
stimulating effect than Χ, Y or D (on a molar bdsis) Since 
antiparallel cross-linking at the carboxyl terminal portions of the 
γ-chain in D dimcr apparently aboli&he;· the enhancing effect, the 
involved sites of (he fragments arc probably located on the 
carboxyl terminal portions of the y-chams 
Го investigale whether the stimulatory effect is due to d direct 
•iLtion of the fragments on tht hepatoevtes (Mich as m сам. of 
enhanced prothrombin *>> π thesis hv the ammo terminal pc ρ tick Ы 
prothrombin (31) or as a result of an indirei.! pathway isolai*.d 
hvpatocvles in monolayer culture were incubali.d with these 
purified Iragments No effect of these fragments tin ihe svnthesis 
and secretion of fibrinogen and on the level of fibnnojçen mRNAs 
in these hepatocytes was found (data not shown) IhiN result is 
consistent with the finding of Ritehic et al (9) and indicates that 
the enhanced fïbnnogcn ^ η thesis is not the effect of a direct 
.iclion of fibrinogen fragments on hepatocytes Nevertheless 
Ritchie et al (9) suggested that a factor produced by mnnocyics 
when these cells were incubated with fragments Ü or fc is 
responsible for the stimulation of fibrinogen synthesis bv the 
hcpatoc)tes bxpenmcnis are currently conducted lo investigate 
this hypothesis 
Whatever the explanation may be for the stimulation of 
fibrinogen fragments on fibrinogen synthesis, the contradictory 
results of in wvo and in vitro (isolated hepatocytes) studies 
indicate (he complex mechanism involved in the regulation of 
fibrinogen synthesis The enhanced fibnnogen synthesis in vivo by 
fibrinogen fragments is again modulated at (he m RNA level as 
has been shown previously m acute phase reaction after tissue 
infurtes (2 3) 
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ABSTRACT 
During the acute phase response, the synthesis of fibnnoqpn and its 
messenger RNA content in the liver are increased. Corticosteroids or 
other hormones can not be implicated as the sole factor for modulating 
the hepatic synthesis of fibrinogen under this condition. Although fi-
brinogen- or fibrin degradation products can stimulate the fibrinogen 
synthesis in rat in vivo, the role of these substances in stimulating 
fibrinogen synthesis during the acute phase response and the molecular 
mechanism by which the fibrinogen synthesis 13 enhanced are still not 
clear. 
In our present study, we demonstrate that monocytic (macrophagic) pro-
ducts and interleukin I (a 15kD.mol.weight protein in rabbits) enhance 
in vivo and in vitro (monolayer culture of hepatocytes) synthesis of 
fibrinogen and increase hepatic content of fibrinogen mRNAs. The in-
creased synthesis of fibrinogen in rats treated with turpentine can be 
partially reversed by a specific antibody against the 15-kD protein of 
monocytic products. This in vivo observation is also supported by the 
in vitro finding of normalization of fibrinogen secretion of hepatocy-
tes by addition of this antiserum in medium containing monocytic pro-
ducts. Thia antibody recognized the 15kD mol.weight component of the 
monocytic products in immunoblotting experiments and was also able to 
completely abolish the IL-1 activity of the monocytic products in the 
thymocyte proliferation assay. 
These findings suggest that a humoral factor or factors produced by 
inflammatory cells is (are) responsible for the stimulation of fibri-
nogen synthesis in the liver during the acute phase response.However, 
the presence of a high concentration of glucocorticoid is essential 
for the increased synthesis of fibrinogen in primary cultures of rat 
hepatocytes. 
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INTRODUCTION 
Durmg the acute phase reaction, fibrinogen synthesis in the liver is 
markedly increased. Several factors such as hormones (1-7), fatty 
acids (B-9), plasmin degradation products of fibrinogen and fibrin 
(10-12) have been reported to play an important role in the stimula-
tion of fibrinogen synthesis during the acute phase response. Although 
experimental data have accumulated in the last ten years, supporting 
the hypothesis that a humoral factor (or factors) is (are) involved in 
the regulation of liver synthesis of fibrinogen during the inflammato-
ry reaction, the precise molecular mechanism of the regulation of 
fibrinogen synthesis is still not elucidated. 
Previously, we demonstrated in vivo (13,14) and in in vitro studies 
(13) that regulation of liver fibrinogen synthesis occurs via the 
fibrinogen mRNA level. Glucocorticoids stimulate the synthesis of 
fibrinogen and its messenger RNA content in hepatocyte suspension cul-
ture but not in intact animals (15) and in primary culture of rat he-
patocytes (16).Other hormones such as insulin and adrenalin have no 
effect on the fibrinogen synthesis in vivo and in vitro (16). Further-
more, intraperitoneal injection of fibrinogen fragments X, Y, D and E 
increase the levels of plasma fibrinogen and liver mRNAs coding for 
fibrinogen polypeptides in rats (17). In this study, we investigate 
the influence of monocytic or macrophagic products and interleukin-I 
(a 15kD mol.weight protein in rabbits) on the fibrinogen synthesis and 
its messenger RNA content in rat liver in vivo and in primary culture 
of rat hepatocytes. furthermore, we have characterized and investiga-
ted the effects of a specific polyvalent antibody against the 15kD 
mol.weight component of monocytic products. The results indicate that 
monocytic products including interleukin-I are responsible for the en-
hanced synthesis of fibrinogen in the liver during the inflammatory 
reaction and that the enhanced synthesis of fibrinogen and its mRNA 
content could be partially (in vivo) or completely (in vitro) reversed 
by the antibody against the 15kD mol.weight component of the monocytic 
products. However, the presence of dexamethasone in a high dose is a 
prereguisite for fibrinogen induction in primary culture of rat hepa-
tocytes indicating the permissive action of glucocorticoids in the 
stimulation of fibrinogen synthesis during the acute phase response. 
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MATERIALS AND KETHODS 
Animals: 
Male Wistar rats weighing 180-200 g were used throughout and maintai­
ned on standard Purina chow and water ad libitum. 
For the acute inflammatory reaction, rats were injected intramuscular­
ly with 1.0 ml of commercial turpentine. 
CBA mice, used for the thymocvte proliferation assay, were from TNO 
Rijswijk, the Netherlands. 
Preparation of rat hepatocytes and primary culture: 
Liver cells were prepared according to the method of Seglen (18) with 
some modifications as described previously (15). All buffers were 
autoclaved prior to use and oxygenated by direct bubbling with oxygen. 
Collagenase buffer (0.5 mg/ml) was supplemented with 0.05 mg/ml soy­
bean trypsin inhibitor. 
Cells were filtered, preincubated and centnfuged in Ca2 + and Mg2+ 
free Hanks' balanced salt solution containing 2% bovine serum albumin. 
Damaged and non-parenchymal cells were removed. The cell suspension 
was then passed through a 100 μΜ nylon filter and the viability of the 
hepatocytes was determined by trypan blue exclusion tests. 
The culture medium was William's medium E supplemented with Ъ"і (v/v) 
fetal calf serum, 2 mM L-glutamine, 20 mil/ml porcine insulin, dexame-
thasone as indicated, 2.5 μg/ml fungizone, 50 μg/ml gentamycinp, and 
100 μς/ιηΐ vancomycjne. Hepatocytes were seeded at a concentration of 
175 χ 10' cells per cm2 in polystyrene flasks or dishes and main­
tained in a humidified atmosphere composed of 95й air and 5°ί C02. The 
medium was renewed 2-4 hours after cell seeding and every 24 hours 
thereafter. 
Incorporation of labelled precursor into protein: 
[ Ή ] leucine (5 μΟι/πι]) was added to the cell culture medium. At the 
indicated times, duplicate 75 μΐ samples were withdrawn from the me­
dium. 10 μΐ samples were diluted to 100 μ] in 0.1N NaOH and 1 ml ID'S 
trichloroacetic acid was added. Samples were heated for 20 m m at 9CPC 
and subsequently cooled on ice for 20 m m . Protein precipitates were 
collected on nitrocellulose filter discs and counted for radioactivi­
ty. 
Immunoprecipitation of ГІНІ -labelled fibrinogen: 
Determination of [^HJ-labelled fibrinogen in the culture medium was 
essentially performed аь described previously (19). 50 μΐ samples were 
diluted in 500 μΐ buffer containing 10 mM sodium phosphate (pH 7.2), 
150 mM NaCl, П Triton X-100, 0.5S sodium deoxycholate, 0.П sodium 
dodecyl sulfate (SDS), 5 mM leucine, 0.1 mM phenylmethylsulfonylfluo-
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ride and 1 mM EDIA and incubated with 1000 dpm [1ήθ] fibrinogen as 
tracer for recovery, 20 μς fibrinoqen as carrier and goat-anti-rat-
fibnnoqen γ-qlobulin. After 16 h incubation at 4 C, the mixture was 
layered over a 200 μΐ IOS (w/w) sucrose cushion and centrifuged for 
5 min in an Eppendorf centrifuqe.The pellet was washed three times, 
dissolved in 0.1 NaOH and precipitated with 10" trichloroacetic acid 
and collected on nitrocellulose filter paper discs for countinq, using 
a double labelling program. [1^C]-fibrinoqen was prepared chemically 
from the purified protein with P*C ] formaldehyde by reductive me-
thylation as described by Crane and Miller (20). 
DNA determination: 
Cells were suspended in water and sonicated. After cent rifuqation, 
DNA in supernatant was measured by a fluorometric technique as descri­
bed by Kapuscinski and Skoczylas (21). 
Preparation of liver and cell RNA: 
Total post nuclear RNA of liver tissue was prepared as described by 
Taylor and Schimke (22). Cytoplasmic RNA from hepatocytes in primary 
cultures was isolated according to the following procedure. Cell pel­
lets were homogenized in a buffer containing 50 mM Tns-HCl (pH 7.ή), 
25 mM NaCl, 5 mM МдСІ2, 0.25 M sucrose and 0.3 mg/ml heparin. After 
addition of 1/10 vol. 10S Triton X-100, and centrifugation of the par­
ticulate material for 10 min at 16000 χ q, RNA was extracted by addi­
tion of 1/2 vol. 0.3 M NaCl, 1.5S SDS, 15 mM EDTA and 30 mM Tns-HCl 
(pH 9.0) and an equal volume of phenol/chloroform/isoamylalcohol 
(50:48:2 v/v/v). When no detectable interface remained 2.5 vol. cold 
ethanol was added. RNA was precipitated overnight at -2CPC and isola­
ted by cent π fugat ion at 16000 χ g for 20 min at -^С. 
Preparation of purified fibrinogen mRNA and [JHl labelled complemen­
tary DNA (cDNA): 
Purification of mRNA specific for rat fibrinoqen and the synthesis of 
the specific complementary DNA probe from this purified mRNA have been 
reported previously (13). Analytical RNA-cDNA hybridization was per­
formed as described previously (13). 
Preparation of monocytic products and specific antibodies against 
interleukin I: 
The monocytic products were prepared by incubation of activated macro­
phages isolated from peritoneal exudates induced by qlycoqen in rab­
bits as described by Ritchie and Fuller (23). These preparations were 
endotoxin frei» as tested by a Limulus test. The 15kD molecular weiqht 
protein was purified from these monocytic products by C50-Sephadex 
chromatoqraphy and qel electrophoresis (24).This protein showed inter-
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leukin I activity as determined by the thymocyte proliferation assay 
(25). 
Specific antibodies against interleukin I were obtained from immunized 
goats using this purified 15kD M.W. protein as immunogen. 
For comparison, in some studies we have used commercially available 
interleukin I obtained from activated human monocytes (Ultrapure human 
interleukin-I. Genzyme, Boston, Mass. U.S.A.). 
ImtTiunoblotting 
The monocytic product preparation was subjected to SDS-PAGE (IBS 
w/v) and then transfered to nitrocellulose. The nitrocellulose sheet 
was blocked with Ti gelatin in phosphate buffered saline (PBS) for 1 
hr at room temperature, washed 5 times with PBS-Tween 20 (0.05S v/v) 
and incubated for 1 hr at room temperature with the antibody against 
the 15KD component of the monocytic products, diluted in PBS contai­
ning 1% gelatin. After washing 5 times with PBS-Tween 20, the sheet 
was incubated with peroxidase conjugated rabbit-anti-goat immunoglobu­
lins (1:1000 dilution) for 1 hr at room temperature. After washing 5 
times with PBS-Tween 20 the nitrocellulose sheet was immersed in sub­
strate solution: 60 mq 4-chloro-1-naphto] in 20 ml cold methanol, ad­
ded to 100 ml PBS, containing 60 μ] of 30% H2O2. The colour developing 
reaction was terminated by washing the sheet in water, containing 20ÎS 
methanol. 
Thymocyte proliferation assay 
The thymocyte proliferation assay as described by Gery et al (25) was 
used to assay monocytic products for IL-1 activity. Briefly: thymocy-
tes were isolated from CBA mice (aged 6-12 weeks) and suspended in 
RPMI 1640 DM medium supplemented with 5й fetal calf serum, 2 mM 
L-glutamine and antibiotics. 50 μΐ thymocyte suspension, corresponding 
to 10 cells was then added to 96-well microtiter plates (serocluster 
TMj Costar) followed by addition of 50 μΐ of a solution containing 5 
μς/ιιιΐ phytohaemagglutinin and 6x10 M 2-mercaptoethanol and 50 μΐ 
test substance. Cells were then incubated for 48 hr. 0.5 μCl [б- н ] -
thymidine was added to each well. After a further incubation for 24 
hr, cells were harvested and assayed for incorporated radioactivity in 
a Uguid scintillation counter. 
Preparation of poly A containing RNA: 
The poly A containing RNA was prepared from total RNA extracts by oli-
qo (dT) cellulose chromatography (26) as described previously (19). 
Materials: 
L - [ 4 , 5 - 3 H ] leucine (76 Ci/mnol), [6-3H]-thymidine (22 Ci/mMol) 
[14c]-formaldehyde (17.6 mCi/mol), [5-Зн] dCTP (1 .4 Ci/mmol) were 
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obtained Ггот the Radiochemical Centre, Amersham. Pollaqenase type I, 
soybean trypsin inhibitor, Oyster glycogen type III, bovine serum al­
bumin, heparin from porcine intestinal mucosa, dithiothreitol and 
Hepes were purchased from Sigma. William's medium E, RPMI 1640 DM me­
dium and fetal calf serum were from Flow Laboratories. Triton X-100 
and SDS were obtained from BDH chemicals Ltd. Ribonuclease free sucro­
se, EDTA, phenol, sodium deoxycholate, salts and solvents were purcha­
sed from E. Merck. Deoxynbonucleoside triphosphates were from 
Schwarz/Mann, and oligo(dT)ig was from Collaborative Research. Avian 
Myeloblastosis virus DNA-dependent RNA polymerase was kindly supplied 
by Or. J.W. Beard, National Cancer Institute U.S.A. Nuclease SI 
(Aspergillus Oryzae) was purchased from Boehnnger and stored at 2.5 
10 5 units/ml in 501Í glycerol, 50 mM NaCl, 0.1 mM ZnCl2 and 20 mM 
Tris HCL pH 7.5 at -2CPC. DradexonR (dexamethasone disodium phospha-
te) was obtained from Organon, The Netherlands. Porcine insulin was 
from NOVO Industri, Amsterdam, the Netherlands. Phytohaemagqlut m m 
was from Wellcome Diagnostics, Dartford, UK. All tissue culture plas-
tic was from NUNC, Denmark. Nitrocellulose filter paper was from 
Schleicher and Schuell, FRG. All glassware was sterilized and soluti-
ons were freshly prepared and autoclaved prior to use. Bovine чегит 
albumin and soybean trypsin inhibitor were dialyzed against 0.15 M 
NaCl and, as all solutions used in the hepatocyte isolation and cultu-
nng, filtered through a 0.22 μΜ Schleicher and Schuell filter and 
stored frozen. 
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RESULTS 
Го study the effect of monocytic (macrophaqic) products and interleu-
kin-I on the biosynthesis of fibrinogen in the liver, we have injected 
these substances intraperitoneally in rats. All preparations were en­
dotoxin free as determined by a Limulus assay. Table 1 shows the plas­
ma fibrinogen concentrations in rats 12 hr after an intraperitoneal 
administration of monocytic products and the purified 15kD mol.weight 
component of monocytic products. The plasma fibrinogen concentration 
in rats after injection of monocytic products was significantly in­
creased as compared with that of control animals. The increased plasma 
fibrinogen concentration was accompanied by an increased content of 
fibrinogen messenger RNA in the liver. For this study the liver RNA 
was prepared 12 hr after injection (figure 1). The plasma concentra­
tion of fibrinogen and its messenger RNA content in the liver of rats 
after intramuscular injection of 1 ml turpentine as a model of inflam­
mation were also determined, as shown in table I, figure 1, and figure 
2. The increased concentration of plasma fibrinogen and liver fibrino­
gen mRNA, 12 hours after turpentine injection were comparable with 
those after administration of monocytic products. Similar resulta were 
obtained after injection of the purified 15kD M.W. protein component 
of the monocytic product (table 1). 
Table 1 Concentration of plasma fibrinogen in control rats and rats 
treated with monocytic products or turpentine (as °i of con­
trol) 
Treatment Fibrinogen 
saline;1 ml;i.p.;12h 100 ± 8 
monocytic products 1-3 mg;i.p.;12h 179 ± 20 
purified 15kD componont of monocytic 
products (100 μg; i.p.; 12h) 158 ± 16 
monocytic products 3 mg;i.p,heat-inact,12h 103 t IB 
turpentine:1 ml;i.m.;12h 160 ± 18 
turpentine;! ml;i.m.;24h 310 t 30 
(the result is the average +S.D of at least 3 experiments, each expe­
riment included at least 3 animals in each group) 
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Figure 1 
Relative levels of fibrinogen polypeptide mRNAs in rat liver 
after treatment with saline (1 ml, i.p.), crude monocytic pro-
ducts (1-3 mq, 12 h after i.p. administration) and turpentine (1 
ml i.m. 12 and 24 hr after administration). 
The relative change in fibrinoqen polypeptide mRNAs levels was 
determined using hybridization data by comparison of the 
Roti/2 value of RNA prepared from liver of control rats to the 
"0*1/2 
values obtained from RNAs of livers of rats after treatment with 
crude monocytic products or turpentine (Rot is the product of 
initial RNA concentration in mol nucleotides per liter and time 
in seconds, assuming that A260 of 1.0 corresponds to 40 μη RNA 
per ml. Roti/2 1 S " ^ value at 50Й hybridization). 
Values are expressed as means t S.D. (n= 4). 
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Figure 2 
Time course of the changes in plasma fibrinogen concentrations 
and fibrinogen polypeptide mRNA levels in the liver during in-
flammation induced by administration of 1 ml turpentine (i.m.) 
in rats. Values for mRNA levels are expressed as percentages of 
controls (mean ± S.D. (n= 4)) and were obtained from hybridiza-
tion data as described in figure 1. Plasma concentration of fi-
brinogen were determined as described previously (17) 
Using the purified 15kD mol.weight component of the monocytic products 
as an immunogen, a specific, polyvalent antibody was raised in qoats. 
This antibody was able to completely abolish the IL-1 activity of the 
monocytic products in the thymocyte proliferation assay (table 2). 
Characterization of this antibody by immunoblottinq experiments showed 
that this antibody recognized the 15kD mol.weight component of the mo-
nocytic products. In addition, this antibody recognized higher mol. 
weight proteins (mol.weight approx.24kD and 34kD), possibly represen-
ting (intermediate) precursors of rabbit IL-1 (27) and a lower mol. 
weight protein (approx. 6kD), possibly a degradation product of IL-1 
(27) (Figure 3). 
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Table 2 Interleukin-I activity of monocytic products as determined 
by the thymocyte proliferation assay (see materials and 
methods) 
medium (control) 
medium+endotoxin ( Ι μ ς / υ ΐ ) 
a n t i b o d y against 15kD component 
monocytic p r o d u c t s 
monocytic p r o d u c t s + a n t i b o d y against 
15 KD component 
cpm[6- H ] - t h y m i d i n e i n ­
c o r p o r a t e d i n t o thymocyte 
76 ± 38 
102 ± 32 
108 t 49 
19,725 t 4320 
104 i 42 
kD 
- 2 4 -
kD 
- 3 4 -
- 2 4 -
- 1 5 -
- 1 5 -
FIG.3 
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Figure 3 
SDS-PAGE (IBS w/v) of monocytic products (lane 1); monocytic 
products after immunoblottinq (lane 3); the purified 15KD mol. 
weight component of monocytic products (lane 2); and the puri­
fied 15KD mol.weight component of monocytic products after immu-
noblotting (lane 4) using the antibody against the purified 15KD 
mol.weight component of monocytic products. Immunoblotting was 
performed as described in materials and methods. After electro­
phoresis duplicate gels were stained with silver, using the 
method described by Heukeshoven et al (35). Approximate mol. 
weight were estimated using ovalbumin (43KD);a-chymotrypsinogen 
(25.7KD);P-lactoglobulin (18.4KD), lysozyme (14.3KD), bovine 
trypsin inhibitor (6.2KD) and insulin (A and В chains) (3KD) as 
marker proteins. 
To examine whether the enhanced liver synthesis of fibrinogen during 
inflammation JS mediated by monocytic products, experiments were per­
formed in rats by concomittant intraperitoneal administration of the 
antibody against the 15-kD M.W. protein of monocytic products. As 
shown in table 3, administration of antibody in turpentine injected 
rats partjally abolished the jncreasinq effect of turpentine on the 
hepatic content of fibrinogen mRNAs. 
In this study, it is also interesting to note that the stimulating ef­
fect of monocytic products on fibrinogen synthesis is in a dose depen­
ding manner. 
Table 3 Relative increase of fibrinogen polypeptide mRNA in rat 
liver in control animals and in animals treated with turpen­
tine and anti IL-1 and in rats treated with turpentine alone 
(as °i of control at t= 9 hr) 
Treatment Fibrinogen mRNAs 
saline;1 ml;i.p. 100 ± 10 
anti IL-1;1 ml;i.p. 101 t 12 
turpentine,1 ml;i.m. 474 ь 27 
turpentine,1 ml;i.m.+anti IL-1 1 ml:i.p. 316 t 34 
(the result is the average t S.D. of at least 3 experiments, each ex­
periment included at least 3 animals in each group) 
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To investigate wether the stimulatory effect of monocytic products on 
the Fibrinogen synthesis is due to a direct action of these products 
on the hepatocytes or as a result of an indirect pathway, experiments 
were also performed in vitro using rat hepatocytes in suspension cul­
ture and hepatocytes in monolayer cultures. In rat hepatocytes in sus­
pension culture, monocytic products had no effect on the fibrinogen 
secretion and mRNA content in the absence or presence of a low dose 
(50 nM) dexamethaqone (data not shown). Since addition of a high dose 
of glucocorticoids including dexamethasone in vitro in hepatocyte sus­
pension cultures lead to an induction of fibrinogen mRNA content and 
fibrinogen secretion (15),this in vitro model is not suitable for in­
vestigating the effect of monocytic product on the fibrinogen synthe­
sis. Therefore, we have designed an experimental model using monolayer 
cultures of rat hepatocytes as shown in figure ή. 
EXPERIMENTAL DESIGN 
day! 
preincubation 
50nM 
dexamethasone 
isolation 
2 
preincubation 
50nM dexamethasone 
'
3 H]-
3 
eucine 
samplmgot media 
I l i , 
\ 
incubation with t incubationwith 
test substances test substances 
attachment determination 
cellular DNA 
J change of medium 
Γιgure 4 
Experimental design. 
After isolation, cells were seeded in polystyrene flasks as 
described in materials and methods using medium containing 50 nM 
dexamethasone. The medium was renewed 2-4 hours after cell 
seeding and every 24 hours thereafter. Test substances were 
supplemented on day 3. Labeling experiments using [^Hj-leucine 
were performed on day 4 in the presence of test substances. 
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Using this experimental system, the effect of monocytic products on 
the secretion of total protein in varying doses of dexamethasone is 
shown in figure 5. Although enhanced secretion of total protein was 
obtained in the presence of a high dose (1 μΜ) dexamethasone, no addi­
tional significant effect was observed when monocytic products was 
given in addition to 1 μΜ dexamethasone.However, the fibrinogen secre­
tion was significantly increased by the monocytic products in the pre­
sence of 1 μΜ dexamethasone (figure 6). The enhanced secretion of 
fibrinogen was accompanied by an increased content of fibrinogen mRNAs 
(table 4). Addition of the antibody against the 15-kD M.W. protein of 
monocytic products lead to a complete normalization of fibrinogen se­
cretion of hepatocytes in medium containing monocytic products (data 
not shown). Enhanced secretion of fibrinogen was also found in in 
vitro experiments using commercially available interleukin-I (data not 
shown). 
Table 4 Relative level of fibrinogen mRNA in hepatocytes cultured 
for 4Θ hrs in presence of 1 μΜ dexamethasone with and 
without monocytic products 
culture medium relative level of hepatocytic 
fibrinogen mRNA 
without monocytic products 100Й 
with monocytic products (200 μg/ml) 275 ± 20Й 
(result is the average ± S.D. of 3 experiments) 
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Secreted protein as ·/·-
of value at T=6h -IL-1 
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dexamethasone = 0 
D-1L-1 
21 hrs 
Figure 5 
The influpncp of crude monocytic products (IL-1) on spcretion of 
total protein in primary cultures of rat hepatocytes into cultu­
re medium in absence of dexamethasone (upper panel) and in pre­
sence of 50 nM (middle panel) and 1 μΜ dexametha4one (lower 
panel). Results were obtained from determination of ['H]-leu-
cine incorporated into total protein per μς cellular DNA as des­
cribed in materials 4 methods and expressed as percentage of va­
lue obtained 6 hours after adding of n'HJ-leucine jn the ab-
sencp of IL-1.1L-1 was added as crude monocytic products (200 μς 
per ml culture medium). Results are the means + 4.D. of 4 expe­
riments. 
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Figure 6 
The effect of crude monocytic products (IL-1) on secretion of 
fibrinogen in primary culture of rat hepatocytes into culture 
medium in absence of dexamethasone (upper panel) and in presen­
ce of 50 πΜ (middle panel) and 1 μΜ dexamethasone (lower panel). 
Results were obtained from determination of Рн]-1еисіпе in­
corporated into immunoprecipitable fibrinogen per μg cellular 
DNA and expressed as percentage of value obtained 6 hours after 
adding of [^H]-leucine in the absence of IL-1. IL-1 was added 
as crude monocytic products (200 μς per ml culture medium). Re­
sults are the means ΐ S.D. of 4 experiments. 
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DISCUSSION 
From our previous studies (15,16),we have demonstrated that cortico-
steroids and other hormones can not be implicated in modulating the 
hepatic synthesis of fibrinogen during the acute phase response. Al-
though the fibrinogen synthesis in rats could be stimulated by in vivo 
administration of fibrinogen- or fibrin-degradation products (12,17), 
the exact molecular mechanism of enhanced synthesis of fibrinogen in 
vivo by these substances is still not clear. In our present study, we 
demonstrate that monocytic (macrophagic) products and interleukin-I 
stimulate the in vivo and in vitro synthesis of fibrinogen and fibri-
nogen mRNA content in hepatocytes. 
In experimental studies, products of inflammatory cells are prepared 
usually by incubation of activated inflammatory cells laolated from 
peritoneal exudates induced by glycogen in rabbits as described in our 
present study. The active principle of these products or so called 
leukocytic endogenous mediator, is interleukm-I. This protein ia pro-
duced by several types of cells such as peritoneal granulocytes, ma-
crophages, Kupffer cells and blood monocytes. It has a molecular 
weight of approximately 15,0(10 (29,30), although both higher and lower 
molecular weight species were also reported (27,28). This protein has 
been shown to play an important role in the physiological alterations 
that characterize the acute phase response, such as fever, granulocy-
tosis, exocytosis of specific granules from blood granulocytes, enhan-
ced oxidative metabolism, changes in serum metal ion concentrations 
and changes in the hepatic synthesis of the acute phase asaociated 
proteins (29,31). 
In a previous paper (32), we have described that monocytic products 
and interleukin-I reduce the hepatocytic albumin synthesis and albumin 
mRNA content in vivo and in vitro. The effect of these substances in 
vitro on the albumin synthesis and secretion of hepatocytes is augmen-
ted by the presence of one micromolar dexamethasone (32,33). In the 
present study, the presence of a high level of glucocorticosteroid is 
also essential for the stimulation of fibrinogen synthesis by monocy-
tic products or interleukin-I in primary cultures of rat hepatocytes. 
Furthermore the increased synthesis of fibrinogen in rats treated with 
turpentine can also be partially reversed by a specific antibody 
against the 15-kD protein of monocytic products. This _i_n viv£ observa-
tion is also supported by the in vitro findings of normalization of 
fibrinogen secretion of hepatocytes by addition of antiserum in medium 
containing monocytic products. It is interesting to note that this 
antibody recognized not only the 15kD mol.weight component of the mo-
nocytic products, but also a lower molecular weight species (approx. 
6kD) and higher molecular weight forms (2ukD and 34kD). Both the 
higher dnd lower molecular weight forms of interleukin-I have also 
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been observed by others (27). In addition, this antibody was able to 
completely abolish the IL-1 activity of the monocytic products. 
From these findings and from the previous results (3J), we can there-
fore conclude that a humoral factor or factors, including IL-1 produ-
ced by inflammatory cells is (are) responsible for the regulation of 
fibrinogen and albumin synthesis during the acute phase response. How-
ever, further studies are required to determine whether interleukin-I 
alone or other monocytic products such as hepatocyte stimulating fac-
tor as suggested by Fuller et al (34) are also involved in the regula-
tion of fibrinogen synthesis. 
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CHAPTER IVB 
STUDY OF THE MOLECULAR MECHANISM OF DECREASED 
LIVER SYNTHESIS OF ALBUMIN IN INFLAMMATION 
Study of the Molecular Mechanism of Decreased Liver Synthesis 
of Albumin in Inflammation 
H J Moahag·, J A. M J w w n , J H Ргагамп, J. С. M HefbwuchaW,* and β. H. Vap 
Ütviuon of Oasiroiniemnal and I iver Diseases and * Division of Chnical Chemutry Depaamtni of Medicine Si Radboud University 
l ¡ospitai Nijmegen The NetheHonds 
Atntmct 
HypoalbunilDcnita fat іпІЬтіішКігу ¿border* b ort ia hifi ι циаі 
finding. However, Utile b known tbotri ilbmaia sysltesb ш ibae 
patients Ια tbc présent ilady we have measured tbc albattU 
syntbesu ш four pihents witfa ІвЛатпмагу diseases оаш% the 
I'^ CJcwbooste technique Became tnfbmnatioa causes ι de­
creased tlbuala syatbesls sad this decreased synlheais coaM 
not be related to a rednced sniao add tuppljr, we have sbo 
eununed the ровІЫе mokcabr BMcfaaobats of ndaad albaatla 
synthesis duriac ілЛавиваімя talng la vivo aad ia vitre eiper-
laents In rats la rats with turpeotiae-iiHlBccd hflamautloB, 
scram albuatfa coocraOatloo and Uvcr albomin aiRNA level we« 
Barkedly decreased The« скааде could not be repradaced by 
admmlstratlon of flbrinogen-, or flbrln^lefnulalloa products, or 
several boraone*, neh as corticosteroids, irowth horatooe, tai 
adreaaUne However, moaocync praíacts, especblly interkokla 
1, postwlsled to be Importaai nc^laton of the mflammtory re-
sponse, reduced •Jbumin syatbeals tad liver albamln messeafv 
RNA coateat bat not total protela syatbeals la rats la vivo aad 
la primary cultam of rat bepatocytes. These Hadings safgest 
tlut monocytic prodacta ptay aa Impwlant rob la redaced al-
buaiiB syatbesls durtag taflamaatloa. 
Introduction 
Albumin is the roost abundant icnim protein produced by the 
liver In clinical practice the senrni level of albumin continues 
to serve as an important marker for the presence, progress, or 
iitiprovement of many diseases, even though it is the complex 
end result of synthesis, degradation or loss, and distribution be-
tween intra- and cxlravascular space 
Hypoalbuminemia in patients with inflammatory diseases 
such as pneumonia, rheumatoid arthritis, and severe bacterial 
infection is not an infrequent finding ( I ) Although it has been 
suggested thai increased dégradation of albumin is the primary 
cause of hypoalbuminemia, little is known about albumin syn-
thesis in such patients The purpose of this study was to inves-
tigate the albumin synthesis as determined by [l4C}cajbonate 
technique in patients with inflammatory disorders Because the 
results indicate that an inflammatory reaction could lead to a 
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and Liver Dueajn, Dqmrtment of Mediane. St Radboud Utuvemty 
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decreased albumin synthesis and no signs of diminished supply 
of amino acids to the liver were found as an explanation of the 
reduction, we have eumined the posible molecular mechanism 
of the decreased albumin synthesis during the inflammation us­
ing in vivo and in vitro eapenments in rats. 
M e t h o d · 
Patients Ар, ял, and diagnosis of the Tour pauents studied are dem-
onsiraied m Tabic I All paticnli had a severe or moderate hypoalbu 
raincmis The control group was compojed of 20 individuals. 17 males 
and 3 females, thor a^s ranging From 26 ю 68 yr They all had normal 
ierum albumin level and normal hver ' function tests. 
Amino acid analysis Conccotranoiu of scrum amino acids were 
eslimaied using • Beckmann Unichromc (Muochen FRG) amino aad 
analyzer After рпсіріиіюп of Ihc protetni (50 mg sulphoaalicylic acid 
was added lo 1 ml icnim) and ccnlnfugation 0 5 ml oTthe supemaiant 
was used for analysis The aocuncy of the tryptophan deiermination on 
the ammo acid analyser ha been laied by wMiu% diflcrcni amounu оГ 
iryptophtn (40-230 JIM) lo в senim sample thai had been dialyzsd pre­
viously After precipuatton of the proteiia the samples were analyzed 
for iryptophan content The mean recovery of the added iryptophao 
«as 89 2% (2) 
Detcrmtnalion of plasma volume and albumin synthesis rate The 
plasma volume was deteranned with '"I labeled albumin just before the 
deiermination of the rate of albumin synthesis 1>ll-labclcd albumin was 
prepared according ю the method desenhed by McFartanc (3) with dighl 
modifkaiion The duappeanncc rate of "'I labeled albumin was alio 
deteranned 7 h after injection of "M-labdal albumin 
Rate of albumin lynlhois was measured by the ("Cfcarbonale 
method of McFaiiaoe (4). as modified and described by Haftenachod 
et al (5) 
Pauents hul a regular hospital diet (— 60 e protein, 60 % fat, and 
230 g carbohydrate), all of which was connimed in the penod of inves­
tigation The thyroid gland was blocked with lugol solution itaiting 2 
d before ihc deiermmauon In the morning of the iDvestigauon blood 
samples were collected for the measurereent of serum or blood kvd of 
hemoglobin hematocnt albumin amino acid*, creatinine urea, irens-
ammases, alkaline pbosphalaie and leucine amino pepudaa Patients 
were not treated wiih oral anubicrtics or chemothenpeutics to reduce 
the bacterial urease activity in the intestine A 50-ml blood ample was 
collecied 7 h after ι ν injection of 100-200 μΟ Nai"CO, for the mea 
sûrement of the speafic activity of the ["Clguanuline group of яіршпе 
m albumin An addiuonal 8-ml blood sample was obtained at the same 
lime for the measurement of the specific acimiy of the endogenouily 
formed f 4C]urea 
I dialer 5-10 μΟ ("CJurea was uyeciHUv for the determination 
of (he disappearance rate of urea (5) 
15 ml plasma was saturated to 50% with (NH^bSO« for the tsolauon 
of albumin The precipitale was sepantcd by ccotnfugation 30,000 g 
for 20 mm The supemaUnt «as adjusted to pH 4 5 by slowly adding I 
M HO and tbc albumin thus pncipiuted was collected by centnfueauoo 
After redusriving the albumin precipitate in 10 ml of water and adjusting 
to pH 7 0 wiih I M NtOH the enure procedure was repeated The 
albumin fraction, 25 ml was dialyzed overnight The punly of the al­
bumin preparation, deiennmed by electrophoresis on ocllulore acetate, 
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wis 97% After on adapted dilution the іІЫітіп was hydnriyzed the 
arginine was isoUlrd from the hydrotyiaie. and the speafk actmiy of 
the guanidine group of the аі^ ішпс was detmmned u descnbed pre­
viously (5) 
The calculitKm of the rate of albumin tynthesis can be made usins 
the precunor-product rdatioosbip The [l4C]ai9inine produced ID the 
liver etil from [l4C]<arbonat£ a the common prvunor Гот ("Cjurea 
and ["Cjguamdme of affinine m albumin Under wclklcftiied сшхЫюп* 
the KWoftc activity of аЛ products of a single labeled prtcunor pool must 
be equal lo lhai of the prrcunor (4) Specific activiiy of albumin from 
fl-fO is then equal lu specific activity of synthesized uro from rl-iO-
syntlKSized albumin (Н-Ю) - (ip act of albumin at Ю/фаЛ of um al 
Ю) X fncuonal synihess rate оГшеа X plasma albumin pool The specific 
aciivit> of albumin tsexpnssed as the activity of tuamdinc С ofaifimne 
in albumin The specific activity ofsenim albumin 7 haftori ν injcmion 
of 100-200 nd Naj'OOj ranged from I 36 to 2 S6 dpm per ^mol ar· 
ginine and the specific activity of urea vaned from 11 25 to 30 4 dpm/ 
mmol urca Because in this study the fnctional synihe&u of urn was 
measured 24 h after injection of Na/^CO) by ι ν administration of 5-
10 KCI ("Cjurca it was imponant lo maintain a steady slate of urea and 
albumin теиЬЫшп in (his period Pauenis were given a comuni did 
at the шпе time in ihe 2 d of the openmeni Only paítenla and control 
individuals who had senim conccntratrons of albumin, um. and unnary 
u m eioetKm at the nine level ш Ihe 2 d of елрептеш woe inctadcri 
in this study 
Laboratory mahods Тгаіиапипак alkaline pbotphaine, and Im­
ane amino pepudav were determined according U> rouunc ІаЬоШшу 
methods. 
Animais Male Winar rats woghing 180-200 g were uzd throughoul 
and maintained on standard Punna chow and water ad lib For the Kute 
inflammatory reaction, rats were injected ininmuscularly with I 0 ml 
of commercial turpentine 
Preparaiion of raí hepaiocytes and pnmary cuhun Liver «Us were 
prepared aocording to the method of Seilen (6) with some modifiaüons 
as doenbed previously (7) All buHen were auloclaved before use and 
oxygenated by direct bubbling with охудо CoUagenase buffer (0 S mg/ 
ml) was supplcmented with O 0 J mg/ml uybean trypsn infaita-
tor (7) 
СеШ were fthered, prancubaied, and omtnfuged in Ca14 and Mg1* 
free Hanks' balanced sah solution (HBSS) containing 2% bovine serum 
albumin (BSA) Damaged and nonparenchymal crib wee removed The 
cd) suspensen was then passed through a 100-fiM nykn filter and the 
viability of the hepatocyus was determined by trypan Ыие едсіююп 
The culture medium was William's medium E supplcmented with 
Ь% (vol/vol) fetal calf serum (PCS), 2 mM ι -glutanune. 20 mU/ml ponaoe 
insulin, deumcthasone as indicated. 2 5 Mg/ml fungizone, 50 Mg/ml grn-
tamyeme, and lOOfi/ml vancomycin llepaiocyus were seeded at acon-
cenirationof I7S X IO1 cells per cm'in polystyrene flasks or diche and 
maintained in a humidified atmosphere composed of 95% air and 5% 
CO] The medium was renewed 2-4 h аЛег cell seeding and every 24 h 
thereafter 
Incorporation oflabeied prtcursar into proietn fHILeuane was added 
to the cell culture medium (5 MCI/IHJ) — 50% of leucine presenl in ihe 
Culture medium was radiolabeled (spécifie activity or[JH]leucine in me· 
diu m is thus — 60 Ci/mmol) At the indicated times, dupJiolc 75-μΙ 
samples were withdrawn from the medium IO-μΙ sample were diluted 
to 100 ta in 0 I N NaOH and I ml 10% inchloroacrtic acid was added 
Samplea wot heated for 20 mm al 90°C and subsequently cooled on 
ке for 20 mm Protein precipitates woe collected on nitrocellulose filler 
diso and counted for radioactivity 
Immunoprmpitaiton o/J// labeled albumin Оеіелпіпаіюп of JH-
labeled albumin in the cuhuic medium was essentially pcHbrmcd as 
described previously (8). 2S-iil samples were diluted in 500 μΙ bufTêr 
cnntaining 10 mM sodium phosphate. pH 7 2 ISOmMNaCl l%Tnlon 
X 100 0 3% sodium deoiycholale. 0 I % sodium dodery) sulfate (SDS). 
5 mM leucine, 0 I mM phenylmeihylsulfony]fluoride and I mM EDTA 
and incubated with 1,000 dpm ['NTJñJbumm as tracer for recovery, 20 
pg albumin as earner, and goat-anti-ral albumin γ-globulin After 16 
b incubation at 4°C, the mixture was layered over 120Ο-μ1 10% (wt/wt) 
sucrose cushion and ccntnfuged for 5 mm in an Eppendorf cenmfuge 
The pellet was washed three tunea, disolved m 0 1 NaOH and precip­
itated wnh 10% inchloroaccUc acid, and collected on mirocellulosc filter 
paper discs for counting, using a double-Labeling program ['*€]Albumin 
was prepared chemiolly from the punned protein with ["Clforrnaldchyde 
by reducuv« methyUbon as descnbed by Crane and Miller (9) 
DNA dfífrmtrvman Cells were suspended m water and snmcaied. 
Afta ctnuifugaüon, DNA in supernatant was mosurtd by в Пиигопкілс 
technique as described by Kapusanskt and Skoczylai ( 10) 
Preparaltan Qf titer and cell RNA Total postnudear RNA of liver 
UBue was prepared as descnbed by Taylor and Schimkc(ll) Cytoplasmic 
RNA from hepalocyles in pnmary cultures was isolated according to 
the following procedure Cell pellets were homogenized in a buffer con­
taining 50 mM Tns-HCI, pH 7 4, 25 mM NaO. 5 mM MgCl,, 0 25 M 
swerrae and 0 Э т^ші hepann After addition of '/«F-VOI Ι0%ΤπΐοπΧ· 
100 and eentnfugalion of ihe particulate material for 10 mm al 16.000 
g. RNA waseitractedbyaddibonof ft-vol 0 î M NaCl. 1 5% SDS 15 
га M EDTA, 30 mM Tns-HCI pH 9 0, and an equal volume of phenol/ 
chloroform/uoamyUlcohol (50-48 2. vol/vol/vol) When no dclcctabfe 
interftoc rcmaiwsi, 2 S vol cold ethanol was added RNA was precipitated 
overnight at -20*C and isolaled by cenuifugauon at 16,000 ; for 20 
mm at 5*C 
Ineorporation cf labeled precursor mio RSA 61 mCi/mmoJ [6-
'Îlortrtic end was added to 3 ¿fCi/ml cell culture medium At the in-
dicated timo, cells of duplicate wells were washed and harvested with 
IIBSScontaining0 l%TntonX-l00 I тІоГке-cold 20% tnchloraacetic 
acid was added to 100-μ] samples and precipitates were collected on 
oitrocellulose filter paps dixs and counted for radioactivity Correction 
was made for incoiporiüon of ["Clorouc acid into non-RNA by deter-
mining the incorporation m duplo amples treated for 30 min al 90°C 
in 10% inchloroaccuc acid 
Preparation ofpunfied albumin mRNA and 'H labeled complemen-
tary DNA (cDNA) Purification of mRNA specific for rat albumin and 
the Synthesis of the speofic compkmeniary DNA probe from this punned 
mRNA have been reported previously (12) Analytical RNA-cDNA hy-
bridization was performed as descnbed previously (13 14) 
I t M Moshage Janssen, Franssen. Hafkenscheid. and Yap - 7 3 -
/Reparation i>f monocytic prvducii and wiifii aaiibm/ies agama 
tmerieukm 1 (IL ¡) The monocytic producís wtre preparrd by incu 
hauon оГасіі аігі mh.Tophagcs iwlatcd from pcmorwal fiudates in­
duced by glycogen in ribbils as described h\ Ruchie and Fuller (IS) 
These preparai ions were cndoionn Tree as tested b> a Limului m i П к 
15 kO mol wt protein was punned from these тснюсуііс pmducu by 
CSO-Scphadex chromaiographv and gel ектітрЬогеиИІб) ThispnMnn 
showed IL I асіі цч udetermined bv the thymocyte рлгііГсгаіюп лвлу 
(|7) Specific antibodies agstntl IL 1 were obtained from immunized 
goati using thu punned 13 kD-mol wt prolan м immunogen 
For companson m юте studies WT have used commemally available 
IL I obtained from aciivaied human monocytes (ulira pure human IL 
I GenzvmcCorp Botton MA) 
Preparation ο/ρυ/\ Λ containing RNA The poly A containing RNA 
was prepared from total RNA « w c « by oitgo (dT) ceUukBe chroma­
tography ( 1 β) os described picviouily ( I I ) 
С eli free рпчет ivmhesis and gel ciectropfwrriis The wheat genu 
enlnct was preparwJ as described by Marcu and Dudock (19) Radio-
actively labeled product synihenied in vitro was analyzed ekctropho-
reticallyon 10% polyacrj^amide/Na DodSO«(SDS)stabgeb(20) Dned 
slab gels were exposed lo a ray film 
Matcriah N a j ' ^ O i [ Î lurca L (4 5 JH]teucine (120 Сі/ттЫ) 
16- *С1огоік and (61 mCi/mmol) [14CJfoTmaldehytk (17 6 mCi/mol) 
uid[3 ,HJdCTP(lfl4Ci/mmo))wereotiuu»ed fnm the Radiodiemical 
Centre Amenham Inumalional, Amenham UK ' " I as N a n i I was 
from Hoechst A G Frankfurt FRC Collagenase type I soybean trfBii 
Inhibitor оуяег gtycngtn type 111 BSA hepen η from porcine intestinal 
mucosa dilhiolhmtol and Hepa wen purchasd from Sigma Chemnl 
Co Si IJ3UIS MO William s medium E and PCS were Ггого Row 
Labcniona Ine McLean VA Tnton X 100 and SDS were obtained 
from BDH Chetnicab Ltd Dageoham E m UK Ribonudease free 
sucrose EDTA phenol, sodium deoiycholale salts, and solvents were 
purchased from E Merck Darmstadt FRG Deonynbonuclcoaide in 
phosphate were (тот Schwarz/Mann Spring Valley NY and ohgo(dT)N 
was from Collaborative Rerneh Ine Waltham MA Avian туво-
Ыаяозіі vims DNA^lependent RNA potymerase was kindly supplied 
by Dr J W Beard National Cancer Inailute Beihesda M D Nucka« 
Si (Aspergillui oryae) was purchased from Boebnnger Mannbein 
GmBH Mannheim FRG and flored at 2 3 IO1 U/ml m 5 0 * glycerol, 
SOmMNaCl 0 1 mM ZnO^ and M m M T n s - H C l p H 7 5 at 20eC 
Oradexon (deKamethaiooc disodium ptaxphaie) was obtajoed from Or 
ganon The Netherlands. 
All glaaware was stenbird and soJutioiw were frahly prepared and 
autocla ved before use BSA and soybean trypsin inhibtiorweiediatyzol 
dgainstO 13 M NaO and, like all solutions used m the hcpaiotytc шЯаіюп 
and cullunng. filtered through a 0 22 μΜ Schleicher & Schnell (Ксеое, 
NH) filter aod stored frozen 
R*autts 
ТаЫе II demonstrates the plasma votum« intravascular albumin 
mass and albumin synthesis rate of four patients with inflam-
maiory disease AH patients had β low serum albumin level and 
a decreased intravascular albumin mass Although the serum 
concentrations of amino aads in these patients were normal 
(Tabic I I I) the albumin synthesis was reduced ranging from 
12 6 to 14 3 g/24 h (mean value 13 4 g/24 h) As compared 
with the control value the result of albumin synthesis in these 
patients with inflammatory disease was sigmftontly reduced with 
a Ρ value of 0 0036 (Witcoxon two-sided tested) The liver 
function tests with the ексеріюп of patient No 2 were all 
with m normal limila. 
For further studies to examine the molecular mechantsm of 
I Abbrenaiton used m ¡his paper IL-l intcrkukm 1 
the reduction of albumin synthesis in inflammatory diseases. 
we have used an animal model of inflammation in rats injected 
intramuscularly with 1 ml turpentine Fig 1 shows the SDS 
Polyacrylamide gel electrophoresis of wheat germ cell free re 
action products under the direction of poly A containing RNAs 
prepared from liven of control rats and animals al intervals 
following turpentine injection Despite the absence of changes 
m liver RNA content (data not shown see also references 11 
and 21) there was a decrease of translational activities of RNAs 
into albumin after turpentine administration Quantitative 
analysis using the hybridization kinetics to measure (he sequence 
content of albumin mRNA in difTerenl RNA fractions during 
the inflammatory reaction indicates that the concentration of 
albumin mRNA sequences in the liver was decreased to 3^-
50% of the control value (control value 7 0% of total poly A 
containing RNA) The variability of the control measurements, 
if repeated in paired animals sham injected with saline over the 
same time course, was I00±9% (mean±SD) The lime course 
of the changes of serum albumin concentrations and albumin 
mRNA levels in the liver is demonstrated in Fig 2 
These changes of serum albumin concentration and liver 
albumin mRNA level could not be reproduced by administration 
of fibrinogen or fibnn degradation products and of several hor 
mones such as comcosterotds, growth hormone and adrenaline 
(data not shown) Because monocytic products especially IL 1 
(a IS kD-mol wt protein in rabbits) have been suggested to play 
an important role in the physiological alterations that charac 
lenze the acute phase response such as fever granulocytosis 
and change in the hepatic synthesis of the acute phasc-asooated 
proteins (22 23) the following in vivo and in vitro eipenmcnls 
were performed to investigate the influence of these monocytic 
products including IL 1 on the albumin synthesis 
As shown in Fig. 3 the albumin mRNA concentration in 
the liver of rats injected inbapentoneally with monocytic prod 
ucts were decreased and comparable with the findings in rats 
treated with turpentine In addition concomitant admimstratton 
of antisera (1 ml ι ρ ) against the 15 kD-mol wt prolcm of 
monocytic products partially abolished the effect of turpentine 
as well as the effect of monocytic products on the serum albumin 
level and on albumin mRNA content (66± 10% vs 4 2 ± 1 0 % o f 
control value for lurpentine treated rats) 
Fig 4 shows the effect of monocytic products on the 
^HJleucme incorporated into the secreted albumin of primary 
cultures of rat hepatocytes Because the specific activity of 
{'H]leucine in the culture medium was high — 50% of leucine 
present in the medium was radiolabeled (60 Ci/mmol) and the 
fact that |JH]Ieuanc incorporated into secreted total protein was 
unchanged and the secreted []H]ñbnnogcn was increased the 
reduction of incorporation into the secreted albumin in the 
presence of IL 1 could not be ascribed to a reduced specific 
activity of leucine iRNA The ('HJleucine incorporated into the 
secreted albumin was therefore the result of decreased albumin 
synthois and secretion The effects of monocytic products on 
the reduction of albumin synthesis and secretion in primary 
cultures of ret hepatocytes were more pronounced when 1 μΜ 
dexamethasone was added to the culture medium Concomitant 
with these findings, the albumin m R N A content was also lower 
in hepatocytes treated with the monocytic products l han in con­
trol hepatocyte (Table IV) Neverthcles the RNA synthesis of 
hepatocytes was not impaired by the addition of monocytic 
products in the culture medium (Fig 5) The rate of albumin 
synthesis and secretion m hepatocytes cultured m the presence 
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Table li Plasma Volume Intravascular Albumin Mass. and Albumtn Synthesis Rale of Four Patients *ith an Inflammatory Disease 
Inlnvuculir iJbur FncuoM] tynihou nie* 
2 885 
í,ÍM8 
2,270 
3.J00 
«4 5 
88 7 
58 6 
10Î 
IM 
21.6 
12 2 
140 
14 3 
12.7 
126 
9 7 
9 0 
127 
7 4 
Control value (η • 20 meantSD) 
* Percent of iniravascuUr albumin mass per day 
of commercially available IL-1 was also lower than in control 
experiments Similar to the in vivo findings, addition of antisera 
against the 15-kD-mol wt protein lead to a normalization of 
albumin synthesis and secretion in hepatocytes cultured in me­
dium containing monocytic products (430±60% vs. 24O±40% 
of control value for hepatocytes cultured for 24 h in the presence 
of monocytic products without antiserum, see Fig. 4). 
Discussion 
If albumin metabolism is in a steady state, the rate of its synthesis 
will be equal to the catabolic rate The estimation of albumin 
Table III Serum Concentrations' of Ammo Acids in Three of 
Four Patients with Ιη/lammalory Disease and Hypoalbuminemia 
ЕшпиаІ 
Threonine 
Valine 
Mahiomne 
ISOICUCIIK 
Leucine 
Phenvlalamne 
Lysine 
Tryptophan 
Toul 
Nonessential 
Senne 
Proline 
Citmlline 
Glycine 
Alanine 
Tyrosine 
Ornithine 
Hisudine 
Arginine 
133 
202 
23 
80 
129 
88 
250 
33 
938 
119 
194 
20 
188 
322 
59 
39 
128 
129 
48 
467 
553 
148 
1I3±32 
227±42 
27±9 
M±21 
I41±33 
74±I5 
I95±47 
4S±I4 
906*213 
19 
12 
23 
ям 
m 
82 
09 
53 
32 
no 
I2S±27 
247192 
37tlS 
259±72 
403±97 
67118 
101130 
88121 
123134 
1.4501406 
synthesis by the indirect method using radioactive iodine -labeled 
albumin has, however, certain limitations because of its long 
duration of measurement ( ~ 2-3 wk) and the requirement for 
a steady state of albumin metabolism during that period By 
using the ["CJcarbonate method for the determination of al­
bumin synthesis rate, a long penod of steady-state metabolism 
is not required The validity of this method for measuring al­
bumin synthesis and the assessment of the possible radiation 
hazard involved m the study have been discussed previously (2, 
5, 24) Because a steady state of albumin metabolism in patients 
with acute inflammation cannot be achieved for a long penod, 
albumin synthesis under these circumstances cannot be deter­
mined by the indirect method of radioactive iodi ne-labe led al­
bumin 
In our present paper we report the albumin synthesis as de­
termined by [ l 4C]carbonate method in four patients with in­
flammatory disorders and severe hypoalbuminemia. Only pa­
tients and control subjects who had unchanged concentrations 
of serum albumin, urea, and unnary urea excretion at the same 
level m the penod of expenments were included for this study 
Although the albumin degradation was not determined in these 
patients, the measurements showed a decreased intravascular 
albumin mass and a reduction of albumin synthesis A reduced 
rate of albumin synthesis can be the result of malnutrition, mal­
digestion. and/or malabsorption, or a severe diffuse liver disease 
45kD 
* In junol/litcr 
' л = 20-, mean±SD 
Figure I Autoradio-
graph of SDS-polyacryl-
amide gel clectrophort-
sis of wheat germ trans­
lation products under 
the direction of liver 
mRNAs isolated from 
control rats and animals 
after turpentine injec­
tion Lane 1 ["CJ-la-
beled marker proteins: 
albumin, 68-kD mol wt, 
ovalbumin, 45-kD mol 
wt, and chymolrypsin, 
25-kD mol wt Lane 2 translation products directed by poly A-con-
tainmg mRNA isolated from rat liver 24 h after injection of 1 ml ι m 
turpentine Lane 3 as indicated in lane i 48 h after turpenune injec­
tion Lane 4 as indicated in lane 2 72 h after injection Lane 5 trans­
lation producís directed by poly A-contaimng mRNA isolated from 
control rat liver ^ т о » denotes position of albumin ongel 
- 8 β 
• s «· • 
35 Ж «·"» -
1β3β Mosbage Janssen. Franssen Hqlkensclieid. and Yap 
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Figure 2 Time course of the changes in serum albumin concentra-
uons and albumin mRNA levels in the liver dunng inflammation in­
duced by admmislrabon of 1 ml ι m turpentine Relative change in 
albumin mRNA levels was determined Ггот hybndizadon data by 
comparison of the КЫ\д value of control poly Λ-conuining RNA 
with the Rftfi/i values obtained from poly A-coniammg RNAs of m 
livers at various time intervals after turpentine trcaimem Serum aibu 
mm concentration was measured according to the routine laboratory 
method with a control value of 30 1+2 0 mg/ml (R«/ и the product 
of ішіші RNA concenlratran m mole nucleotides per liter and time in 
seconds, given that A260 of I 0 correspond»to 40 *ig RNA per ml 
Rtrfi,! is Ro< value at 50% hybridization) 
(I) Because clinical evidence of liver disease and intestinal ab­
normalities was absent in our patients and there were normal 
serum concentrations of amino acids, the reduction of albumin 
synthesis m our patients was most likely not due to a diminished 
supply of ammo acids to the liver or the result of a pnmary liver 
disease 
To examine the possible molecular mechanism of decreased 
albumin synthesis in the Liver dunng inflammation, we have 
therefore studied the liver content of albumin messenger RNA 
in rats and its translational activities in vitro using a wheat germ 
CTSAJHE 
С З с т л ж а ι ІГТЧЧЕАТ 
HBCRbOE L ι Imç 
CRuOeiL 1 I m j 
tH]TURPENTINE m l I Î1 
URPENTINE Imi ЦП 
Figure 3 Relative levels of albumin mRNA in rat liver after treatment 
with saline (1ml ι ρ ) crude leucocyiic extran ( 1 -3 mg, 12 h after ι ρ 
administration) and turpenune (1 ml ι m 12 and 24 h after «Immis-
tration) Values are expressed as pertentages of controls (mean+SD л 
~ 4) and were obtained from hybridization data as descnbed in Fig. 2 
Figuri 4 Sccrrtion of albumin in pnmary cultures of rat hcpaiocytes 
into culture medium in absence of deiamethasone (upper рале') ind 
in presence of 50 nM {rmddle panel) and 1 μΜ dexamethasone (lower 
panel) Results were obtained from detenmiaiion оГ['Н]Іеисіік in 
corpora ted into immunoprtcipitahle albumin per microgram cellular 
DNA and expressed as perceniage of value obtained 6 h after adding 
[JH]leueine m the absence of ILI ILI was added as crude leukocvtic 
extract (200 Mg per ml culture medium) Results are the mcans±SD of 
four experiments Hepatocytes were cultured for 24 h with test sub­
stances before adding ['H]leucine 
cell-free translational system The results indicate that dunng 
the inflammatory reaction after tissue injurv the decreased le\el 
of serum albumin is associated with a reduced concentration of 
albumin mRNA in the liver (Figs 1 and 2) Because an inflam 
mdtory reaction docs not lead to a decreased level of total liver 
RNA and the fibnnogen mRNA content and the fibnnogen syn­
thesis were increased under this condition (13 21) the decreased 
content of liver albumin mRNA is most lilccly regulated specif­
ically b> a different molecular process or mechanism 
Hypoalbummemia and a decreased albumin synthesis dunng 
the acute phase response have been descnbed previously and 
Table ¡l Relame Level oÍAlbumm mRNA in Hepaiocytes 
Cultured for 48 h in Presence of Ι μ 4 
Dexamethasone With and Wnhoul Чопосуііс Products 
V-iihouilL-l 
With 200 Mg/ml IL 1 
100% 
49+10% 
Mean±SD of four experiments 
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( 6 - " θ OtMic «cid №£θΐρο>*ΐ«4 
«lo Iota) RNAIDPM ш I0"*p*f «g ΟΝΛ) 
Л ^ и г г J Incorporauon оГ |6-,*С|опиіс aod mio іоіжі RNA of hep»· 
tocyte in pnmtry cultura in «hence (ypm cirri«) i n d presen« 
(c /c íWciT / í í )o f IL- l in cuhure medium A l the indicated tuna, cefls 
wert harvottd and procend u d e x n b e d m Meihoh. І Ы w u added 
as crude leukocyiic «tract (200 μ$ per ml culmre medium) R c u l u 
are the meaiK±SD of four expcnmenis Hepatocyln were cultured Гог 
24 h with ten lubsunca befoie addint (l4C)on>bc a « L 
albumin has been indicated as a negaiive acute-phase reactant 
( 2 1 , 23) However, the precise molecular mechanism Гог the 
reduction o f a l b u m i n synthesis has l u l l not been completely 
d u a d a t e d Neverthelea, a number o f factors have been suggested 
to play an important role in the regulation of liver synthesis o f 
acute phase proteins, such as hormones, fibrinogen-, o r fibnn 
dégradation products, and monocytic products, including I L - l 
( I S , 25, 26) From our previous studies ( 7 , 25, 26) and other 
investigations (data not shown) we have demonstrated that cor-
ucosterotds, growth hormone insulin, adrenaline, fibrinogen, 
and fibnn degradation product» cannot be implicated in mod-
ulating the hepatic synthesis o f a lbumin dunng the acute-phase 
response because administration of these hormones in vivo in 
rats or in vitro in expenments using pr imary cultures of ral 
hepatneytes did not lead to a reduced synthesis of a lbumin , al-
though in other studies, the fibrinogen synthesis in rats could 
be stimulated by in vivo administration of fibrinogen or fibnn 
degradation products (26) 
I n our present study, we demonstrate that monocytic prod-
ucts reduce the hepatocytic a lbumin m R N A content in vivo and 
in vitro Because the orotic acid incorporation into total R N A 
was unchanged (Fig. 5) and there was a stable R N A content, 
the level of a lbumin m R N A must be affected specificallv by the 
monocytic products and not b e c a u x o f a decreased R N A syn-
thesis or level in general In fact the level of m R N A s of acute-
phase protein was increased under this condition (data not 
shown) T h e effect of mooocytic products on the a lbumin syn-
thesis and secretion of hepatocytes in vitro is augmented in the 
presence of 1 μ Μ dexamethasnnc T h e role o f deiamethasone 
on albumin secretion and the content o f a l b u m i n m R N A in 
hepatocytes in vitro has been discussed previously ( 7 ) T h e lack 
of a significant decrease o f serum a l b u m i n level in rats alier 
administration of monocytic products (data not shown) is due 
to the masking effect o f a relatively long half-life o f serum al­
b u m i n in the relatively short duration of expenmenis and the 
absence o f protein loss, as was the case in turpentine injection 
due to exudauon Nevertheless, reduced a l b u m i n synthesis and 
secretion by hepatocytes can he clearly observed in p r i m a r y cul­
tures after the addition o f monocytic products ( f i g 4) I n c o n ­
trasi the synthesis and secretion o f total protein in vitro is not 
affected by the monocytic products (data not shown) Although 
in these cKpmments we did not utilize a specific punned product 
of macrophages, the results of скреп ment s m vivo in rats after 
turpentine injection or administration o f monocytic products 
in vivo and in vitro indicate that reduced a l b u m i n synthesis 
under these circumstances can be p a m a l l y abolished by the a d -
m i m s t m i o n of specific anu-sera against the 1 5 - k D - m o l w t pro­
tein o f monocytic products I n addition, similar findings have 
also been obtained in e x p e n m e n u using commercial ly available 
punned I L - l Therefore, we can c o n d u d e from these findings 
that hypoalbumincnua d u n n g the inf lammatory reaction can 
be partially ascribed to a specifically decreased synthesis of a l­
b u m i n in the liver as the result of monocytic (macrophagic) 
products, including I L - l 
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ABSTRACT 
Cultured human hepatocytes provide a useful method for studies of spe-
cific metabolic functions, such as plasma protein synthesis or drug 
metabolism in man and specific interaction of microorganisms with the 
human liver cell. In vitro studies using human hepatocytes are seri-
ously hampered by the limited availability of viable tissue and the 
lack of suitable methods for preservation of hepatocytes. In addition, 
normal adult human hepatocytes using classical culture conditions do 
not proliferate in vitro. Recently, we have reported a method for 
long-term storage of human hepatocytes, using a cryopreaervation tech-
nique. However, after thawing, the efficiency of cell seeding onto 
tissue culture plastic, and accordingly, the survival of hepatocytes 
in primary cultures were decreased as compared to freshly prepared and 
cultured hepatocytes. In the present study, we report the effects of 
extracellular matrix (ECM), obtained from normal liver of kidney do-
nors on the attachment efficiency, survival, some metabolic functions 
and fine structures of human hepatocytes. It was found that the dele-
terious effect of deep-freezing storage on attachment efficiency and 
survival of hepatocytes could be significantly reduced by using tissue 
culture plastic precoated with human liver ECM. Hepatocytes survived 
for more than k-6 weeks, without evidences of fibroblast overgrowth. 
Using this in vitro experimental system: we have also shownathat mono-
cytic products were able to decrease the hepatocytic synthesis of al-
bumin while the total protein synthesis was unchanged. These results 
support our previous observations in cultured rodent hepatocytes, in-
dicating the important role of monocytic products in the regulation of 
liver synthesis of albumin in inflammatory diseases in man. 
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INTRODUCTION 
For the study of specific metabolic function of the liver, such as 
plasma protein synthesis or drug metabolism in man and the specific 
interaction of microorganisms with human liver cells, the use of iso-
lated and cultured human hepatocytes is an attractive approach. How-
ever, in vitro studies using human liver cells are scarce due to limi-
ted availability of viable tissue and the lack of suitable methods for 
preservation of viable hepatocytes. In addition, normal adult human 
hepatocytes under classical culture conditions are not able to proli-
ferate in vitro (1). In a previous paper, we have shown that viable 
human hepatocytes can be stored for a long period of time by cryopre-
servation, although, after thawing, the efficiency of cell seeding 
onto tissue culture plastic and accordingly survival of hepatocytes 
were decreased as compared to freshly isolated hepatocytes (2). Since 
substrata of extracellular matrix (ECM) have been reported to improve 
the attachment efficiency and maintenance of specific cellular func-
tions in cultures of rat hepatocytes (1,3), we have investigated the 
influence of homologous liver ECM on attachment efficiency, survival, 
synthesis of RNA and protein and on the morphology and fine structures 
of human hepatocytes. In addition, under this experimental condition 
we investigated the effect of monocytic products on the synthesis of 
albumin. Monocytic products, especially interleukin-I, have been found 
in experimental animals to play an important role in the regulation of 
liver albumin synthesis during inflammation (4). 
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MATERIALS AND hETHODS 
Materials: L-[4,5-3H] Leucine (76 Ci/mmol) [6-3H]-thymidine (22 
Ci/mMol) and [б-1^С] orotic acid (61mCi/mmol) were obtained from the 
Hadiochemical Centre, Amersham. Collagenase type I, oyster glycogen 
type III, dithiothreitol, endotoxin (E.Coli 055: B5) bovine serum al­
bumin, 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (Hepes) and 
TES (2-[2-Hydroxy, 1,1-bis (hydroxy-methyl) ethyl] amino ethane sulfo­
nic acid) were purchased from Чідта. William's medium Ε,ΗΡΜΙ 1640 DM 
medium and fetal calf serum were from Flow Laboratories. Triton X-100 
and sodium dodecyl-sulfate were obtained from BDH Chemicals Ltd. 
Percoli was from Pharmacia. EDTA, phenol, sodium deoxycholate, 
2-mercaptoethanol, salts and solvents were purchased from E. Merck. 
Dexamethasone disodium phosphate (Oradexon"), was obtained from 
Organon, The Netherlands. Porcine insulin was from Novo Industri, 
phytohaemagglutinin (PHA) was from Wellcome Diagnostics, Dartford, 
UK. All tissue culture plastic was from NUNC, Denmark. 
Chemicals, unless otherwise specified were of analytical purity. 
All glassware was sterilized and solutions were freshly prepared and 
autoclaved prior to use. 
All solutions used in the hepatocyte isolation and cultunng, were 
filtered through a 0.22 μ.™ Schleicher and Schuell filter and stored 
frozen. 
Preparation of isolated hepatocytes: Post mortem human liver tissues 
were obtained from nine kidney donors aged from 16 to 51 years. Hepa­
tocytes were isolated by a two-step perfusion technique modified from 
that described for the isolation of rodent hepatocytes, as described 
previously (2) with the following modification: EGTA was omitted in 
the Ca 2 +-Mg 2 + free Hepes buffer. The liver was perfused with 200 
ml of a Hepes buffer, pH 7.6, containing collagenase (0.05Ж w/v) and 
10 mM CaCl2 and subsequently with 200 ml of a Hepes buffer, pH 7.6, 
containing collagenase (0.1Í« w/v) and 20 mM СаСІ2 for 20-40 min in a 
recirculation system. 
Deep freezing storage, thawing of hepatocytes and cell cultures were 
performed as described previously (2). Cells were seeded at a density 
of 175 χ 103 hepatocytes per cm2. 
Preparation of cell culture substrata. 
Extracellular matrix (ECM) from normal adult human liver, Wistar rat 
liver and rat tail tendon collagen type I, were prepared according to 
the methods described by Price (5) and Hojkind et al (6) with slight 
modification. After isolation, the extracellular matrix was lyophili-
zed and dissolved in 0.1 M acetic acid in a final concentration of 200 
-ЭІ-
ug protein per ml. This suspension was layered on tissue culture plas­
tic (20 μg/cm2) and the acetic acid was allowed to evaponze. The cul­
ture plastic precoated with ECM wan washed with Hanks'balanced salt 
solution prior to use. 
Characterization of human liver extracellular matrix was performed by 
immunofluorescence on glass cover slips coated with LCM by the same 
procedure. Antibodies used were kindly provided by Dr. F. Ramaekers, 
dept. of pathology, St. Radboud University Hospital, Nijmegen, The 
Netherlands. 
Incorporation of labelled precursors into RNA and protein. 
Incorporation of labelled precursors into RNA and protein and immuno-
precipitation of [3H]-leucine labelled albumin, using specific antibo­
dies against human albumin were performed as described previously (4). 
DNA determination, cells were suspended in water and sonicated. After 
centrifugation, UNA in supernatant was measured by a fluorometric 
technique as described by Kapuscinski and Skoczylas (7). 
Enzyme assays: aspartate aminotransferase (ASAT), alanine aminotrans­
ferase (AtAT) and lactate dehydrogenase (LDH) in culture medium, were 
determined according to routine clinical laboratory methods. 
Plasma protein assays: determination of albumin (in the long-term cul-
turf; studies), al-acid glycoprotein, al-antitrypsin, a1-antichymotryp-
sin, fibrinogen and haptoglobin in culture medium was performed by 
rddial immunodiffusion technique as described by Mancini et al (8). 
All anMsera wore absorbed with fetal calf serum prior to the assay. 
Light and electron microscopy studies were performed as described pre­
viously (2). 
Preparation of monocytic products: monocytic products from rabbits 
were obtained by incubation of activated macrophages, isolated from 
peritoneal exudates induced by glycogen in rabbits, as described pre­
viously 9). 
Human monocytic products were obtained by stimulation of adherent 
monocytes with endotoxin (15 μg/ml). Monocyte-ennched fractions of 
human leucocytes were obtained from "buffy-coats" of blood-donors by 
centrifugation in a Percoli gradient, and cultured in RPMI 1640 DM 
medium, supplemented with 5S (v/v) fetal calf serum and 2 mM L-gluta-
mine. Medium was changed, and cells vigorously washed, 3 hr after see­
ding and subsequently incubated for 4Θ hr in the same medium supple­
mented with endotoxin. This conditioned medium was used as the source 
of human monocytic products. 
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Thymocyte proliferation assay: The thymocyte proliferation assay as 
described previously in (10) was used to assay the monocytic products 
for 11-1 activity. Briefly: thymocytes were isolated from CBA mice, 
aged 6-12 week (TNO Rijswijk, The Netherlands) and suspended in RPMI 
1640 DM medium supplemented with 5й (v/v) fetal calf serum, 2 mM 
L-glut ami ne and antibiotics. 50 μΐ of the thymocyte suspension, cor­
responding to 106 cells were then added to 96-well microtiter plates 
(Serocluster TM, Costar) followed by addition of 50 μΐ of a solution 
containing 5 μΐ}/π\1 PHA and 6x10-5 M 2-mercaptoethanol and 50 μΐ test 
substance. Cells were incubatoci for 48 hr. 0.5 μCl [6-3H]-thymidine 
was then added to each well. After a further incubation for 24 hr 
cells were harvested and assayed for incorporated radioactivity in a 
liquid scintillation counter. 
Influence of monocytic products on plasma protein synthesis: 
After isolation and attachment (day 1), cells were cultured for 1 day 
in the presence of 50 nM dexamethasone (day 2). On day 3, test sub­
stances were added and cells were incubated in culture mediun contai­
ning 1 μΜ dexamethasone. Rabbit monocytic products were added as a 
concentrated atock aolution to a final concentration of 200 μg per ml 
culture medium. Human monocytic products were added as conditioned 
monocyte medium to a final concentration of 108. At day 4, fresh 
medium, containing the same additives and [3H]-leucine (5.0 цСі per 
ml) was added and cells were incubated for the next 24 hours after 
which cells were washed with phosphate buffered saline and harvested 
for DNA determination. In the co-culture experimenta, monocytes were 
added at day 3 (ratio hepatocytes/adherent monocytes: 3:1) and stimu­
lated with endotoxin (15 μg/ml). At day 4, fresh medium containing 
endotoxin (15 цд/ті) and 3H-leucine (5.0 μCl/ml) was added and cells 
were incubated for the next 24 hr. 
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RESULTS 
To examine the influence of extracellular matrix on the long-term cul­
tures of normal adult human hepatocytes, freshly prepared as well as 
cryopreserved cells were used. Cryopreserved hepatocytes had been sto­
red for 25 to 275 days prior to experiments. The viability of hepato­
cytes ач determined by trypan blue exclusion test was decreased from 
average 75$ (60- 7й) to 57Й (a4-70S) due to the cryopreservation pro­
cedure (2). Consequently, the attachment efficiency with a cell densi­
ty of 175 χ 1ü' cells per cm^, onto the plastic dish was alao re-
duced to 85-7(K> of that of freshly prepared hepatocytes. 
Attachment efficiency and survival: In table I, the effect of diffe-
rent substrates on the attachment efficiency of cryopreserved hepato-
cytes is demonstrated. After 12 hours in culture, the hepatocytes have 
a lower attachment and survival efficiency on tissue culture plastic 
than on plastic dishes precoated with extracellular matrix. The diffe-
rences in substrates became increasingly apparent in the studies on 
the long-term cultures. The number of hepatocytes cultured on plastic 
declined gradually. From the end of second week, the cell cultures 
were overgrown by fibroblasts and accordingly the DNA content was in-
creasing during the third week of culture (figure 1). In contrast, 
liver extracellular matrix improved the attachment and survival of he-
patocytes. They survived more than 4 to 6 weeks without evidences of 
fibroblast proliferation (figure 1). In various experiments, hepatocy-
tes could be maintained for longer than 3 months. For the freshly pre-
pared hepatocytes, the beneficial effect of extracellular matrix on 
the cell attachment was not obvious (data not shown). 
Table 1 Attachment efficiency and survival of cryopreserved human 
hepatocytes in primary culture on different substrata. 
Attachment efficiency or survival was calculated as % of DNA 
content of viable cells* seeded per dish at time zero (ave-
rage of 3 experiments). 
Days after cell seeding Day 1 Day 4 Day 10 Day 14 
Tissue culture plastic 51 43 40 35 
Collagen Type I (rat 55 51 47 43 
tail tendon) 
Extracellular matrix 63 55 52 49 
(rat liver) 
Extracellular matrix 6Θ 62 60 5Θ 
(human liver) 
• v i a b i l i t y of c e l l s was determined before cryopreservation. 
- 8 6 -
as percentage of DNA at T = 0 
17 19 21 
day of c u l t u r e 
Fig. 1 
The attachment efficiency and survival of cryopreserved human 
adult hepatocytes in primary cultures on tissue culture plastic 
(• ·) and on plastic precoated with extracellular matrix pre­
pared from human liver tissue ( o — o ) . Attachment efficiency was 
calculated as described in table 1. Each point on the curve is 
the average measurement +S.D, of at least 5 experiments. The in­
creased content of DNA at the last week of experiments on plas­
tic was due to fibroblastic proliferation. 
RNA synthesis and protein secretion: To characterize the effect of ex­
tracellular matrix from human liver tissue on the capabilities of hu­
man adult hepatocytes in primary cultures to synthesize RNA and to se­
crete protein, incorporation of labelled precursors into RNA and pro­
tein were studied. The incorporation of [6-14СІ orotic acid into RNA 
of freshly prepared or cryopreserved hepatocytes in primary cultures 
24 hours after cell seeding, was found at a linear rate for at least 
20 hours, regardless of the different substrata used (data not shown). 
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The i n c o r p o r a t i o n of [ ^ н ] leucine i n t o s e c r e t e d p r o t e i n was a lso 
l i n e a r f o r over 30 hours on a l l s u b s t r a t e t e s t e d . No s i g n i f i c a n t d i f ­
ferences were found between c u l t u r e s o f human hepatocytes on t i s s u e 
c u l t u r e p l a s t i c and homologous ECM, i n i n c o r p o r a t i o n of [ 6 - C j - o r o t i c 
a c i d i n t o t o t a l RNA and [ H j - l e u c i n e i n t o s e c r e t e d p r o t e i n ( f i g u r e 2 ) . 
I n c o r p o r a t i o n o f l a b e l e d precursors i n t o t o t a l RNA and secreted p r o ­
t e i n i n c u l t u r e s o f cryopreserved human hepatocytes was about 80% as 
compared to values of c u l t u r e s of f r e s h l y i s o l a t e d human h e p a t o c y t e s . 
[ 4 , 5 - э н ] leucine incorporated into 
secreted protein (DPM χ 10"%jg DNA) 
ι 1 1 1 1 1 
θ 16 24 32 40 4Θ 
time (hrs) 
Fig. 2 
Incorporation of [4,5-Ή| leucine into secreted protein of 
freshly prepared human adult hepatocytes in primary cultures on 
tissue culture plastic ( · — · ) and on plastic precoated with ex­
tracellular matrix prepared from human liver (о-—o). Each point 
on the curve is the average measurement +S.D. of at least 4 ex­
periments. 
500-
400-
300-
200-
100-
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Albumin secretion and enzyme activities: 
During the first week of culture, human hepatocytes secreted signifi­
cant amounts of albumin into the culture medium. After the first week 
of culture, the albumin secretion dropped gradually and the reduction 
of albumin secretion was associated with enhanced activities of tran­
saminases and lactate dehydrogenase in the culture medium. This pat­
tern of changes in albumin secretion and enzyme activities in culture 
medium was observed in primary cultures of hepatocytes on plastic as 
well as on extracellular matrix. However, these changes were delayed 
for at least 5 days in primary cultures on extracellular matrix (fi­
gure 3 and 4) 
AL AT A SAT 
Fig. 3 
The albumin secretion and enzyme activities in medium of human 
adult hepatocytes in primary cultures on tissue culture plastic. 
Each point on the curves is the average value +S.D. of at least 
6 experiments. 
-Θ9-
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Fig. 4 
The albumin secretion and enzyme activities in medium of human 
adult hepatocytes in primary cultures on plastic precoated with 
extracellular matrix prepared from human liver tissue. Fach 
point on thf» curves is the average value +S.D. of at least 6 ex-
periments. 
Morphology and fine structures: After 12 hours in culture, freshly 
prepared or cryopreserved hepatocytes attached on plastic or on extra-
cellular matrix had formed the confluent monolayer of polygonal shaped 
cells with granular cytoplasm (figure 5). On tissue culture plastic, 
attached hepatocytes spread rapidly and after one week, cell morpholo-
gy was less regular and hepatocytes flattened with multiple cytoplas-
mic projections. At the fourth week cells detached and died with appa-
rent fibroblast proliferation in the culture. These changes were asso-
ciated with the reduction of albumin secretion, enhanced activities of 
transaminases and lactate dehydrogenase in culture medium and an in-
creased level of DNA content due to the fibroblast proliferation. 
In primary cultures on extracellular matrix, hepatocytes maintained 
their cuhoidal morphology and typical fine structures for at least 2 
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weeks longer than hepatocytes attached to plastic. Mitochondria, gly­
cogen particles, rough and smooth endoplasmic reticulum were easy to 
identify, newly formed bile canaliculi with numerous microvilli were 
reconstituted. Structures similar to tight junctions and desmosomes 
could also be observed. The classical biliary polarity -the presence 
of Golgi complexes and lysosomes with lipofuscin pigments in the cyto­
plasm near the bile canaliculi- was very evident (figure 6). Despite 
the maintainance of these typical hepatocytic fine structures and the 
absence of fibroblast proliferation in tissue culture, the albumin se­
cretion of hepatocytes on extracellular matrix was decreased to lower 
than 4 μg per μg DNA in the fourth week of culture (figure 4). 
A <4t* 
*% ЧР-. i 
-
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Fig. 5 
Light micrographs of cryopreserved human adult hepatocytes in 
primary cultures on tissue culture plastic (A) and on plastic 
precoated with extracellular matrix prepared from human liver 
tissue (B), 48 hours after cell seeding. Hepatocytes were fixed 
with methanol and stained with Giemsa solution. Hepatocytes had 
formed the confluent monolayer of polygonal shaped cells with 
granular cytoplasm. The nuclei contained prominent nuceoli. 
Magnification: 440x 
:Ш'
:
Ч* BC 
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Fig. 6 
Transmission electronmicrographs of cryopreserved human adult 
hepatocytes in primary cultures on tissue culture plastic (A and 
8) and on plastic precoated with extracellular matrix prepared 
from human liver tissue (C and D), 10 days after cell seeding. 
Lipofuscin pigments (L) and Golgi apparatus (G) were distributed 
around structures similar to bile canalicoli (ВС). Structures 
similar to tight junctions (TJ) could also be observed. 
Magnification: 12A: 1920x 128: 7ü6Qx 
12C: 2860x 12D: 4870x 
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Characterization of human liver extracellular matrix: 
Immunofluorescence studies, using specific antibodies, showed the pre­
sence of the basement membrane components laminiη and fibronectin and 
the collagens type I and III. No desmin or cytokeratin 18 was detected 
in the liver ECM (table 2). In this study, the presence of other col­
lagen types in the extracellular matrix was not tested. 
Table 2 Characterization of human liver extracellular matrix. 
immunofluorescence 
Laminin + 
Desmin 
Fibronectin + 
Cytokeratin 18 
Collagen type I + 
Collagen type III + 
Influence of monocytic products on albumin synthesis by cultured human 
hepatocytes: 
Using the radial immunodiffusion technique as described by Mancini et 
al (12), the secretion of ai-antitrypsin, αι-antichymotrypsin, aj-acid 
glycoprotein, haptoglobin, fibrinogen and albumin into culture medium 
of human hepatocytes have been detected (data not shown). As all anti-
sera were absorbed with fetal calf serum, the detection of these pro­
teins could not be due to an immune cross-reactivity of the antisera 
with the fetal calf serum present in the medium. To study the effects 
of monocytic products on albumin synthesis, [3H]-leucine was added to 
the culture media and the labelled albumin secreted into culture me­
dium was determined. Monocytic products of both human (conditioned mo­
nocyte medium) and rabbit origin were shown to decrease the secretion 
of albumin to 40-45й of the value of control experiments (figure 7, 
table 3). In some studies, human hepatocytes were cocultured with hu­
man adherent monocytes. Upon stimulation of the monocytes in coculture 
with endotoxin, albumin secretion was decreased to 45S of the value of 
non-stimulated cocultures or cultures of human hepatocytes alone 
(table 3). The effect of human monocytic products on albumin secretion 
could not be due to a direct effect of endotoxin in the conditioned 
medium, as non-conditioned medium plus endotoxin did not affect the 
secretion of albumin (table 3, figure 7). In addition, the presence of 
adherent monocytes without endotoxin did not lead to a decreased albu­
min synthesis (table 3). However, endotoxin induces interleukin-I re­
lease from monocytes or macrophages as shown by the thymocyte proli­
feration assay (table 4). These results indicate that the release of a 
mediator or mediators by the monocytes upon stimulation by endotoxin 
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is responsible for the decrease of albumin synthesis in the liver 
cell. The decrease of albumin synthesis under this condition is speci­
fic, since the amount of secreted total protein by cultured hepatocy-
tes was not influenced by the monocytic products (table 3, figure 7). 
Table 3 Influence of monocytic products on protein and albumin se­
cretion in primary cultures of human hepatocytes 
secreted protein secreted albumin 
control (medium alone) 100 ± 14 
medium+endotoxin (Ιίμς/πιΐ) 116 t 15 
human monocytic products 129 ± 18 
rabbit monocytic products 119 ± 14 
coculture with adherent monocytea110 ±11 
coculture with adherent mono­
cytes en endotoxin (15 μς/πιΐ) 115 ±12 4 5 + 7 
The effects of monocytic products on the secretion of protein 
and albumin by human hepatocytes cultured on homologous extra­
cellular matrix in presence of 1 μΜ dexamethasone. [3H]-leucine 
incorporation into hot TCA precipitatole material (secreted pro­
tein) or immunoprecipitable albumin were determined and calcula­
ted as DPM per \xq cellular ONA. Results are expressed as percen­
tage of control value at T= 24 hr after addition of [3H]-leucine 
and are means ±50 of 4 experiments. 
Table 4 Interleukin-I activity of monocytic products as determined 
by the thymocyte proliferation assay (see materials and 
methods section) 
cpm[6-3H]-thymidine incorporated 
into thymocytes 
medium (control) 102 ± 41 
medium+endotoxin (15 μg/ml) 121 ± 3 7 
human monocytic products 23.047 ± 4128 
rabbit monocytic products 21 .354 ± 3724 
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secreted protein 
(сірт.ІО- цд DNA) 
secreted albumin 
Юрт.ІСН/цд DNA) 
2U 
time (hrs) 
Fig. 7 
The effects of human monocytic products and endotoxin on the 
secretion of protein and albumin by human hepatocytes cultured 
on homologous extracellular matrix, in the presence of 1 μΜ 
dexamethasone. [3H]-leucine incorporation into hot TCA 
precipitatile material (secreted protein) or immunoprecipitable 
albumin were determined and expressed as dpm per μς cellular DNA 
and are means +SD of 4 experiments. Control cultures:·—· , 
cultures with human monocytic products:©—о and cultures with 
endotoxin (1.5 μg/ml):Δ—d. 
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DISCUSSION 
In elucidating the molecular mechanism of reduced albumin synthesis 
during inflammation (4), We have demonstrated in a previous study in 
rats and in primary cultures of rodent hepatocytes (4), that monocytic 
(macrophagic) products and interleukin-1 reduce in vivo and in vitro 
synthesis of albumin and decrease hepatic content of albumin messenger 
UNA. The decreased synthesis of albumin in rata treated with turpen-
tine (inflammatory model) can be partially reversed by a specific 
antibody against the ISkD protein of monocytic products (interleukin-
1: a 15kD mol.weight protein in rabbits). This in vivo observation is 
also supported by the in vitro finding of normalization of albumin 
secretion of hepatocytes by addition of this antiserum in medium con-
taining monocytic products. These findings suggest that monocytic pro-
ducts in rats play an important role in reduced albumin synthesis du-
ring inflammation. However, in previous reports we have also shown 
that considerable interspecies differences exist with regard to liver 
metabolic activities and susceptiblity to drugs, genotoxic agents and 
microorganisms (2,15-20). The finding in rats can therefore not be ex-
trapolated into man without further examinations. Primary cultures of 
human hepatocytes provide a useful model for the study of specific me-
tabolic and pathogenic processes in liver cells in man (2,15-20), To 
confirm the validity of results obtained in studies using rodent hepa-
tocytes, we have therefore investigated in this study the effect of 
monocytic products and interleukin-1 on the synthesis of albumin and 
its mRNA content in primary cultures of human hepatocytes. Conform the 
findings in rodent hepatocytes monocytic products and interleukin-1 
were also found to reduce the synthesis of albumin and its mRNA in hu-
man hepatocytes. These changes could also be reversed by antibodies 
against the 15kD M.W. component of the rabbit monocytic products. 
Endotoxin is not able to decrease the albumin synthesis, when the 
hepatocytes were not cocultured with adherent monocytes. However, 
endotoxin induces interleukin-1 release from monocytes as shown by the 
thymocyte proliferation assay (table 4). These results support our 
previous observations in cultured rodent hepatocytes, indicating the 
important role of monocytic products in the regulation of liver syn-
thesis of albumin in inflammatory diseases in man. 
Studies employing human hepatocytes are still scarce. Availability of 
viable tissue for cell isolation is very limifed and irregular. In a 
previous report, we have presented techniques and adapted a deep-free-
zing preservation procedure for long-term storage of viable human 
hepatocytes to facilitate well-programmed experiments (2). Neverthe-
less, cryopreservation lead to a considerable cell loss due to a 10-
302í reduction of attachment efficiency and survival of hepatocytes 
seeded on tissue culture plastic, despite the maintainance of specific 
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metabolic function and typical fine structure (2). In the present stu-
dy, we demonstrate that the deleterious effect of freezing storage on 
attachment and survival of hepatocytes can be significantly reversed 
by using tissue culture plastic precoated with homologous liver extra-
cellular matrix (table 1, figure 1). In addition our findings indicate 
the existence of specific factors (tissue- and species-specific) which 
are required for different cells of different species in culture to 
attach to a substrate and to survive as has been suggested by others 
(1,3). The use of extracellular matrix (biomatrix) in liver cell cul-
ture has been advocated for many years. It has become evident that the 
function of extracellular matrix is not only structural, but may also 
influence and maintain specific cellular functions (1,3,21). Specific 
substrates or cellular factors have been found to be essential for 
maintaince of phenotypic expression of a specific cell type in vitro. 
Following culture of hepatocytes on substrata prepared from collagen 
type I, cell survival could be prolonged for 1-2 weeks, although hepa-
tocytic functions declined rapidly (22-25). Rojkind et al (6), how-
ever, reported that rat hepatocytes maintained on rat liver biomatrix 
synthesized albumin, conjugated bilirubin and contained phénobarbital 
activated cytochrome P-450 enzymes, for at least 4 months. Using a co-
cultunng system with rat liver epithelial cells, prolonged survival 
of normal adult human hepatocytes has also been reported (10). Since 
cells from non-human origin were used, this cocultunng system has 
been subjected to criticism in studying specific metabolic functions 
of human hepatocytes. In this study we prepared extracellular matrix 
from normal liver of kidney donors according to the method described 
by Rojkind et al for rat liver (6). By this method of preparation it 
was found that this extracellular matrix contained the collagens type 
I ind III and the basement membrane components laminin and fibronectin 
(table 2). Although we did not test for the presence of other compo-
nents, Rojkind et al showed that rat liver extracellular matrix also 
contained, collagens type IV and V, glycosaminoglycana, glycoproteins 
and other non-collagenous proteins. 
Ultrastructural studies showed maintainance of typical fine structures 
of hepatocytes cultured on ECM for at least 4 weeks versus 1-2 weeks 
on tissue culture plastic. Increased enzyme activities (transaminases 
and tDH) in culture medium, as observed in the second and third week 
of long-term culture on plastic, were delayed in cultures on extracel-
lular matrix. Furthermore liver extracellular matrix appeared to sup-
press fibroblast proliferation (figure 1). 
We can therefore conclude that ECM prepared from normal, adult human 
liver significantly improves attachment efficiency and survival of hu 
man hepatocytes, particularly after cryopreservation and has a benefi-
cial effect on the maintainance of typical fine structures and pheno-
typic expression. Human hepatocytes cultured on homologous extracellu-
-9Θ-
lar matrix provide an useful model for the study of specific liver 
cell functions, such as regulation of protein synthesis and the ef-
fects of biological response modifiers such as monocytic products. 
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ABSTRACT 
During the acute phase response, the synthesis of fibrinogen and its 
mRNA content in the liver are increased due to a direct effect of 
interleukin-I (IL-1) on hepatocytes. In several physiological altera­
tions of the acute phase induced by IL-1, such as fever, muscle was­
ting and immunoregulation, it has been shown that prostaglandins have 
an important role as a secondary messenger. In this study we have exa­
mined in rats in vivo and in primary cultures of rat hepatocytes, the 
effect of prostaglandins on the biosynthesis of fibrinogen and the ef­
fect of cyclo-oxygenase inhibitors [indomethacin and naproxen] on the 
IL-1 induced stimulation of fibrinogen synthesis and its mRNA level in 
hepatocytes. 
Plasma levels of fibrinogen were not changed in rats after i.p. admi­
nistration of prostaglandins: PGE2, PGF20 а п ^ 16,16 dimethyl PGE2, 
in doses ranging from 5 to 500 цд/кд body weight. The synthesis of fi­
brinogen was also not affected in primary cultures of rat hepatocytes 
in the presence of prostaglandins (50 nM-5 μΜ). 
In IL-1 induced stimulation of fibrinogen synthesis in rats and in 
primary cultures of rat hepatocytes, indomethacin (in vivo: 1-7x0.2 
mg/rat, in vitro: 10-5-10"7 M) and naproxen (in vitro: 3-0.3 
μq/ml) given simultaneously or prior to administration of monocytic 
products (IL-1) did not change the increased plasma levels of fibrino­
gen or the enhanced fibrinogen secretion and the elevated level of he-
patocytic fibrinogen mRNA. These findings suggest that the enhanced 
synthesis of fibrinogen induced by monocytic products (IL-1) during 
the acute phase response is not mediated by prostaglandins or other 
products of the cyclooxygenase pathway of arachidomc acid. 
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INTRODUCTION 
During the acute phase response, the synthesis of fibrinogen and its 
messenger RNA content in the liver are increased !l). Corticosteroids 
and other hormones can not be implicated as the sole factor for modu­
lating the hepatic synthesis of fibrinogen under this condition (2). 
Recently, we have demonstrated that monocytic (macrophagic) products 
and interleukin-1 enhance synthesis of fibrinogen and increase hepatic 
content of fibrinogen messenger RNA via a direct effect on hepatocytea 
(manuscript submitted). In experimental studies, it has been shown 
that products of inflammatory cells play an important role in the phy­
siological alterations that characterize the acute phase response. The 
active principle of these products, or so called leucocytic endogenous 
mediator, is interleukin-1. This protein is produced by several types 
of cells such as macrophages, blood monocytes and Kupffer cells. It 
has a molecular weight of approximately 15,000 (in rabbits) (3,4). 
This protein has also been shown to induce the formation of prosta­
glandin E2 in many different cell types (5,6,7), and this phenomenon 
may represent a general characteristic of interleukin-1 in mediating 
physiological processes, such as fever (8), muscle wasting (9) and im-
munoregulation (10). In this study, we investigate the influence of 
prostaglandin E2 агк* ^2a o n *-he fibrinogen synthesis and its messen­
ger RNA content, and the effect of cyclo-oxygenase inhibitors (indo-
methacin and naproxen) on the interleukin-1 induced stimulation of 
fibrinogen synthesis and its messenger RNA content in rat liver in 
vivo and in primary cultures of rat hepatocytes. 
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MATERIALS AND METHODS 
Animals 
Male Wistar rats weighing 180-200 g were used throughout and maintai­
ned on standard punna chow and water ad libitum. 
Monocytic products were administered intrapentoneally (1 ml: 1-3mg). 
Indomethacin was given intragastric as a suspension by intubation 
(volume 1 ml). The following experiments were performed: 1) Indometha­
cin (0.2 mg) was given simultaneously with monocytic products, total 
dose 1x 0.2 mg; 2) Indomethacin (0.2 mg) was given 9 hr prior to and 
simultaneously with monocytic products; total dose 2x 0.2 mg); 3) 
Indomethacin (0.2 mq) was given twice a day for 3 days prior to and 
simultaneously with monocytic products; total dose 7x 0.2 mq. Blood 
samples were withdrawn by intracardiac puncture under ether anaesthe­
sia. Plasma fibrinogen concentrations were determined as described by 
Vermylen et al (11) 
Preparation of rat hepatocytes and primary culture 
Liver cells were prepared according to the method of Seglen (12) with 
some modifications as described previously (13) Rats were anaesthesi-
zed by pentobarbital i.p; 6 mq/ΙΟΠ g body weight. All buffers were 
autoclaved before use and oxygenated by direct bubbling with oxygen. 
Collaqenase buffer (0.5 mg/ml) was supplemented with 0.05 mq/ml soy­
bean trypsin inhibitor. Cells were filtered, preincubated and centri-
fuqated in Ca + free Hanks' balanced salt solution containing 2% 
bovine serum albumin. Damaged and nonparenchymal cells were removed. 
The cell suspension was then passed through a 100 μΜ nylon filter. The 
viability of the hepatocytes as determined by trypan blue exclusion 
tests was more than 95Й. 
The culture medium was William's medium E supplemented with 5Й (v/v) 
fetal calf serum, 2mM L-qlutamine, 20 mU/ml porcine insulin, dexame-
thasone as indicated, 2.5 μg/ml fungizone, 50 μg/ml gentamycine and 
100 μq/ml vancomycin. Hepatocytes were seeded at a concentration of 
175 χ 10 cells per cm in polystyrene flasks or dishes and maintained 
in a humidified atmosphere composed of 95" air and 55» COj. The medium 
was renewed 2-4 hr after cell seeding and every 24 hr thereafter. 
Incorporation of labelled precursor into protein and immunoprecipita-
tion of [ЗНІ labelled fibrinogen were essentially performed as descri­
bed previously (14,15) 
DNA determination 
Cells were suspended in water and sonicated. After centrifugation, DNA 
in supernatant was measured by a fluorometric techmgue as described 
by Kapuscinski and Skoczylas (16). 
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U1 
Preparation oF liver cell RNA 
Total postnuclear RNA oF liver tissue was prepared according to the 
method oF Taylor and Schimke (17) as described previously (1Θ). 
Preparation oF purified Fibrinogen polypeptide mRNAs and Γ Η] labeled 
complementary DNA (cDNA) 
PunFication of mRNAs specific For rat Fibrinogen polypeptides and the 
synthesies of the speciFic complementary DNA probe From these punFied 
mRNAs have been reported previously (19). Analytical RNA-cDNA hybridi­
zation was perFormed as described previously (20). 
Preparation oF monocytic products 
The monocytic products were prepared by incubation of activated macro­
phages isolated from peritoneal exudates induced by qlycoqen in New 
Zealand white rahbits as described by Ritchie and Fuller (21). These 
preparations were endotoxin free as tested by a Limulua test and sho­
wed interleukin-1 activity as determined by the thymocyte prolifera­
tion assay. 
Thymocyte proliferation assay 
The thymocyte proliFeration assay as described by Gery et al (22) was 
used to assay monocytic products For IL-1 activity. 
BneFly: thymocytes were isolated form CBA mice, aqed 6-12 weeks (TNO 
Rijswijk, the Netherlands) and suspended in RPMI 1640 DM medium, sup­
plemented with 5!« fetal calf serum and 2 mM L-qlutamine.50 μΐ thymo­
cyte suspension, corresponding to 10 cells was added to 96-well 
microtiter plates followed by addition of 50 μΐ of a solution contai­
ning 5 μq/ml phytohaemaqglut m m (Wellcome Diagnostica, Dart ford, 
England) and 6 χ 10 M 2-mercaptoethanol and 50 μΐ test substance. 
Cella were incubated for 4B hr. 0.5 цСі^еІІ [6- H]-thynudine was then 
added to each well and cells were further incubated for 24 h. Cells 
were harvested and assayed for incorporated radioactivity. 
Materials 
L-[4,5-3H] Leucine (76 Ci/mmol), [6-3H]-thymidine (22 Ci/mMol), [^C] 
formaldehyde (17.6 mCi/mol) and [5-3Н] dCTP (1 .4 Ci/mmol) were obtai­
ned from the Radiochemical Centre, Amersham International, Amersham, 
UK. Collagenase type I, soybean trypsin inhibitor, bovine serum albu­
min, heparin from porcine intestinal mucosa, dithiothreitol, Hepes, 
prostaglandins ΐ.2^2α< 16,16-dimethylprostaglandin Ег and indometha-
cin were purchased from Sigma, Chemical Co, St. Louis, M0, USA. 
Naproxen was from Sarva-Syntex B.V., Rijswijk, The Netherlands. 
William's medium E, RPMI 1640 DM medium and Fetal cal F serum were From 
Flow Laboratories Ine, Irvine, UK. Triton X-100 and SDS were obtained 
From BDH Chemicals Ltd, Dagenham, Essex, UK. Ribonuclease-free sucro-
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se, EDTA, phenol, sodium deoxycholate, salts and solvents were purcha­
sed from F. Merck, Darmstadt, FRG. Deoxyribonuclposide t npliosphates 
from Schwarz/Mann,Spring Valley, NY, USA. Oligo (dT)io from Collabora­
tive Research, Ine, Waltham, MA, USA. Avian myeloblastosis virus RNA-
dependent DNA polymerase was kindly supplied by Dr. J.W. Beard, Natio­
nal Cancer Institute, Bethesda, MD, U.S.A. Nuclease Sj (aspergillus 
oryzae) was purchased from Boehnnger Mannheim GmBH, Mannheim FRG, and 
stored at 2.5 χ ID3 units/ml in 5ΙΚ glycerol, 50 mM NaCl, 0.1 mM ZnC12 
and 20 mM Tris HCl pH 7.5 at -2CPC. Oradexon" (dexamethasone diao-
dium phosphate) was obtained from Organon Oss, The Netherlands. Porci­
ne insulin was from Novo Industri BV, Amsterdam, The Netherlands All 
tissue culture plastic was from NUNC, Roskilde, Denmark. All glassware 
was sterilized and solutions were freshly prepared and autoclaved, 
prior to use. Bovine serum albumin and soybean trypsin inhibitor were 
dialyzed against 0.15 M NaCl and as all solutions used in the hepato-
cyte isolation and cultunng filtered through a 0.22 цт filter, 
Schleicher and Schuell, Dassel, FRG and stored frozen. 
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RESULTS 
To study the effects of prostaglandins ЕгСРСЬг), ?2а (PGF2a) and 
16,16 dimethyl PGE2 on the biosynthesis of fibrinogen and i t s messen­
ger RNA content in the l i ver c e l l s , we have injected these prostaglan­
dins in doses ranging from 5-500 цд/кд body weight intraperitoneal!у 
in r a t s . In addi t ion, experiments were also performed in v i t r o using 
primary cultures of rat hepatocytes. Table 1 shows the plasma f i b r i n o ­
gen levels in rats 16 hr after an intraperitoneal in ject ion of prosta­
glandins. 
Table 1 Concentrations of plasma fibrinogen in rats 16 hr after i.p. 
injection of prostaglandins (PC's) or nonocytic products 
Treatment fibrinogen (mq/ml) 
saline (1 ml; i .p . ) 2.Θ6 ± 0.47 
PGEj (5 .ig/kg hodyweight) 2.99 ± 0.15 
PGE2 (50 цд/кд b.w.) 3.27 t 0.35 
PG£2 (500 μg/kg b.w.) 2.90 ± 0.44 
PGF2(I(5 μ9Λς b.w.) 3.40 ± 0.59 
PGF2(I(50 цд/кд b.w.) 3.33 ± 0.59 
PGF2(I(500 μg/kg b.w.) 2.64 ± 0.19 
16,16 dinethylPGE2 (5 vq/Uq b.w.) 3.20 ± 0.28 
16,16 dimethylPGE2 (50 μg/kg b.w) 3.0 ± 0.60 
16,16 dimethylPGEj (500 μςΛς b.w.) 3.55 ± 0.43 
monocytic products (3 mg; i . p . l 6.08 ± 0.45 (*) 
Data are expressed as the average of at least three experiments 
with 3 rats per experiment •'S.D. *; s t a t i s t i c a l l y s igni f icant 
difference as compared to saline injected control animals; 
p<0.001: Student's t - t e s t . 
Likewise, in in v i t r o experiments, using primary cultures of rat hepa­
tocytes, and using the experimental design depicted in f igure 1, PGE2, 
PGF?(I and 16,16 dimethylPGE2 also have no effect on the fibrinogen 
secretion ( f igure 2) . Furthermore, no differences were found in f i b r i ­
nogen polypeptide mRNAs levels both in vivo in rat l i ver and in v i t r o 
in primary cultures of rat hepatocytes (data not shown). However, in 
th is experimental system, the fibrinogen secretion was s i g n i f i c a n t l y 
increased by monocytic products (or interleukin-1) in the presence of 
1 μΜ dexamethasone ( f i g 2). 
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EXPERIMENTAL DESIGN 
dayl 2 
3H -leucine 
sampling of media 
• I ! i J 
3 i 
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Fig 1 
Experimental design. 
After isolation, cells were seeded in polystyrene dishes or 
flasks, using medium containing 50 nmol/1 dexamethasone. The me-
dium was renewed 2-4 hours after cell seeding and every 24 hours 
thereafter. Test substances were supplemented on day 3. Label-
ling experiments using [ Hj-leucine were performed on day 4 in 
the presence of test substances. 
-Ill-
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Fig 2 
The effect of Prostaglandins and monocytic producta on secretion 
of fibrinogen in primary culture of rat hepatocytes into culture 
medium in the presence of 1 μΜ dexamethasone. Results were ob­
tained from determination of [ H]-leucine incorporated into im-
munoprecipitahle fibrinogen per цд cellular DNA and expressed as 
percentage of control value obtained 6 hours after addition of 
[ H]-]eucine. Monocytic products (end concentration 2П0 цд 
protein/ml culture medium) and prostaglandins were added as con­
centrated slock solutions. Data are averages of 3 experiments 
±S.D. 
The enhanced secretion of fibrinogen was also accompanied by an in­
creased content of fibrinogen polypeptide mRNAs. Addition of antiserum 
against the 15 KD MW protein component of these monocytic products 
lead to a normalization of fibrinogen secretion and of hepatocytic 
fibrinogen uRNA content (manuscript submitted). To examine wether this 
stimulatory effect of monocytic products (or interleukin-1) on the 
fibrinogen synthesis is mediated by the formation of prostaglandins, 
experiments were also performed in vivo and in vitro by prior and 
simultaneous administration of indomethacin and naproxen, potent inhi­
bitors of cyclooxygenase, a key enzyme in the synthesis of prostaglan­
dins. As shown in figure 3 and table 2 administration of indomethacin 
as a representative inhibitor of cyclooxygenase in various doses and 
various time intervals prior to and simultaneous with the injection 
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of monocytic products (see materials and methods) in rats, did not 
lead to a reduction of the elpvated plasma fibrinogen concentration 
and of the increased content of the fibrinogen polypeptide mRNAs con­
tent.This lack of an inhibitory effect of indomethacin and naproxen as 
cyclooxyqenase inhibitors on the monocytic products (interleukin-1) 
induced stimulation of fibrinogen synthesis and its mRNA's contents, 
was also observed in un vitro experiments using rat hepatocytes in 
primary cultures as shown in table 3. 
Table 2 Concentrations of ріазиа fibrinogen in rats 12 hr after 
injection of teatsubstances 
Treatment 
saline (1 ml; i.p.) 
indomethacin (0.2 mg) 
monocytic products (1 mg; i.p.) 
monocytic products (3 mg; i.p.) 
indomethacin (0.2 mg) simultaneously 
with monocytic products (1 mg; i.p.) 
indomethacin (0.2 mg) simultaneously 
with monocytic products (3 mg; i.p.) 
indomethacin (2x0.2 mq) 9 hr prior to and 
simultaneously with monocytic products (1 mq; i.p.) 4.2 i 0.3 
indomethacin (7x0.2 mg) over 3 days prior to and 
simultaneously with monocytic products (1 mg; i.p.) 4.3 i 0.2 
Data are expressed as the average of at least three experiments 
with 4 rats per experiment tS.D. As compared to the controle 
value, the increased fibrinogen concentrations are statistically 
significant (p<0.001; Student's t-test) 
fibrinogen (mq/ml) 
2.9 Í 0.3 
2.7 ± 0.4 N.S 
4.1 t 0.5 
4.7 ± 0.6 
4.3 t 0.10 
4.5 ± 0.3 
-113-
Table 3 Influence of indomethacin and naproxen on the induction of 
fibrinogen secretion by monocytic products in primary cultu­
res of rat hepatocytes at T= 24 hours 
A. Indomethacin 
c o n t r o l 1.54 t 0.16 
indomethacin 0.04 μς/πιΐ 1.75 i 0.18 
indomethacin 0.1 μς/πιΐ 1.40 t 0.14 
indomethacin 4 μρ/πι] 1.46 t 0.15 
B. Naproxen 
control 1.63 ± 0.20 
naproxen 0.3 μρΛηΙ 1.48 t 0.18 
naproxen 1.0 μς/ιηΐ 1.68 ± 0.20 
naproxen 3.0 \iq/ml 1.56 t 0.19 
Data are expressed as the ratio of secreted fibrinogen in pre­
sence of indomethacin, naproxen or saline (control) and monocy­
tic products and secreted fibrinogen in presence of indomethacin 
or naproxen or saline (control) alone. Monocytic products were 
added as a concentrated stock solution to an end concentration 
of 200 μς protein per ml culture medium. 
Data are averages of at least 3 experiments ±5.D. Differences as 
compared to control values are not statistically significant 
(Student's t-test). 
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relative increase of fibrinogen polypeptide mRNA as % of control 
500 
¿.00 
300 
I I saline (1 ml) 
|%%| mdomethacin (0 2 mg) 
[ ' | monocytic products (1 mg) 
monocytic products (1 mg)· 
mdomethacin (02 mg) 
monocytic products (3 mg) 
monocytic products (3 mg)* 
mdomethacin (02 mg) 
Fiq.3 
Relative increase of fibrinogen polypeptide mRNA in rat liver in 
control animals and in animala treated with monocytic products, 
indomethacin or both, at 12 hours after administration of test 
substances. 
The relative change in polypeptide mRNAs levels was determined 
using hybridization data by comparison of the R0t1/2 value of 
RNA prepared from liver of control rats to the R0t1/2 values 
obtained from RNAs of livers of rats after treatment with test 
substances (R0t is the product of the initial RNA concentra-
tion in mol nucleotides per liter and time in seconds, assuming 
that A 2 6 0 ™ of 1.0 corresponds to 40 μς RNA per ml. R0t1/2 
is R0t value at 50% hybridization). Values are means ±S.D. 
(n=3). 
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DISCUSSION 
Infection, inflammation, tissue injury or neoplasms are often attended 
wilh d systemic reaction consisting of, amonqst others, a rise m body 
temperature, leukocytosis, activation of Τ and Η lymphocytes and an 
increased production of so called "acute phase" proteins by the liver. 
After years of investigation, it became clear that endogenous media­
tors such as endogenous pyrogen (EP), leukocytic endogenous mediator 
(LFM) and lymphocyte activating factor (LAF) play a key role in this 
acute phase reaction. Since EP, LEM and LAF appear to be closely rela­
ted and share many common physical properties and biological activi­
ties, the name interleukin-1 was introduced to indicate this family of 
polypeptides (23-26). 
Interleukin-1 induces in many different cell types the formation of 
prostaglandin E2. This phenomenon has been thought to be a general 
characteristic of interleukin-1 in exerting its influences in many 
physiological processes that characterize the acute phase reaction. 
On the central nervous system, the action of interleukin-1 is located 
primarily in the pre-optic anterior hypothalamus. Microinjections of 
interleukin-1 into this area result in fever (8,27) by induction of 
PGE2 synthesis in certain cells of this area (8,27,28). Administration 
of antipyretics that inhibit the synthesis of PGE2 from arachidonic 
acid lead to a suppression of interleukin-1 induced fever (8,28,29). 
Interleukin-1 is also involved in muscle wasting (proteolysis) during 
the acute phase reaction. The proteolysis is accompanied by increased 
levels of PGE2 and when indomethacin or other non-steroidal anti­
inflammatory drugs (NSAIO'S) are administered in the experiments with 
interleukin-1, PGE2 release and the rate of proteolysis decrease (9). 
Recently, it has also been shown, that addition of the cyclooxygenase 
inhibitor indomethacin to human synovial cells in culture, reversibly 
inhibited the interleukin-1 induced stimulation of cell-associated and 
extracellular plasminogen activator production (30). 
The above findings indicate that interleukin-1 induces physiological 
alterations by First stimulating the synthesis of PGE2. However, in 
this study we demonstrate that interleukin-1 induced stimulation of 
hepatic fibrinogen synthesis occurs without PGE2 involvement. The en­
hanced secretion or synthesis of fibrinogen and the increased content 
of fibrinogen mRNA induced by intprleukin-1 in vivo and in vitro, were 
not reversibly inhibited by the administration of the cyclooxygenase 
inhibitors: indomethacin or naproxen, at concentrations which are con­
sidered to completely block PGE2 synthesis. Furthermore administration 
of prostaglandin E2 in vivo and in vitro doeb not lead to an increased 
synthesis of fibrinogen and an elevated level of hepatocytic content 
of Fibrinogen mRNAs. These findings are consistent with the clinical 
observation which showed that indomethacin and other non-steroidal 
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anti-inflammatory drugs do not influence the plasma levels of fibrino-
gen and other acute phase proteins during the course of treatment in 
patients with rheumatoid arthritis (31, unpublished own observation). 
Further studies on the mode of action of interleukin-1 in inducing 
synthesis of fibrinogen in the liver remains reguired. 
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SUMMARY 
Previously, we have shown that the increased synthesis of fibrinogen 
and decreased synthesis of albumin during the acute phase response or 
after i.p. administration of monocytic products in rats are related to 
corresponding changes in liver cytoplasmic mRNA levels. In the present 
study, we investigated the possible molecular mechanism of these chan-
ges in mRNA levels. Using in vitro transcription assays of isolated 
rat liver nuclei, obtained from rats with turpentine induced inflamma-
tion, we demonstrated an enhanced transcription of the fibrinogen po-
lypeptide genes and a reduced transcription of the albumin gene. The 
changes in the fibrinogen polypeptide transcriptional rate were found 
to precede the change in albumin gene transcription. Furthermore, 
identical results were obtained after in vivo administration of mono-
cytic products, containing high levels of interleukin-1 activity. The-
se findings indicate that the altered synthesis of fibrinogen and al-
bumin during inflammation are regulated at the transcriptional level 
and are mediated by monocytic products (including interleukin-1). 
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INTRODUCTION 
During the acute phase response, plasma concentrations of a number of 
liver-derived proteins, including fibrinogen, are dramatically increa-
sed, whereas plasma concentrations of a relatively few proteins, in-
cluding albumin, are decreased (1,2). However, the molecular mechanism 
of the altered pattern of protein synthesis during the acute phase 
response is not yet entirely clarified. The increased synthesis of 
fibrinogen and decreased synthesis of serum albumin after intramuscu-
lar injection of turpentine, a model for inflammation, or intraperito-
neal administration of monocytic products, important mediators of the 
acute phase response, have been ascribed to changes in cytoplasmic 
mRNA levels coding for these proteins (3,4). Cytoplasmic mRNA levels 
in eukaryotic cells can be regulated al the level of transcription or 
by posttransenpt lonal mechanisms, such as differential processing of 
hnRNA, nucleocytoplasmic transport of processed mRNAs or changes in 
cytoplasmic mRNA stability (turn over rates). Determination of cyto-
plasmic mRNA levels alone, therefore, does not distinguish between 
these possibilities. To examine the possible changes in synthesis of 
mRNAs coding for fibrinogen polypeptides and albumin during inflamma-
tion, we determined the rate of transcription of the genes coding for 
these proteins, using isolated rat liver nuclei. Furthermore, we stu-
died the effects of monocytic products, contamina high levels of 
interleukin-1 activity, on the transcriptional rates of fibrinogen po-
lypeptide and albumin genes. 
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MATERIALS AND METHODS 
Animals: male Wistar rats (1ΒΠ-200 qr) were used throughout and main­
tained on standard punna chow and water ad libitum. For the acute in­
flammatory reaction, rats were injected intramuscularly with 1.0 ml of 
commercial turpentine 3-9 hrs prior to sacrifice. In other experi­
ments, monocytic products ( 3 mq protein) were administered intrapen-
toneally. In all experiments, rat liver nuclei were isolated at 9.00 
a.m. 
Preparation of monocytic products: monocytic products were prepared by 
incubation of activated macrophages, isolated from peritoneal exuda­
tes, induced by glycogen in New Zealand white rabbits, as described by 
Ritchie and Fuller (5). These preparations were endotoxin free as de­
termined by a Limulus assay and contained high levels of IL-1 activity 
as determined by the thymocyte proliferation assay. 
Thymocyte proliferation assay of Gery et al (6) was performed as des­
cribed previously (3). Briefly, thymocytes were isolated from CBA mice 
Caged 6-12 weeks) and suspended in RPMI 1640 DM medium supplemented 
with 5% (v/v) fetal calf serum, 2 mM L-qlutamine and antibiotics. 50 
μΐ suspension (corresponding to 10 thymocytes) were incubated with 50 
μΐ testsubstance and 50 μΐ medium containing phytohaemagglut m m ( 5 
μς/ηιΐ) and 2-mercaptoethanol (6x10 M) in 96-well microtiter plates. 
After 48 hr, 0.5 μCl [б- Η] thymidine was added to each well and cells 
were further incubated for 24 hr after which cells were harvested and 
assayed for incorporated radioactivity. 
Isolation of liver nuclei. 
Liver nuclei were isolated according to the method of Marzluff et al 
(7). Briefly, livers were perfused in situ with a solution containing 
0.14 M NaCl, 0.3 mg/ml heparin and 10 mM Tris.HCl pH B.O. After perfu­
sion, 6 gr liver tissue was mixed and homogenised with a dounce homo-
geniser with loose fitting pestle in a buffer containing 0.32 M sucro­
se, 3.0 mM СаСІ2, 2.0 mM Mg-acetate, 0.1 mM EDTA, 0.1 mM phenylmethyl-
sulfonylfluonde, 1.0 mM dithiothrei tol, О.П Triton X-100 and 10 mM 
Tris. HCl pH 8.0, followed by passage through a 250 μπι nylon gauze and 
homogemsation with a dounce homogemser with tight fitting pestle. 
The resulting homogenate was diluted with 2 volumes of a buffer con­
taining 2.0 M sucrose, 50 mM Mg-acetate, 0.1 mM EDTA, 0.1 mM phenyl-
methylsulfonylfluoride, 1.0 mM diLhiothreitol and 10 mM Tris.HCl pH 
8.0, layered on a 2.0 M sucrose cushion in the same buffer and centn-
fugated for 1 hr at 30.000 g. The pellet was resuspended in a buffer 
containing 25% glycerol, 5.0 mM Mg-acetate, 0.1 mM EDTA, 0.1 mM phe-
nylmethylsulfonylfluoride, 5.0 mM dithiothreitol and 50 mM Tris.HCl pH 
8.0, centrifugated for 1 hr at 30.000 g and resuspended in the same 
buffer. All procedures were carried out at ¿PC. 
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In v i l го t r a n s c r i p t i o n o f i s o l a t e d n u c l e i and h y b r i d i s a t i o n . 
In v i t r o t r a n s c r i p t i o n experiments were performed as descr ibed by 
M a r z l u f f et al ( 7 ) . In a t y p i c a l exper iment , 50х1П n u c l e i were i n c u ­
bated in 800 μΐ o f a s o l u t i o n c o n t a i m n q 0.5 mM ATP, 0.5 mM CTP, 0.5 
mM UTP, 0.12 4 KCl, 2.6 mM Mq-acetate, 2.5 mq/ml c r e a t i n phosphate, 
0.6 mq/ml c r e a t i n k inase and 80 μΟι q u a n o s i n e - 5 1 - a - [ P ] - t r i p h o s p h a t e . 
I n c u b a t i o n s were c a r r i e d out f o r 30 m m . at 30PC. The r e a c t i o n was 
stopped by a d d i t i o n o f 10 volumes o f a s o l u t i o n c o n t a i n i n g О.П SOS 
and 50 mM EDTA pH 7 . 0 . RNA was e x t r a c t e d , p r e c i p i t a t e d and p u r i f i e d as 
d e s c r i b e d by M a r z l u f f et al (7) and f i n a l l y d i s s o l v e d i n 400 μΐ 10 mM 
T r i s . H C l pH 6 . 9 . Hybond nylon f i l t e r s , c o n t a i n i n g 3 μο DNA per c lone 
were p r e h y b r i d i z e d w i t h 0.25 M sodium phosphate, 7S SDS, 1 mM EDTA and 
O.To bovine serum albumin f o r 30 mm at б^РС. F i l t e r s were h y b r i d i z e d 
w i t h [ P ] - l a b e l e d RNA t r a n s c r i p t s i n the same s o l u t i o n f o r 4B hr at 
65 0 C. A f t e r h y b r i d i z a t i o n , f i l t e r s were washed 4 t imes 20 mm at 7(PC 
w i t h 1.5 ml o f a s o l u t i o n composed of П SDS, 1 mM EDTA pH 7.0 and, 
r e s p e c t i v e l y , 0.25 M, 0.125 M, 0.05 M and 0.025 M sodium phosphate. 
A f t e r washinq, h y b r i d i z e d m a t e r i a l was e l u t e d w i t h a s o l u t i o n c o n t a i ­
m n q 9B% formamide, 0.21S SDS and 10 μο/πι] E.Coli tRNA and assayed f o r 
r a d i o a c t i v i t y . A l t e r n a t i v e l y , i n some experiments f i l t e r s were a u t o r a -
d i o g r a p h e d . 
cDNAs and s p o t t i n g o f cDNAs onto f i l t e r s . 
pBR 322 plasmids c o n t a i m n q cDNAs coding f o r the α, β and γ chains o f 
rat f i b r i n o g e n were a k i n d g i f t o f Dr. G.R. Crabtree (Laboratory o f 
Pathology, NIH, Bethesda, Md). The c h a r a c t e r i s t i c s of these plasmids 
were d e s c r i b e d p r e v i o u s l y ( 8 ) . pBR 322 plasmid c o n t a i n i n g rat albumin 
cDNA has been d e s c r i b e d p r e v i o u s l y ( 9 ) . pBR 322 plasmid DNA c o n t a i m n q 
i n s e r t s were i m m o b i l i z e d on Hybond-N n y l o n f i l t e r s according t o the 
m a n u f a c t u r e r ' s manual. B r i e f l y , 3 μq DNA i n 10 μΐ of a b u f f e r composed 
o" 10 mM T r i s . t K l pH 7.5 and 1.0 mM EDTA was s p o t t e d on the n y l o n f i l ­
t e r . DNA was denatured by a l k a l i t reatment ( 2 . 5 M NaTl, 0.5 M NaOH), 
f o l l o w e d by n e u t r a l i s a t i o n ( 3 . 0 M NaAc pH 5 . 5 ) , baked f o r 2 hr at 
8fPC, f o l l o w e d by UV i r r a d i a t i o n f o r 5 m m . 
Materials 
Guanosine-S'-i-f^Pj-triphosphate (410 Ci/mmol), [6-3H]-thymidine (22 
Ci/mmol) and Hybond-N nylon membranes were obtained from the Radioche­
mical Centre, Amersham. ATP, CTP, UTP, GTP, creatin phosphate, creatin 
kinase, bovine serum albumin and E.Coli tRNA were from Boehrmqer 
Mannheim. Oyster qlycoqen type III, heparin from porcine intestinal 
mucosa and dithiothreitol were from Sigma Co- Triton X-100 was from 
BDH Chemicals. Formamide was purchased from J.T. Baker Chemicals. 
Ribonuclease free sucrose, phenol, chloroform, EDTA, salts and sol­
vents were from E. Merck. G50-sephadex was from Pharmacia. SDS was 
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obtained from Biorad Laboratories and phytohaemagqlutinin from 
Wellcome Diagnostics. For autoradiography, Kodak XAR-2 films were 
used. 
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RTSULTS AND DISCUSSION 
Usino an РХ;ІРГiinental model of inflammation in rats wc have previously 
shown that plasma fibnnnnen concentration and hepatic mRNA content 
are markedly increased (4). Tn contrast, serum albumin concentration 
and hepatic mRNA content are decreased (3). To further elucidate the 
regulation of fibrinogen and albumin synthesis during inflammation and 
to determine whether the changes in hepatic mRNA content under these 
circumstances are the result of corresponding chanaes in transcriptio­
nal rates of these nenes or the result of post t ransenpt lonal regula­
tory mechanisms, we performed in vitro transcription experiments using 
isolated rat liver nuclei. The results, presented in table 1 and figu­
re 1 demonstrate that transcription of the fibrinogen polypeptide 
(a,p.γ) genes was dramatically increased after in vivo administration 
of turpentine. The maximal induction was found between 3 and 6 hr and 
transcriptional rates were still significantly elevated 9 hr after 
turpentine treatment. In contrast, transcription of the albumin gene 
was flffo of control value 3 hr after turpentine treatment and was still 
further depressed at 6 hr and 9 hr (ca. 20% of control value) after 
turpentine treatment. 
Table 1 Relative transcriptional rates of fibrinogen polypeptide and 
albumin genes after turpentine treatment 
control value- time after turpentine treatment 
background 'dpm) (ΐ of control) 
3 hr 6 hr 9 hr 
Albumin 
Fibrinogen 
Fibrinogen 
Fibrinogen 
Background 
α-chain 
ß-chain 
γ-chain 
(pBR 322) 
639 ± 
209 t 
2Π9 t 
24(1 t 
47 + 
124 
34 
29 
41 
21 
flO ± 12 
885 h 142 
856 t 1П4 
705 i 100 
21 t 8 
779 t 118 
769 t 124 
727 ± 109 
18 t 10 
508 t 117 
506 i 101 
453 t 89 
Data are means ± S.D. of three experiments. 
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1 2 3 4 5 
Fig. 1 
Autoradiogram of radiolabeled transcripts of fibrinogen polypep­
tide and albumin penes prepared from isolated rat liver nuclei 9 
hr after turpentine treatment. ['2p ]_]
a
beled RNA transcripts 
were hybridized and washed as described in Materials and Methods 
and exposed to Kodak XAR-2 film for 2A hr at - СРС. Legend: 1; 
fibrinogen ot-chain; 2: fibrinogen ß-chain: 3: fibrinogen γ-
chain: 4: albumin: 5: nonrecombinant pBR 322. Upper row: con­
trol; lower row: after turpentine treatment. The results show an 
increased transcriptional rate of fibrinogen polypeptide genes 
and a decreased rate of albumin gene transcription 
The results presented in table 1 are in accordance with previous fin­
dings (3,4): after turpentine treatment, fibrinogen polypeptide mRNA 
content of rat liver rises at 6 hr (1505Í) and is maximally elevated at 
24 hr (8005!) and still above control values at 48 hr (150%). Likewise, 
fibrinogen plasma concentration increases at 12 hr, reaching a maximum 
at 36 hr and is still elevated at 72 hr. In contrast, albumin mRNA 
content declines at 9 hr (85") and is minimal at 12 hr (45S0 and still 
reduced at 72 hr {67%). However, serum albumin concentration is only 
moderately depressed, probably as a conseguence of the relatively long 
half life of albumin in the circulation. As shown in table 1, the 
transcriptional rates of the different fibrinogen polypeptide genes 
are increased to the same extent at any time after induction. These 
findings indicate that a common mechanism regulates the transcriptio-
nal rate of these three different genes as has also been reported for 
the increase of fibrinogen polypeptide mRNAs, following defibrination 
with snake venom (10). Modulation of protein synthesis as a conseguen-
ce of changes at the transcriptional level has been observed for hor-
monally regulated, developmentally regulated and tissue-specific genes 
(11-14). Recently, it has been demonstrated that the enhanced synthe-
sis and increased mRNA levels of the acute phase proteins C-reactive 
protein, complement factor 3 and serum amyloid A protein during in-
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flammation an· regulated at I he transcriptional level '15). Transcrip­
tional regulation oF acute phase proteins has also been shown For іц-
ndjor acute phase protein, transFerrin, !i2-qlobul in, ai-acid alycopro-
tein and aj-mai. roqlobul in, although these authors do not exclude pos­
sible additional posttranscript lonal mechanisms m the regulation oF 
the latter two proteins (16). Regulation oF protein synthesis at the 
post transcriptlonal level has been observed For vitellogenin (17), 
growth hormone (18) and the 1 iver-speciFie proteins albumin and αι-
antitrypsin (19). In these examples, cytoplasmic mRNA stability is re­
gulated by hormones. In this respect it is interesting to note that 
Piccoletti et al observed an increased synthesis of pre-ribosomal RNA 
and pre-mRNA and an increased activity of cytoplasmic soluble Factors, 
participating in translation oF RNA during inflammation (20), sugges­
ting that both transcriptional and post transcriptlonal regulatory me­
chanisms operate in the regulation of acute phase protein synthesis. 
In addition, these authors also demonstrated an increased methylation 
and nucleocytoplasmic transport of ribosomal RNA in rats during in­
flammation, again indicating the importance of posttranscriptlonal re­
gulatory mechanisms '21). The data presented in table 1 and Fig. 1 in­
dicate that the changes in Fibrinogen polypeptide and albumin mRNA 
content in the liver during inflammation are predominantly reoulated 
at the transcriptional level, although additional posttranscripttonal 
regulatory mechanisms, aFFectinq nucleocytoplasmic transport oF pro­
cessed mRNA and ribosomal RNA and changes in mRNA translation and sta­
bility might also be involved (20,21). Both magnitude and time course 
of the changes in transcriptional rates are in good agreement with the 
observed changes in hepatic mRNA content coding For Fibrinogen poly­
peptides and albumin (3,4). 
Numerous studies have demonstrated that monocytic products, especially 
interleukin-1, are important mediators For the acute phase response 
'2,22). Previously, we hdve also shown that monocytic products, con­
taining high levels oF interleukin-1 activity as assayed by the thymo­
cyte proliFeration assay (table 2), increase Fibrinogen synthesis and 
mRNA content and decrease albumin synthesis and mRNA content both in 
vivo and in vitro (4, manuscript submitted). To assess whether these 
changes are also regulated at the transcriptional level, in this study 
we have also determined transcriptional rates oF Fibrinogen oolypepti-
de and albumin genes aFter administration of monocytic products to 
rats (i.p.1. 
The results presented in table 3 show that the changes in transcripti­
onal rates of the fibrinogen polypeptide and albumin genes after admi­
nistration of monocytic products are similar to the changes after tur­
pentine treatment. From these findings we can therefore conclude that 
the synthesis oF Fibrinogen and albumin during the acute phase respon­
se are predominantly regulated at the transcriptional level. In addi-
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tion monocytic products, containing high levels of IL-1 activity lead 
to similar changes in transcriptional rates, indicating the importance 
of these monocytic products in the mediation of the acute phase res­
ponse , 
Table 2 Interleukin-1 activity of monocytic products as determined by 
the thymocyte proliferation assay (see Materials and 
Methods). 
cpm [б-'н]thymidine incorporated 
into 10е thymocytes 
Sal ine 
Monocytic products 
(1:10 diluted in saline) 
134 ± 58 
20.973 ± 325Θ 
Table 3 Relative transcriptional rates of fibrinogen polypeptide and 
albumin genes in isolated rat liver nuclei 9 hr after admini­
stration of monocytic products ( 3 mg). 
control value-
background (dpm) 
relative transcriptio­
nal rate as % of control 
Albumin 704 ± 132 
Fibrinogen α-chain 20Θ t 42 
Fibrinogen ß-chain 237 ì 36 
Fibrinogen γ-chain 314 t 49 
Background (pBR 322) 41 ± 22 
31 ± 13 
576 t 9B 
527 ± 77 
489 ± 91 
Data are means ± S.D. of three experiments. 
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SUMMARY 
During tissue injury, a coordinated seguence of metabolic alterations 
occurs in an organism. This complex of changes in metabolism is called 
the acute phase response. One of the characteristic phenomena of the 
acute phase response is the rapid rise of plasma concentrations of a 
number of proteins, synthesized by the liver: the acute phase pro-
teins, including fibrinogen, while plasma concentrations of relatively 
few proteins, including albumin, is decreased. In chapter I, the vari-
ous aspects of the acute phase response are discussed, with special 
emphasis on the changes in synthesis of fibrinogen and albumin. 
Although numerous studies on the synthesis of these proteins during 
the acute phase response have been performed, detailed knowledge about 
the regulation of the synthesis of these proteins is still scarce. 
Several possible mediators of the acute phase response have been pro-
posed, including hormones, notably glucocorticoids, fibrin- and fibri-
nogen-degradation products, free fatty acids and monocytic products, 
especially interleukin-1 (11-1). In chapter I, an extensive review of 
the literature on IL-1 is therefore presented. 
In chapter II, the possible role of glucocorticoids in the regulation 
of the synthesis of fibrinogen and albumin was studied. During the 
acute phase response, elevated plasma concentrations of these hormones 
are observed, suggesting an important role of these hormones in the 
acute phase response. To study the influence of glucocorticoids on the 
synthesis of fibrinogen and albumin, concentrations of mRNAs coding 
for these proteins were determined, both in vivo in rat liver and in 
vitro in suspension cultures of isolated hepatocytes. Furthermore, 
plasma concentrations and secretion of these proteins in suspension 
cultures of rat hepatocytes were measured. It was shown that in vivo 
glucocorticoids do not influence plasma concentrations and mRNA levels 
of fibrinogen and albumin in a wide range of doses tested. In con-
trast, in suspension cultures of hepatocytes, glucocorticoids were 
able to significantly increase the secretion and hepatocytic mRNA con-
centration of fibrinogen in a dose dependent manner. The secretion of 
albumin was only slightly stimulated by glucocorticoids, although glu-
cocorticoids were found to prevent the decline of albumin mRNA level 
in hepatocytes in suspension cultures in the absence of glucocorti-
coids. These results indicate that a differential regulation of the 
synthesis of fibrinogen and albumin exists in suspension cultures of 
hepatocytes. Furthermore it can be concluded that glucocorticoids are 
not the (sole) regulatory factor responsible for the changes in syn-
thesis of fibrinogen and albumin during the acute phase response. A 
(permissive) role in cooperation with other mediator(s) cannot be ex-
cluded. 
Conflicting results exist with regard to the role of fibrin- and 
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fibrinogen-degradation products in the regulation of fibrinogen syn­
thesis. In chapter III, the influence of these degradation products on 
plasma fibrinogen concentrations and fibrinogen mRNA levels in rat 
liver was studied. It was shown that both the early fibrinogen degra­
dation products X and Y and the late degradation products D and E as 
well as the fibrin degradation product E' were able to increase plasma 
fibrinogen concentration and fibrinogen mRNA level in the liver. The 
degradation products Χ, Y and D are in this respect more effective 
than the degradation products E and E'. Native fibrinogen and the 
fibrin degradation product D-dimer were found to be ineffective in 
stimulating the fibrinogen synthesis. These latter proteins are dis­
tinct from the other degradation products in possessing antiparallel 
cross-linking of the carboxy-terminals of the fibrinogen γ-chains, 
suggesting that the active site responsible for the stimulating effect 
is located in this region. To determine whether the effects of the de­
gradation products were due to a direct action on heoatocytes, experi­
ments were performed employing hepatocytes in monolayer culture. Incu­
bation of these hepatocytes with fibrinogen- and fibrin degradation 
products had no effect on the synthesis of fibrinogen, indicating that 
the induction of fibrinogen synthesis by these degradation products 
involves a second mediator. Chapter IVa and IVb describe the investi­
gations on the possible role of monocytic products and IL-1 on the 
synthesis of fibrinogen and albumin. Monocytic products, particularly 
IL-1 (a 15 kD mol. weight protein in rabbits) are considered to be im­
portant mediators of the acute phase response. It was found that 
fibrinogen plasma concentration and mRNA content in the liver increa­
sed significantly after intraperitoneal administration of monocytic 
products to rats. In contrast, albumin mRNA content was markedly redu­
ced. Serum albumin concentration decreased only slightly, probably as 
a conseguence of the relatively long halflife of serum albumin. 
Furthermore it was shown that a polyvalent antibody raised against the 
15 kD component of monocytic products, was able to partially abolish 
the increase in plasma fibrinogen concentration and fibrinogen mRNA 
level in the liver during experimental inflammation. The monocytic 
products contained high levels of IL-1 activity, as determined in the 
thymocyte proliferation assay, which could be completely blocked by 
addition of the polyvalent antibody against the 15 kD component of 
monocytic products. More extensive characterisation of the antibody by 
immunoblotting experiments revealed that this antibody recognized not 
only the 15 kD component, but, in addition, components with apparent 
molecular weights of 34 kD, 24 kD and 6 kD in agreement with previous 
reports in literature. These components probably represent (interme­
diate) precursors and a proteolytic degradation product of IL-1. In 
vitro experiments, employing monolayer cultures of hepatocytes showed 
identical results, although the presence of 1 μΜ dexamethasone, a syn-
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thetic glucocorticoid, was required to obtain the maximal effect, sug­
gesting a permissive role of glucocorticoids in the IL-1 induced chan­
ges of the synthesis of fibrinogen and albumin. Addition of the mono­
cytic products to the incubation medium of these cultured hepatocytes 
led to a significant increase of fibrinogen secretion and fibrinogen 
mRNA content in hepatocytes, while albumin secretion and hepatocytic 
albumin mRNA level decreased markedly. Additon of the polyvalent anti­
body against the 15 kD component of monocytic products to the incuba­
tion medium led to a complete normalisation of fibrinogen and albumin 
secretion and hepatocytic mRNA levels. Identical results were obtained 
with a commercial purified IL-1 preparation. These results point to an 
important role of monocytic products, especially IL-1, in the regula­
tion of the synthesis of fibrinogen and albumin during the acute phase 
response. The influence of monocytic products on the synthesis of al­
bumin was also studied in monolayer cultures of hepatocytes isolated 
from human liver tissue and cultured on a substratum of homologous ex­
tracellular matrix. The results of this study, described in chapter 
IVc, were in accordance with the findings observed in experiments 
using rodent hepatocytes, indicating that in man monocytic products 
also play an important role in the regulation of albumin synthesis 
during inflammation and that this culture system of human hepatocytes 
provide a useful model for the study of metabolic processes in the 
human liver. In addition, in chapter IVb, it was shown that in 
patients with inflammatory diseases and hypoalbuminaemia, albumin syn­
thesis decreased significantly. Experiments performed with cocultures 
of human hepatocytes and human adherent blood monocytes showed that 
addition of endotoxin, a potent inducer of IL-1 production by mononu­
clear cells, led to a significant decrease of albumin secretion. Iden­
tical results were observed after addition of conditioned medium ob­
tained from endotoxin-stimulated human adherent monocytes, whereas ad­
dition of endotoxin to monolayer cultures of human hepatocytes in ab­
sence of adherent monocytes or conditioned medium from non-stimulated 
monocytes did not reduce albumin secretion. 
Many studies have shown that IL-1 exerts its effects by inducing the 
production of prostaglandins from arachidomc acid present in plasma 
membranes via the cyclo-oxygenase pathway. Such a mechanism has been 
found in the induction of fever in the hypothalamus and the induction 
of protein catabolism in skeletal muscle cells. To investigate whether 
this mechanism іэ also responsible for the monocytic products (IL-1) 
induced stimulation of hepatic fibrinogen synthesis, experiments were 
also performed to examine the influence of prostaglandins on fibrino­
gen synthesis and described in chapter IVd. Prostaglandins (PGE2, 
PGF2
a
 and 16,16-dimethyl-PGE2) both in vivo and in vitro had no in­
fluence on plasma fibrinogen concentrations and fibrinogen mRNA con­
tent in the liver and the secretion of fibrinogen and hepatocytic mRNA 
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content. Furthermore it was shown that the monocytic products induced 
stimulation of fibrinoqen synthesis could not be prevented by the non-
steroidal antiinflammatory drugs indomethacin and naproxen, potent in-
hibitors of the cyclo-oxygenase pathway, both in vivo and in vitro, 
suggesting that the IL-1 induced stimulation of hepatic fibrinogen 
synthesis is not mediated via the production of prostaglandins. 
Chapter V describes the experiments performed to elucidate the mecha-
nism involved in the regulation of fibrinogen and albumin mRNA levels 
during the acute phase response. For this purpose, in vitro transcrip-
tion experiments using isolated nuclei' were carried out. The results 
show that the enhanced fibrinogen synthesis and the reduced albumin 
synthesis during the acute phase response or after administration of 
monocytic products is regulated at the transcriptional level. 
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Samenvatting 
Tijdens een weefselbeschadiging treedt er in het lichaam een gecoördi-
neerde serie metabole veranderingen op. Dit gehele complex van veran-
deringen wordt de acuut-fasereactie genoemd. Een karakteristiek onder-
deel van de acuut-fasereactie is de snelle toename van de plasmacon-
centraties van een aantal door de lever gesynthetiseerde eiwitten, de 
acuut-fase-eiwitten, waaronder fibnnogeen, terwijl de plasmaconcen-
tratie van enkele eiwitten, waaronder albumine verlaagd is. In hoofd-
stuk I worden de diverse aspecten van de acuut-fasereactie beschreven, 
met bijzondere aandacht voor de veranderingen in plasmaconcentraties 
en synthese van fibrinogen en albumine. Hoewel reeds veel bekend is 
over de synthese van fibnnogeen en albumine tijdens de acuut-fase-
reactie, ontbreekt het nog aan kennis omtrent de moleculaire regulatie 
van de synthese van deze eiwitten tijdens de acuut-fasereactie en ken-
nis omtrent de mogelijke mediator(en). 
Naast hormonen, met name glucocorticoïden, worden fibrine- en fibrino-
geen-afbraakproducten, vrije vetzuren en vooral interleukine-1, een 
monocytair eiwit, genoemd als mediatoren van de acuut-fasereactie. In 
hoofdstuk I wordt dan ook een uitgebreid overzicht gegeven van de hui-
dige kennis over interleukine-1. 
In hoofdstuk II wordt de mogelijke rol van glucocorticoïden in de re-
gulatie van de synthese van fibnnogeen en albumine bestudeerd. Tij-
dens de acuut-fasereactie worden verhoogde plasmaconcentraties van de-
ze hormonen gevonden, hetgeen suggereert dat die hormonen een belang-
rijke rol kunnen spelen als mediatoren. Om de invloed van glucocorti-
coïden op de synthese van fibnnogeen en albumine te onderzoeken, werd 
de concentratie mRNAs, coderend voor deze eiwitten, bepaald in vivo in 
rat lever en in vitro in suspensiekweken van geïsoleerde ratte-hepato-
cyten. Tevens werden de plasmaconcentraties en secretie in suspensie-
kweken van deze eiwitten bepaald. Het blijkt dat de onderzochte gluco-
corticoïden (cortisol, corticosteron en het synthetische glucocorti-
coid dexamethason) in vivo, in diverse doseringen (5 цд tot 10 mg per 
rat) geen invloed hebben op de plasmaconcentraties en mRNA-gehaltes in 
de lever van fibnnogeen en albumine. In vitro, in suspensiekweken van 
geïsoleerde hepatocyten werd gevonden dat glucocorticoïden de fibrmo-
geensecretie en fibnnogeen-mRNA-concentratie, op een dosis-afhanke-
lijke wijze, in hepatocyten kunnen verhogen. 
De albuminesecretie daarentegen neemt slechts licht toe na toevoeging 
van glucocorticoïden, hoewel glucocorticoïden de afname van het albu-
mine-mRNA-qehalte welke optreedt in afwezigheid van glucocorticoïden, 
weten te voorkomen. Deze resultaten duiden op een different le'le regu-
latie van de synthese van fibnnogeen en albumine door glucocorticoï-
den: een specifiek inducerend effect op de fibnnogeensynthese en een 
stabiliserend effect op het albumine-mRNA. Bovendien kan uit deze re-
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sulfaten qpconrludeprd worden dat glucocorticoiden niet de (enigen me-
dierendp factor zijn voor de veranderingen van de synthese van fibri-
ηοηρρπ en albumine tijdpns de dcuut-fasereactie, hoewel pen (permis-
тір е^ rol in sampnwerkinq mp| dndere mediatoren niet uitgesloten is. 
In dp literdtuiir bestaan tegenstrijdige bevindingen met betrekking tot 
de rol van fibrine- en fibnnoqeen-afbraakproductpn op de fibnnogpen-
4yfithp4e. In hoofdstuk III wordt de invloed nagegaan van deze afbraak­
producten op de fibnnoqeen plasmaconcentrat les en mRNA-qehaltes in de 
lever na int râpent oneale toedieninq van deze producten aan ratten. 
Het blijkt dat zowel de vroege fibnnogeen-afbraakproducten X en Y als 
de late afbraakproductpn D en E alsmede het fibnne-afbraakproduct E' 
in staat zijn de fibrinoqeen-plasmaconcentratie en fibnnogeen-mRNA-
gehalte in dp lever te verhogen. De afbraakproducten X, Y en D zijn 
wat betreft dit stimulerend effect sterker dan E en E'. Intact fibn-
nogeen en het fibnne-afbraakproduct D-dimeer hebben geen enkel effect 
op de plasmaconcentratie en mRNA-gehalte van fibnnogeen. Omdat intact 
fibnnogeen en D-dimeer zich onderscheiden van de biologisch actieve 
afbraakproducten door de aanwezigheid van antiparallele cross-1inking 
van de COOH-termim van de у-кеіепч is het aannemelijk te veronder­
stellen dat de 'active site' verantwoordelijk voor het stimulerend ef­
fect in deze regio gelegen is. Om vast te stellen of de effecten van 
de afbraakproducten berusten op een direct effect op de hepatocyten 
werden dp hepatocyten in monolayerkweken geïncubeerd met fibnnogeen-
afbraakproducten. Geen effect op de fibnnoqeensynthese en het fibn-
nogeen-mRNA-qehalte in hepatocyten kon in deze experimenten worden 
aangetoond, hetgeen suggereert dat de inductie van de fibnnogeensyn-
these door fibnnogeen-afbraakproducten, indirect via een secundaire 
mediator verloopt. 
Hoofdstuk IVa en IVb beschrijven de resultaten van het onderzoek naar 
de mogelijke rol van monocytaire producten, in het bijzonder interleu-
kine-1 (IL-1) op de fibnnoqeen- en albuminesynthese. Monocytaire pro-
ducten, in het bijzonder IL-1 (een eiwit met een MW van 15 kD in ko-
nijnen) worden beschouwd als belangrijke mediatoren van ontstekings-
reacties. Monocytaire producten, geïsoleerd uit peritoneale exudaat-
cellen van konijnen met een opgewekte steriele peritonitis blijken in 
vivo na intraperitoneale toediening in staat te zijn de fibnnogeen-
plasmaconcentratie en fibrinogeen-mRNA-gehalte in de lever sterk te 
verhogen, terwijl het albumine-mRNA-qehalte in de lever na toediening 
van de monocytaire producten sterk daalt. De albumine-serumconcentra-
tie neemt minder sterk af, waarschijnlijk als gevolg van de lange 
halfwaardetijd van albumine in serum. Ook bleek dat een polyvalent 
antilichaam opgewekt tegen de gezuiverde 15 kD-component van monocy-
taire producten in staat was de stimulatie van de fibrmogeen-plasma-
concentratie en -mRNA-gehalte in de lever tijdens een experimentele 
ontsteking opgewekt met terpentijn gedeeltelijk op te heffen. De ge-
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bruikte monocytaire producten bezaten een hoqe IL-1-activiteit bepaald 
in de thymocyten-proliferatie-assay, die volledig weggenomen kan wor­
den na incubatie van de monocytaire producten met het polyvalente 
antilichaam. Karakterisering van dit polyvalente antilichaam met be­
hulp van immunoblottinq-experimenten toonde aan dat dit antilichaam 
niet alleen de 15 kD-component van monocytaire producten herkende, 
maar tevens componenten met molecuulgewichten 34 kD, 24 kD en 6 kD in 
overeenstemmina met literatuurgegevens. Deze componenten zijn waar­
schijnlijk (intermediaire) precursors en afbraakproducten van IL-1. In 
vitro experimenten uitgevoerd met primaire kweken van rntte-hepatocy-
ten in monolayerkweek gaven dezelfde resultaten te zien, hoewel voor 
het maximale effect van monocytaire producten de aanwezigheid van 1 μΜ 
dexamethason een vereiste was, hetgeen een permissieve rol van gluco-
corticoïden in de IL-1 geïnduceerde veranderingen in de synthese van 
fibrinogeen en albumine impliceert. Toevoeging van monocytaire produc-
ten aan het incubâtlemediurn van de hepatocyten leidt tot een sterke 
toename van de fibnnogeensecretie en fibnnoqeen-mRNA-gehalte in he-
patocyten en een afname van de albumineaecretie en albumine-mRNA-qe-
halte. Toevoeging van het polyvalente antilichaam tegen de 15 kD-com-
ponent van monocytaire producten leidt tot een volledige normalisatie 
van de fibrinogeen- en albuminesecretie en mRNA-gehaltes in hepatocy-
ten. Identieke resultaten werden verkregen met een commercieel, ge-
zuiverd IL-1 preparaat. Deze resultaten duiden erop dat monocytaire 
producten, in het bijzonder IL-1, een belangrijke rol spelen in de re-
gulatie van de synthese van fibrinogeen en albumine tijdens de acuut-
fasereactie. 
De invloed van monocytaire producten op de synthese van albumine werd 
tevens onderzocht in primaire kweken van hepatocyten geïsoleerd uit 
humaan leverweefsel en gekweekt op een substraat van homologe extra-
cellulaire matrix, eveneens geïsoleerd uit humaan leverweefsel. De 
resultaten, beschreven in hoofdstuk IVc, laten zien dat monocytaire 
producten ook in monolayerkweken van humane hepatocyten in staat zijn 
de albuminesecretie sterk te verlagen, hetgeen een aanwijzing is dat 
monocytaire producten ook bij de mens een belangrijke rol spelen in de 
regulatie van de acuut-fase-eiwitsynthese. Bovendien bleek uit een 
studie bij patiënten met inflammatoire aandoeningen en een hypoalbu-
minaemie, beschreven in hoofdstuk IVb, dat de albuminesynthese signi-
ficant verlaagd is. Experimenten uitgevoerd met co-cultures van humane 
hepatocyten en humane adhérente mononucléaire bloedcellen toonden aan 
dat toevoeging van endotoxine, een potente inductor van IL-1-productie 
door mononucléaire bloedcellen, aan het incubatiemedium eveneens leidt 
tot een sterke afname van de albuminesecretie. Deze resultaten konden 
ook bereikt worden door toevoeging van geconditioneerd medium afkom-
stig van endotoxine-qestimuleerde humane mononucléaire bloedcellen aan 
monolayerkweken van humane hepatocyten. Toevoeging van endotoxine aan 
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monolayerkweken van humane hepatocyten in afwezigheid van mononuclé-
aire bloedcellen of geconditioneerd medium afkomstig van niet gestimu-
leerde mononucléaire cellen leidde met tot veranderingen in de albu-
minesecretie. Primaire kweken van humane hepatocyten bleken tevens in 
staat te zijn een scala aan acuut-fase-eiwitten te produceren, waar-
onder haptoglobine, fibrinogeen, <ц-апІitrypsine, aj-antichymotrypsine 
en m-acid glycoprotein, zodat deze monolayerkweken van humane hepa­
tocyten een geschikt model vormen voor de bestudering van metabole 
processen in de menselijke lever. 
Er zijn sterke aanwijzingen dat IL-1 zijn effecten uitoefent door de 
productie van Prostaglandines uit arachidonzuur, gelocaliseerd in 
plasmamembranen via de cyclo-oxyqenase pathway. Een dergelijk mecha­
nisme wordt aangetroffen bij de inductie van koorts door IL-1 in de 
hypothalamus en bij de inductie van eiwitcatabolisme in spiercellen. 
In hoofdstuk IVd is onderzocht of een dergelijk werkingsmechanisme ook 
geldt voor de inductie van de fibnnogeensynthese tijdens de acuut-
fasereactie. De invloed van verschillende Prostaglandines (PGE2, 
PGF2
a
 en 16,16-dimethyl-PGE2 op de fibrinoqeensecretie en fibrino-
geen-mRNA-qehaltes in de lever en op de fibrinoqeensecret ie en fibn-
nogeen-mRNA-gehaltes in hepatocyten werd onderzocht. Het bleek dat 
Prostaglandines zowel in vivo als in vitro qeen effect hebben op de 
fibnnoqeensynthese. Ook bleek dat de inductie van de fibrinogeensyn-
these en fibnnoqeen-mRNA-gehaltes door monocytaire producten, zowel 
in vivo als in vitro niet voorkomen kon worden door toediening van de 
non-steroïdale ontstekingsremmers indocid en naproxen, Inhibitoren van 
de cyclo-oxygenase pathway. Deze resultaten duiden erop dat de effec-
ten van IL-1 op hepatocyten niet gemedieerd worden via de productie 
van Prostaglandines. 
In hoofdstuk V wordt het onderzoek beschreven naar het niveau van de 
regulatie van de fibnnoqeen- en albuminesynthese tijdens de acuut-
fasereactie. Het onderzoek naar de transcriptie van de qenen coderend 
voor fibrinogeen en albumine werd uitgevoerd met behulp van in vitro 
transcriptie-experimenten met geïsoleerde kernen. De resultaten tonen 
aan dat de toename van de fibnnogeensynthese en de afname van de 
albuminesynthese tijdens de acuut-fasereactie en na toediening van 
monocytaire producten gereguleerd worden op transcnptioneel niveau. 
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CURRICULUM VITAE 
De auteur van dit proefschrift werd geboren op 31 januari 1959 te 
Goor. Na het behalen van het diploma Atheneum В in 1977 aan de Rijks­
scholengemeenschap te Lochern, werd in hetzelfde jaar begonnen met de 
studie scheikunde aan de Katholieke Universiteit te Nijmegen. In 
januari 1981 werd het kandidaatsexamen scheikunde (S2) behaald. Het 
doctoraalexamen, behaald in december 1963, omvatte het hoofdvak Bio­
chemie (Prof. Dr. H. Bloemendal) en de bijvakken Biofysische Chemie 
(Prof. Dr. C.W. Hilbers) en Cyto-Histologie (Prof. Dr. Chr. 
Jerusalem). Sinds december 19B3 19 hij als wetenschappelijk medewerker 
verbonden aan het laboratorium voor maag-, darm- en leverziekten van 
het St. Radboudziekenhuis te Nijmegen. Het onderzoek dat tot dit 
proefschrift leidde, werd uitgevoerd in de werkgroep van Dr. S.H. Yap. 
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